Operational Research for improving care of HIV-infected TB patients in India by Madhugiri Venkatachalaiah, A.K.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/200696
 
 
 
Please be advised that this information was generated on 2019-06-02 and may be subject to
change.
Presented by
Dr Ajay Kumar Madhugiri Venkatachalaiah
OPERATIONAL RESEARCH FOR IMPROVING 
CARE OF HIV-INFECTED TB PATIENTS IN INDIA
Supervisors: Professor Richard Dekhuijzen
 Professor Anthony D. Harries
 Dr Martin Boeree
 Dr Rony Zachariah
ISBN: 978-94-6380-214-7
Layout  Dennis Hendriks || ProefschriftMaken.nl
Printed by Digiforce || ProefschriftMaken.nl
Copyright © 2018, Dr Ajay Kumar Madhugiri Venkatachalaiah
All rights reserved. No part of this publication may be reproduced or transmitted in 
any form or by any means, electronic or mechanical, including photocopy, recording, 
or any information storage or retrieval system, without permission in writing from 
the author. 
Promotoren:
Prof. dr. P.N.R. Dekhuijzen
Prof. dr. A.D. Harries (London School of Hygiene and Tropical Medicine, Verenigd Koninkrijk)
Copromotoren:
Dr. M.J. Boeree
Dr. R. Zachariah (World Health Organization, Zwitserland)
Manuscriptcommissie:
Prof. dr. K. van der Velden
Prof. dr. M.W. Borgdorff (Amsterdam UMC)
Dr. M. van Cleeff (KNCV Tuberculosefonds)
OPERATIONAL RESEARCH FOR IMPROVING 
CARE OF HIV-INFECTED TB PATIENTS IN INDIA
Proefschrift
ter verkrijging van de graad van doctor
aan de Radboud Universiteit Nijmegen
op gezag van de rector magnificus prof. dr. J.H.J.M. van Krieken,
volgens besluit van het college van decanen
in het openbaar te verdedigen op maandag 25 Februari 2019
om 12.30 uur precies
door
Dr Ajay Kumar Madhugiri Venkatachalaiah
geboren op  15 maart 1977
te Bengaluru (India)
Supervisors:
Prof. dr. P.N.R. Dekhuijzen
Prof. dr. A.D. Harries (London School of Hygiene and Tropical Medicine, United Kingdom)
Co-supervisors:
Dr. M.J. Boeree
Dr. R. Zachariah (World Health Organization, Switzerland)
Doctoral Thesis Committee:
Prof. dr. K. van der Velden
Prof. dr. M.W. Borgdorff (Amsterdam UMC)
Dr. M. van Cleeff (KNCV Tuberculosis Foundation)
OPERATIONAL RESEARCH FOR IMPROVING 
CARE OF HIV-INFECTED TB PATIENTS IN INDIA
Doctoral Thesis
to obtain the degree of doctor 
from Radboud University Nijmegen 
on the authority of the Rector Magnificus prof. dr. J.H.J.M. van Krieken ,  
according to the decision of the Council of Deans 
to be defended in public on Monday, February 25, 2019 
at 12.30 hours 
by
Dr Ajay Kumar Madhugiri Venkatachalaiah
Born on March 15, 1977
in Bengaluru (India)

TABLE OF CONTENTS
 List of Acronyms 8
Chapter 1: Introduction and Outline of Thesis 11
Chapter 2: Will Adoption of the 2010 WHO ART Guidelines for HIV-Infected 
 TB Patients Increase the Demand for ART Services in India?  29
Chapter 3: HIV prevalence among persons suspected of tuberculosis: 
 policy implications for India.  43
Chapter 4: Feasibility and Effectiveness of Provider Initiated HIV Testing and    
 Counseling of TB Suspects in Vizianagaram District, South India.  57
Chapter 5: HIV Testing among Patients with Presumptive Tuberculosis:  
 How Do We Implement in a Routine Programmatic Setting?  
 Results of a Large Operational Research from India.  71
Chapter 6: Efficient, quality-assured data capture in operational research  
 through innovative use of open-access technology. 95
Chapter 7: Uptake of HIV testing and HIV positivity among presumptive  
 tuberculosis patients at Puducherry, South India. 103
Chapter 8: HIV-infected presumptive tuberculosis patients without tuberculosis:  
 how many are eligible for antiretroviral therapy in Karnataka, India?  113
Chapter 9: Does research through Structured Operational Research and Training  
 (SORT IT) courses impact policy and practice?  129
Chapter 10: Promoting operational research through fellowships: a case study  
 from the South-East Asia Union Office. 145
Chapter 11: Operational research capacity building in Asia: innovations,  
 successes and challenges of a training course.  179
Chapter 12: Operational research capacity building using 'The Union/MSF' model:  
 adapting as we go along.  189
Chapter 13: Discussion and Conclusion 199
 Summary 223
 Samenvatting 229
 Vote of Thanks 237
 About the Author 239
 Curriculum Vitae 240
 List of Publications 242
LIST OF ACRONYMS
AFB Acid Fast Bacillus
AIDS Acquired Immune Deficiency Syndrome 
ART Antiretroviral Therapy
ARTC ART Centre
BMCRI Bangalore Medical College and Research Institute
CD4 Cluster of Differentiation 4
CI Confidence Intervals
CNS Central Nervous System
CPT Cotrimoxazole Preventive Therapy 
DCC District Coordination Committees
DFID Department for International Development
DMC Designated Microscopy Centres 
DOT Direct Observation of Treatment
DOTS Directly Observed Treatment Short course
EPTB Extra-pulmonary tuberculosis
GFATM The Global Fund Against AIDS, Tuberculosis and Malaria 
HBV Hepatitis B Virus
HIV Human Immunodeficiency Virus
HRG High Risk Groups 
IC  Infection Control 
ICF Intensified Tuberculosis Case Finding 
ICTC Integrated Counselling and Testing Centre
IDU Intravenous Drug Users 
IPT Isoniazid Preventive Therapy 
IQR Inter Quartile Range
ISTC International Standards for TB Care 
JIPMER Jawaharlal Nehru Institute of Postgraduate Medical Education and Research 
LED FM Light Emitting Diode Fluorescent Microscopy
LT Laboratory Technician 
MDR TB Multidrug Resistant Tuberculosis
MMP Methadone Maintenance Programme
MPH Masters in Public Health
MSF Médecins Sans Frontières 
MTB Mycobacterium Tuberculosis
NACO National AIDS Control Organization 
NACP National AIDS Control Programme
NAICC National Airborne Infection Control Committee
NIRT National Institute for Research in Tuberculosis 
NNS Number Needed to Screen 
NTP National Tuberculosis Programme
NTWG National Technical Working Group 
OR Operational Research
OSE On Site Evaluation
PHI Peripheral Health Institutions
PI Principal Investigator
PID Patient Identification Digit 
PITC Provider-Initiated HIV Testing and Counselling 
PLHIV People living with HIV
PMDT Programmatic Management of Drug-resistant Tuberculosis
PMR Programme Management Report
PTB Pulmonary Tuberculosis
RNTCP Revised National Tuberculosis Control Programme
SACS State AIDS Control Societies 
SCC State Coordination Committees
SORT IT Structured Operational Research Training Initiative 
STCI Standards of TB care in India
STLS Senior TB laboratory supervisor 
STROBE Strengthening the Reporting of Observational Studies in Epidemiology
SWG State Working Group
TB Tuberculosis
The Union International Union Against Tuberculosis and Lung Disease 
UK United Kingdom
UNAIDS The Joint United Nations Programme on HIV/AIDS 
USAID United States Aid for International Development
USD United States Dollar
USEA The Union South-East Asia Office
VCT Voluntary HIV Counselling and Testing
WDF World Diabetes Foundation
WHO World Health Organization
WHO/TDR Special Programme for Research and Training in Tropical Diseases at the  
 World Health Organization 

1.
Introduction and Outline of Thesis 
CHAPTER 1
12
INTRODUCTION AND OUTLINE OF THESIS 
13
Ch
ap
te
r 1
This thesis describes operational research studies planned and conducted to improve 
the care and management of patients co-infected with Tuberculosis (TB) and Human 
Immunodeficiency Virus (HIV) in India between 2011 and 2015, particularly in relation 
to improving HIV testing among patients with presumptive TB and linking HIV-infected 
presumptive TB to antiretroviral therapy. The thesis also describes the overarching 
operational research capacity building initiative under which these studies were carried out, 
its evolution and impact on policy and practice.
GLOBAL BURDEN OF TUBERCULOSIS AND HIV 
Tuberculosis (TB) and the Human Immunodeficiency Virus (HIV) have probably taken more 
lives than any other infectious diseases in the history of humanity. Despite great progress 
over the years in the care of TB and HIV, they still remain the leading infectious causes of 
death globally.1,2 In 2015, an estimated 10.4 million patients fell ill with TB implying about 20 
new TB patients every minute! 1 About 1.8 million individuals with TB also died during the 
same year, translating to about 5000 deaths due to TB every day! 1 An estimated 1.2 million 
(11%) new TB cases occurred among people living with HIV (PLHIV) and 400,000 TB related 
deaths were among PLHIV. 1 With an estimated  pool of about 3 billion people with latent TB 
infection,1 the end of the TB epidemic remains rather far from sight. 
Globally, 36.7 million [34.0–39.8 million] people were living with HIV at the end of 
2015, and 1.1 million people died of HIV-related disease or the acquired immune deficiency 
syndrome (AIDS) in 2015.2 Tuberculosis and HIV act in deadly synergy. HIV infection increases 
the risk of progression from latent to active TB and from disease to death if HIV and TB are 
not treated in a timely manner.3 Further, the risk of TB recurrence is greater even if the patient 
is successfully treated. Similarly, TB remains the most common opportunistic infection and 
cause of mortality among PLHIV. There are challenges to diagnose and treat TB among PLHIV 
that include atypical clinical presentations which can lead to missed diagnoses, the high pill 
burden, co-toxicity of using several drugs simultaneously and drug-drug interactions.4  
There has been great progress with TB and HIV care over the years. It is estimated 
that TB treatment averted 49 million deaths between 2000 and 2015, and incidence and 
death rates fell during this period.1 Similarly, HIV incidence is declining in many parts of 
the world and access to antiretroviral therapy (ART) has increased several fold.2 The Joint 
United Nations Programme on HIV/AIDS (UNAIDS) estimates showed that more than 18 
million people were receiving ART in mid-2016. Buoyed by these developments, the global 
community has pledged to end the TB and AIDS epidemics by 2030 as part of the larger 
sustainable development goals.5 To achieve this, the World Health Organization (WHO)’s 
Global TB Programme has formulated an ‘End TB strategy’ with an overall vision of a TB-free 
world (meaning zero deaths, zero disease and zero suffering due to TB) and a goal of ending 
the TB epidemic (operationally defined as reducing the annual incidence of TB to 10 new 
cases per 100,000 population).6 Similarly, UNAIDS has provisionally defined ending the AIDS 
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epidemic as the reduction of new HIV infections, stigma and discrimination experienced by 
PLHIV and key populations, and AIDS-related deaths by 90% compared to 2010 levels.7 Both 
the TB and HIV worlds have set themselves ambitious 90-90-90 targets to achieve by 2020.8,9 
With respect to HIV, it means diagnosing 90% of estimated PLHIV, treating 90% of those 
diagnosed with HIV and achieving viral suppression in 90% of those treated with ART.8 In the 
case of TB, this means diagnosing and treating 90% of all people with TB (PWTB), including 
90% of the key populations at risk of TB, and achieving 90% treatment success for all people 
diagnosed with TB. 9 
BURDEN OF TUBERCULOSIS AND HIV IN INDIA
The global TB burden is primarily driven by the large absolute numbers in India. In 2015, an 
estimated 2.8 million people fell ill with TB in India thus accounting for 27% of the global 
TB burden. Similarly, about 480,000 people died due to TB in India accounting for one-third 
of global TB mortality.10 About 2.1 million people were estimated to be living with HIV in 
India (prevalence of 0.26%) in 2015 making the country home to the third largest number 
of PLHIV globally. The HIV epidemic in India is heterogenous and concentrated among high 
risk groups, but it is showing a declining trend, probably due to prevention and treatment 
strategies by the National AIDS Control Programme (NACP). According to recent estimates, 
86,000 new HIV infections occurred in 2015 in India, a decline of 66% compared to estimated 
numbers in 2000.10 With an estimated HIV prevalence of 5% among people with TB,11 India is 
home to the second largest number of HIV-infected TB patients in absolute terms (113,000), 
next only to South Africa (270,000), and accounts for about 10% of the global HIV-TB burden.1 
The number of deaths among HIV-TB patients was estimated at 37,000 in 2015.¹ 
The evolution and progress of TB-HIV collaborative activities in India has been 
showcased as a success story globally, particularly for a country with a concentrated HIV 
epidemic.12 As of now, India follows all the recommendations enshrined in the 2012 WHO 
global policy on TB-HIV collaborative activities,13 though the extent of implementation varies 
across the components.14 The basic mechanisms of collaboration between the national TB 
and HIV programmes in India are in place at all levels of the health service (national, state 
and district), and these include joint recording and reporting, joint monitoring and review. To 
quote a few performance indicators, the proportion of TB patients with a known HIV status 
was 67% which is higher than the global average of 55% while the proportion of HIV-TB 
patients receiving ART was 92% in India compared to 78% globally in 2015.1 Despite this, the 
death rate among HIV-infected TB patients continues to be high at about 13%.1 
SITUATIONAL ANALYSIS OF TUBERCULOSIS AND HIV IN INDIA IN 2010
Since this thesis consists of TB-HIV related operational research studies conducted in India 
during the period 2011-2015, we begin here by providing a brief overview of the evolution of 
TB-HIV care in India and analyse the situation in 2010 which stimulated and necessitated the 
conduct of these operational research studies.
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Although the numbers of people living with HIV and TB were slightly different to 
what they are today, India in 2010 was the highest TB burden country in the world and was 
home to the second highest number of HIV-infected TB patients globally. In addition to these 
high absolute numbers, an important and unique challenge was the huge variation in TB-HIV 
burden across the states and districts of the country. This heterogenous distribution of HIV-
associated TB continues to pose challenges in service delivery. 
EVOLUTION OF JOINT TB-HIV COLLABORATION IN INDIA
The milestones in the evolution of joint TB-HIV collaboration in India are described below 
and depicted in Figure 1. 
2001-2004
TB-HIV collaboration started in India in 2001, in six selected states of the country - 
Maharashtra, Manipur, Nagaland, Karnataka, Tamil Nadu and Andhra Pradesh (Figure 1). 
The early activities were primarily joint training of health staff in TB-HIV and cross-referrals 
(referral of people with presumptive TB among clients attending the HIV testing centres to 
the TB programme for diagnosis and treatment and vice versa).12 These activities were then 
extended to eight additional states (Delhi, Gujarat, Himachal Pradesh, Kerala, Orissa, Punjab, 
Rajasthan and West Bengal) in the year 2004. 
2005-2009
Several operational research studies conducted between 2005 and 2008 showed that i) 
it was feasible to implement intensified TB case finding in all HIV testing centres and ART 
centres, ii) it was feasible and acceptable to routinely offer HIV testing to TB patients under 
programmatic settings, and iii) it was feasible to provide cotrimoxazole preventive therapy 
to HIV-infected TB patients in a decentralised manner (at every peripheral health institution) 
and refer them to ART.15–18 Based on this evidence and given the heterogeneity of the TB-HIV 
epidemic in the country, a decision was made at national level to implement a differential 
strategy in the country - a package of essential TB-HIV interventions to be implemented 
in all states, while an intensified package was to be implemented in selected states with a 
higher burden of HIV, improved availability of HIV testing, better treatment infrastructure and 
services and higher programme management capacity. 
In 2007, the first National Framework for Joint TB-HIV Collaborative Activities 
was developed that endorsed a differential strategy, reflecting the heterogeneity of TB-
HIV epidemic.19 The components of the differential package were put together drawing 
on the WHO’s 2004 interim policy of TB-HIV collaborative activities at the time.20 These are 
summarized in Table 1 and are described below. 
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THE ESSENTIAL TB-HIV PACKAGE INCLUDED: 
1. Establishment of a formal mechanism for coordination, at the national, state and 
district levels. At the national level, a National Technical Working Group (NTWG) was 
established, comprising key officials from both TB and HIV programmes dealing with 
TB-HIV Collaborative activities and experts from the WHO. The purpose of the NTWG 
was to plan, review, optimize, monitor and evaluate TB-HIV coordination activities in the 
country. At the state level, State Coordination Committees (SCC) chaired by the Principal 
Health Secretary were established to ensure smooth implementation and regular review 
of TB-HIV Collaborative activities in the state. The State Working Group (SWG) was 
another body at state level, comprising key officials from State AIDS Control Societies 
(SACS) (Project Director and Additional Project Director) and the State TB Cell (State TB 
Officer), along with other officials and WHO consultants involved in TB-HIV collaborative 
activities. At the district level, District Coordination Committees (DCC), chaired by the 
District Magistrate, were formed in most districts of the country. In addition, monthly 
joint co-ordination meetings between the field staff of both TB and HIV programmes 
were started.
2. Training of programme officials and field staff on TB-HIV. Training manuals for the 
different cadres of staff were drafted at the national level and provided to states for 
training purposes. Budgets were allocated to conduct trainings at state and district level.
3. Intensified TB case finding at HIV counselling and testing centres, ART Centres, and other 
HIV care and support centres. Separate recording and reporting formats were designed 
to document and monitor this activity.
4. Risk-based, selective referral of TB patients for voluntary HIV counselling and testing.
5. Referral of HIV-infected TB patients to NACP settings for additional care and support, 
including ART.
THE INTENSIFIED TB-HIV PACKAGE INCLUDED IN ADDITION TO THE ABOVE:
1. Routine referral of all TB patients for HIV counselling and testing.
2. Provision of cotrimoxazole preventive therapy (CPT) to HIV-infected TB patients in a 
decentralized manner at every peripheral health institution.
3. Referral of HIV-infected TB patients to ART centres for initiation of ART. Initiation of ART 
followed CD4-cell count based guidelines, which at the time were based on WHO 2006 
guidelines (ART for any HIV-infected extra-pulmonary TB patient or for HIV-infected 
pulmonary patients whose CD4 counts were less than 350 cells per µL).
4. Expanded recording and reporting, including recording HIV status, CPT and ART status in 
the TB treatment cards and TB registers and reporting of related indicators in quarterly 
reports of the TB programme.
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2009-2012
The National Framework for joint TB-HIV collaborative activities was revised in 2009 and it 
was decided to scale-up the implementation of “Intensified TB-HIV activities” nationwide 
and the goal was reached in July 2012.19 The scale-up of TB-HIV collaboration in India is 
summarized in Figure 1. 
This expansion was accompanied by provision of additional dedicated human 
resources for coordinating TB-HIV activities, strengthening of joint monitoring and 
evaluation, with specified national TB-HIV programme indicators and performance targets. 
The additional human resources for supervision and monitoring included:
• A full-time regular government officer in-charge of TB-HIV collaborative activities in the 
programmes at the National and State level in both the NACP and Revised National TB 
Control Programme (RNTCP).
• National Consultants for TB-HIV provided to the NACP and RNTCP through the WHO 
technical assistance project.21 
• Technical officers at SACS for basic services (including TB-HIV) (1-2 per state).
• State TB-HIV Coordinators initially sanctioned by the RNTCP in all states.
• District level supervisors for monitoring TB-HIV and drug resistant TB related activities 
who were sanctioned for all districts by the RNTCP. 
In addition, joint planning, supervision, monitoring and review were started through joint TB-
HIV visits to states and districts and joint programme reviews were conducted at national and 
state level. National targets for assessing TB-HIV collaborative activities were defined. The 
performance of TB-HIV collaborative activities was analysed and indicators were published 
by the RNTCP every quarter in their website http://tbcindia.nic.in/. However, despite the 
planning, there were important challenges for implementation. 
CHALLENGES IN TB-HIV COLLABORATION
The challenges are described under three broad headings, in line with those present in the 
global policy document on TB/HIV collaboration : i) Overarching challenges in setting up 
mechanisms of collaboration ii) Challenges in reducing the burden of TB among PLHIV iii) 
Challenges in reducing the burden of HIV among TB patients. 
OVERARCHING CHALLENGES IN SETTING UP COLLABORATION MECHANISMS
Setting up mechanisms of collaboration
• Establishing a coordinating body for TB-HIV collaborative activities at all levels of 
the health system was challenging. Some districts did not have a functional district co-
ordination committee, especially those without a full-time nodal officer for HIV/AIDS. 
Only about 65% of the district level committees were reported to be functioning in 2010.
• Administrative guidelines for organizing training of staff were not uniform under the 
NACP and RNTCP and were frequently a source of conflict in programme implementation. 
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These needed to be aligned. There was no joint planning, joint implementation and joint 
monitoring between NACP and RNTCP, especially at state and district levels. 
• Lack of time and capacity to conduct policy-relevant operational research within 
the national programmes 
CHALLENGES IN REDUCING THE BURDEN OF TB AMONG PLHIV
• Intensified TB case finding (ICF) activities, though were established in all HIV 
testing and counselling centres and ART centres across the country, there were many 
challenges in implementation, especially from states with lower prevalence of HIV, 
perhaps reflecting the low perceived priority among decision makers. There were many 
recording and reporting errors. Changing the definition of presumptive TB patient 
in PLHIV from “any cough” to “any of the four symptoms of “cough, fever, weight loss 
and night sweats” needed to be disseminated. Sputum smear microscopy was still the 
mainstay of diagnosis at the time despite its known limitations among PLHIV (limited 
sensitivity, inability to identify drug resistance). The widely acclaimed newer and rapid 
diagnostic test such as the Xpert MTB/RIF assay (a cartridge based automated nucleic 
acid amplification test that uses a common platform to diagnose both TB and Rifampicin 
resistance) was still not widely available in India.
• Isoniazid preventive therapy (IPT) for PLHIV without TB was not a policy at the 
time. However, the NTWG for TB-HIV recognized the value of IPT and recommended 
operational research to assess the operational feasibility of adoption of the IPT strategy 
into programme settings. 22
• TB infection control in health care and congregate settings (IC): The National 
Airborne Infection Control Committee (NAICC) was established and national guidelines 
were developed in 2008. Despite these, the TB infection control measures were not 
implemented or poorly practiced in many HIV settings. 22
CHALLENGES IN REDUCING THE BURDEN OF HIV AMONG TB PATIENTS
• HIV testing of TB patients: On the basis of international recommendations and Indian 
operational research,16 routine referral of all TB patients for HIV testing was incorporated 
into the national policy in 2008. This increased the number and proportion of TB patients 
with known HIV status from 34% in 2008 to 65% in 2010. However, there were several 
implementation challenges which included i) wide geographic variations ii) lack of HIV 
testing services at TB diagnostic centres iii) delays in trainings and procurement and iv) 
interrupted supply of HIV testing kits.22
• HIV testing of presumptive TB patients was not a national policy at the time, even 
though WHO recommended moving HIV testing upstream by testing all patients with 
presumptive TB (formerly referred to as TB suspects) as a way of early detection of HIV-
infected TB patients.13 Evidence from observational studies in sub-Saharan Africa23–29 
had shown that testing for HIV in patients with presumptive TB yielded a high number 
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of new diagnoses of HIV infection as the prevalence of HIV was higher than among the 
general adult population; these findings, however, could not be generalized to the Indian 
situation. HIV testing of contacts of HIV-infected TB patients was not a policy in India at 
the time, despite favourable evidence from other settings. 30 
• Provision of CPT and ART to all HIV-infected TB patients: At the time, while nearly 
90% of HIV-infected TB patients received CPT, only about 50% HIV-infected TB patients 
were linked to ART care and support. One of the reasons ascribed to the low proportion 
of HIV-TB patients on ART was that not all HIV-infected TB patients were eligible for ART. 
India still followed the WHO 2006 guidelines and had concerns about adopting the WHO 
2010 ART guidelines (these specified that all HIV-infected TB patients were eligible for 
ART irrespective of the CD4-cell count) since there were concerns about the resource 
implications and the increased workload that such a strategy would impose on the 
national ART programme. Other barriers to ART linkage were related to long travel times, 
distances and financial barriers as ART services were centralised and were provided in 
selected health facilities only.22 
To address some of the challenges described above, several operational research studies 
were planned and carried out. The aims and objectives and their rationale are described 
below.
AIM AND OBJECTIVES AND THEIR RATIONALE
The aim of the operational research projects that constitute this thesis was to generate 
and use policy-relevant national evidence to improve the management of HIV-infected TB 
patients in India. 
There were three key objectives namely: 
1. To evaluate the additional number of patients that would be initiated on ART if India 
adopted the current 2010 WHO ART guidelines of placing all HIV-infected TB patients on 
ART regardless of CD4 cell count. 
2. To assess the prevalence of HIV among patients with presumptive TB in different settings 
with different levels of HIV prevalence and the proportion eligible for starting ART 
according to 2015 WHO Guidelines.
3. To document the operational research capacity building initiatives undertaken in India, 
their evolution and impact on policy and practice. 
The Sustainable Development Goals (SDGs) of the United Nations aim to end HIV and TB 
epidemics by 2030 and this is also endorsed by the WHO’s END TB strategy. To achieve these 
goals, UNAIDS and the STOP TB partnership of the WHO have proposed 90-90-90 targets. 
All the studies included in this thesis were conducted in India, which harbours the highest 
number of TB patients and about 10% of all HIV-TB patients globally. Importantly, the studies 
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address the HIV-TB component of these international goals and efforts to achieve the set 
targets. A conceptual framework of the work in thesis and how they fit into the international 
communities’ ambition to end the TB and HIV epidemics by 2030 is depicted in Figure 2.
OUTLINE OF THE THESIS
We describe six operational research studies (including two multicentre operational research 
projects) and their findings in this thesis and discuss their overall contribution to changes in 
policy, practice and the improvement of health outcomes among HIV-infected TB patients 
in India.31–37 Most of these studies were carried out in collaboration with national TB and HIV 
programmes and other key stakeholders at international and local levels. 
To catalyse the generation of evidence, we built capacity of several public health 
professionals in India using the SORT IT (Structured Operational Research Training Initiative) 
model of capacity building, developed by the International Union Against Tuberculosis 
and Lung Disease (The Union) and Médecins Sans Frontières in partnership with the WHO’s 
Special Programme for Research and Training in Tropical Diseases (WHO-TDR).38 In addition, 
the author of this thesis was mentored under a global OR fellowship programme run by The 
Union in 2012. The SORT IT model and its adaptations, the OR fellowship programme and 
the impact of these on policy and practice has been described in a series of viewpoint and 
original research articles.39–42    
A brief outline of what is covered in each chapter is provided below structured as per the key 
objectives. 
Objective 1: This is covered in Chapter 2. In 2010, WHO expanded previously-recommended 
indications for ART to include all HIV-infected TB patients irrespective of the CD4 count. 
India, however, still limited ART to TB patients with CD4-cell counts <350/mm3 or with extra-
pulmonary TB. We sought to evaluate the additional number of patients that would be 
initiated on ART if India adopted the current 2010 WHO ART guidelines for HIV-infected TB 
patients. The findings of this research study are described in Chapter 2.
Objective 2: This is covered in Chapters 3-8. HIV testing of persons referred for tuberculosis 
diagnosis (patients with presumptive TB) is recommended by the WHO, but was not a policy 
in India where HIV prevalence among presumptive TB patients had never been studied. 
To fill this knowledge gap, a study was conducted in two districts of South India to assess 
the prevalence of HIV among patients with presumptive TB and the feasibility of provider 
initiated HIV testing under programmatic settings. The findings of these studies are reported 
in Chapters 3 and 4. Based on the findings of the studies described in Chapters 3 and 4, a 
national policy decision was taken to routinely offer HIV testing to patients with presumptive 
TB in high-burden HIV states of India. However, how this should best be implemented and 
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monitored in routine health care settings in India was not known. An operational research 
was conducted in Karnataka State (South India, population 64 million and accounting for 
10% of India’s national HIV burden), to test processes and learn the challenges of screening 
presumptive TB patients for HIV within routine health care settings. The findings of this 
operational research study are described in Chapter 5. An innovative process using open-
access technologies like EpiData, Dropbox and TeamViewer was used to co-ordinate quality-
assured data capture in the multicentre study described in Chapter 5. This model of data 
capture is described in detail in Chapter 6. While it became clear that HIV testing among 
presumptive TB patients was of value in high-HIV burden settings of India, it was not clear if 
it was of value in low-HIV burden settings. A study was undertaken in Puducherry to answer 
this question. The findings of this study are described in Chapter 7. Chapter 8 describes the 
results of an operational research study conducted in the state of Karnataka to assess the 
proportion of HIV-infected presumptive TB patients eligible for initiating ART according to the 
WHO guidelines at the point in time.
Objective 3: This is covered in chapters 9-12. As mentioned earlier, capacity building using 
the SORT IT model and the OR Fellowship programme was key to catalyse the generation 
of programme relevant operational research evidence. Most of the papers described in this 
thesis are a result and outcome of these two initiatives. We describe in chapters 9-12 the 
evolution of this model of capacity building and its impact on policy and practice. 
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2001 (Essential Package initiated)
2007 (Shift to intensified Package)
Coverage (in purple), of 6 states 
(Maharashtra, Manipur, Nagaland, 
Karnataka, Tamil Nadu and Andhra 
Pradesh)
2004 (Essential Package initiated)
2009 (Shift to intensified Package)
Coverage (in purple), extended to 8 
more states  (Delhi, Gujarat, Himachal 
Pradesh, Kerala, Orissa, Punjab, 
Rajasthan and West Bengal)
2007 (Essential Package initiated)
2012 (Shift to intensified Package)
Coverage (in purple) extended 
Nationwide
Figure 1. Scale-up of TB-HIV collaborative activities in India 2001-12
Essential Package: 1. Establishing mechanisms of coordination at national, state (sub-national) and district 
levels. 2. Joint Training of field staff on TB-HIV. 3. Intensified TB case finding at HIV testing and ART centres 
(documentation and reporting in dedicated formats). 4. Risk-based selective referral of TB patients for HIV 
testing 5. Referral of HIV-infected TB patients to HIV care, support and treatment centres
Intensified Package: 1. Provider-initiated, routine offer of HIV testing to all TB patients 2. Decentralized provision 
of CPT to all HIV-TB patients at peripheral health institution level  3. Referral of HIV-infected TB patients to ART 
centres for initiation of ART based on eligibility 4. Expanded recording and reporting system which includes 
documentation of HIV status, CPT and ART in TB treatment cards and TB registers
TB=Tuberculosis; HIV=Human Immunodeficiency Virus; ART=Antiretroviral therapy; CPT= Cotrimoxazole 
Preventive Therapy;
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Figure 2: Conceptual Framework
Table 1: Components of differential packages provided in the early years of TB-HIV collaboration 
in India, 2007-09.
Essential TB-HIV Package (all states) Intensified TB-HIV Package (selected states 
with high burden of TB-HIV)
1. Establishing mechanisms of coordination at 
national, state (sub-national) and district levels
1. Provider-initiated, routine offer of HIV testing 
to all TB patients
2. Joint Training of field staff on TB-HIV 2. Decentralized provision of CPT to all HIV-TB 
patients at peripheral health institution level
3. Intensified TB case finding at HIV testing and 
ART centres (documentation and reporting in 
dedicated formats)
3. Referral of HIV-infected TB patients to ART 
centres for initiation of ART based on eligibility
4. Risk-based selective referral of TB patients for 
HIV testing
4. Expanded recording and reporting system 
which includes documentation of HIV status, 
CPT and ART in TB treatment cards and TB 
registers
5. Referral of HIV-infected TB patients to HIV 
care, support and treatment centres
TB=Tuberculosis; HIV=Human Immunodeficiency Virus; ART=Antiretroviral therapy; CPT= Cotrimoxazole 
Preventive Therapy.
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Background
In 2010, WHO expanded previously-recommended indications for anti-retroviral treatment to 
include all HIV-infected TB patients irrespective of CD4 count.  India, however, still limits ART 
to those TB patients with CD4 counts <350/mm³ or with extrapulmonary TB manifestations. 
We sought to evaluate the additional number of patients that would be initiated on ART if 
India adopted the current 2010 WHO ART guidelines for HIV-infected TB patients.
Methods
We evaluated all TB patients recorded in treatment registers of the Revised National TB 
Control Programme in June 2010 in the high-HIV prevalence state of Karnataka, and cross-
matched HIV-infected TB patients with ART programme records. 
Results
Of 6182 TB patients registered, HIV status was ascertained for 5761(93%) and 710(12%) were 
HIV-infected. 146(21%) HIV-infected TB patients were on ART prior to TB diagnosis. Of the 
remaining 564, 497(88%) were assessed for ART eligibility; of these, 436(88%) were eligible for 
ART according to 2006 WHO ART guidelines. Altogether, 487(69%) HIV-infected TB patients 
received ART during TB treatment. About 80% started ART within 8 weeks of TB treatment 
and 95% received an efavirenz based regimen.
Conclusion
In Karnataka, India, about nine out of ten HIV-infected TB patients were eligible for ART 
according to 2006 WHO ART guidelines. The efficiency of HIV case finding, ART evaluation, 
and ART initiation was relatively high, with 78% of eligible HIV-infected patients actually 
initiated on ART, and 80% within 8 weeks of diagnosis. ART could be extended to all HIV-
infected TB patients irrespective of CD4 count with relatively little additional burden on the 
national ART programme.
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INTRODUCTION
HIV-infected TB patients experience a high case-fatality rate during anti-tuberculosis (TB) 
treatment1. Antiretroviral therapy (ART) reduces this risk of death, provided ART is started 
early enough during anti-TB treatment2. The efficient and timely initiation of ART in HIV-
infected TB patients is crucial to reduce mortality among HIV-infected TB patients. 
In India, the National AIDS Control Programme (NACP) ART guidelines are still in 
line with 2006 World Health Organization (WHO) Guidelines for ART3,4. As per 2006 guidelines, 
all HIV-infected persons with extra-pulmonary (EPTB) or disseminated TB and HIV-infected 
pulmonary tuberculosis (PTB) patients with a CD4-lymphocyte count <350/mm3 are 
considered eligible for ART. In contrast, the 2010 WHO ART Guidelines recommend that ART 
be initiated in all HIV-infected TB patients (PTB and EPTB), irrespective of CD4 count, as soon 
as possible during the initial phase of anti-TB treatment5. 
India proposes to change over to the new 2010 WHO ART Guidelines, but there is 
concern that giving ART to all HIV-infected TB patients may have major resource implications 
for the national ART programme. There is little information available about what proportion 
of HIV-infected TB patients are eligible for ART according to the current NACP criteria and 
how this might change if the new 2010 WHO ART Guidelines were adopted and implemented 
in India. There was some information on ART eligibility from a previous study, but this was 
not representative as most of the HIV-infected TB patients could not be evaluated for ART 
eligibility because of poor information on CD4 counts 6. Better knowledge of ART eligibility 
and the efficiency with which patients are initiated on ART is critical for policy makers to plan 
for increases in demand for drugs and services. 
We conducted a cross-sectional survey in the state of Karnataka, one of the highest 
HIV prevalent states in India, to evaluate the additional number of patients that would be 
initiated on ART if India adopted current WHO ART guidelines for HIV-infected TB patients. 
The specific objectives were to assess:- i) number (proportion) of TB patients ascertained for 
HIV status with their results, ii) number (proportion) of HIV-infected TB patients eligible for 
ART and started on ART during anti-TB treatment and iii) when ART was started and the type 
of regimen used. 
METHODS
DESIGN
This was a cross sectional study involving review of routinely collected data recorded in TB 
and HIV programme records.
SETTING
Karnataka, a south Indian state with a population of 61 million, has an estimated 0.25 million 
people living with HIV in 2009 and accounts for about 10% of country’s HIV burden7. Hence, 
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the state has been classified as ‘high priority’ for HIV interventions by the Indian National 
AIDS Control Organization (NACO) on the basis of consistently high HIV seroprevalence rates 
of >1% during sentinel surveillance at antenatal clinics8,9. In the state, tuberculosis control 
programme services are available through a decentralized network of primary health care 
facilities which provide general health services including diagnosis and treatment for TB. 
All TB patients are treated with standardized fully intermittent thrice-weekly short-course 
regimens (6-9 months) administered under direct observation and are registered at one of 
the 125 sub-district level TB programme management units according to Indian programme 
guidelines10. 
There is a national policy of Provider-Initiated HIV Testing and Counseling (PITC) of 
all TB patients, and HIV-infected TB patients are provided cotrimoxazole preventive therapy 
(CPT) and referred to ART centres for assessment of ART eligibility and initiation on ART if 
found to be eligible11. TB patients are referred for free HIV counseling and testing to one of 
the 1000 integrated counseling and testing centre (ICTC) throughout the state, which are 
usually co-located with sputum microscopy services. Free ART is provided through a network 
of 40 ART centres (with at-least one ART centre in every district), where HIV-infected patients 
(including TB patients) are screened for ART eligibility and offered treatment and care. These 
service delivery sites under NACP follow the national guidelines for counseling, testing, care 
and treatment of HIV-infected patients12. In the year 2010, of 68,655 TB patients registered in 
Karnataka, 82% were tested for HIV and 8,485 HIV-infected TB patients were identified13.
STUDY POPULATION
From a cohort of TB patients (except transfer-in cases) registered in Karnataka state, India, 
between 1st and 30th June 2010, all those identified as HIV-infected were consecutively 
included in the study. 
DATA COLLECTION AND VALIDATION
Data on the number of TB patients registered, number with known HIV status and number 
HIV-infected were extracted from the TB registers. TB-HIV data were collected into a pre-
tested structured data abstraction form by trained consultants between November and 
December 2010. Data collected included age, sex, type and category of TB, CD4 count, ART 
initiation, timing of ART initiation and ART regimen. These data were collected from the 
existing programme records of Revised National TB Control Programme (TB registers and TB 
treatment cards) and NACP (TB/HIV register, pre-ART registers, ART registers and the electronic 
patient database maintained at the ART centres). If HIV-infected TB patients were receiving 
ART from another district, the records of the respective ART centres were reviewed. If there 
were discrepancies between data in the different records, these were resolved by interviewing 
the medical officers of the respective health institution. Except where mentioned, standard 
definitions according to the national programme guidelines were used.
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DATA ENTRY AND ANALYSIS
Data were double-entered into an EpiData database by two data entry operators 
independently14. Databases were compared and discrepancies resolved through referral to 
the original questionnaire. Proportions of TB patients with known HIV status and proportions 
of HIV-infected TB patients who were eligible for ART, initiated on ART with timing of ART 
initiation were calculated. 
ETHICS APPROVAL
Ethics approval was obtained by the Ethics Advisory Group of the International Union against 
TB and lung disease (The Union). Approvals of Central TB Division, Ministry of Health and 
Family Welfare and National AIDS Control organization were also obtained for conducting 
this evaluation. 
RESULTS
Of 6,182 TB patients registered in Karnataka in June 2010, HIV status was known for 5,761 
(93%), and 710 (12%) were recorded as HIV-infected. The demographic, clinical and 
immunological characteristics of HIV-infected TB patients are shown in Table 1. Two thirds 
of the patients were men, with the majority being in the age group 25-54 years. Most of the 
patients had new TB and about three quarters of patients were classified as pulmonary 
tuberculosis with almost equal division between sputum-smear positive and sputum smear 
negative. CD4-counts were recorded for 621 (87%) patients, of whom 512 (82%) had a CD4 
count less than or equal to 350 cells/mm3.
Assessment for ART eligibility and initiation of ART is shown in Figure 1. Of all 710 
HIV-infected TB patients identified, 146 (21%) were already on ART prior to TB diagnosis. 
Of the 564 patients who were not on ART at the time of TB diagnosis, 145 (25%) had extra-
pulmonary TB and were immediately ART eligible. Of the 419 pulmonary TB patients not 
already on ART, 352 (84%) had available CD4 information, among whom 291 (83%) had a CD4 
count <350 cells/mm³ and were ART eligible. Altogether, 497/564 (88%) could be assessed for 
ART eligibility and among them, 436 (88%) were eligible for ART. 
Overall, 487(67%) HIV-infected TB patients received ART during TB treatment, with 
ART started either before or after the diagnosis of TB.  
For those patients who received ART either before or after TB diagnosis, the time 
of initiation of ART and the type of regimen are shown in Table 2. Of the 341 patients who 
started ART after TB diagnosis, 272 (80%) started within eight weeks of commencing anti-TB 
treatment. Almost 95% of patients received an efavirenz-based ART regimen.  
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DISCUSSION
This study in Karnataka state showed the majority of TB patients in a high HIV prevalence 
state in India were tested for HIV, and of those found to be HIV-positive nearly 90% were 
eligible for ART according to current NACP and 2006 WHO ART guidelines. As a public health 
approach to ART, this strongly justifies the adoption of the WHO 2010 ART Guidelines, 
recommending that all HIV-infected TB patients are started on ART regardless of CD4 count. 
As <10% of HIV-infected TB patients had CD4 counts > 350 cells/mm³, the adoption of the 
WHO ART Guideline recommendation for HIV-infected TB patients is not likely to place a large 
additional burden on the national ART programme. 
We also determined sub-optimal programme efficiency in the initiation of ART 
for patients eligible under current guidelines; 23% of HIV-infected TB patients should have 
got ART, but did not. To illustrate this point, we can apply these findings to the state of 
Karnataka. In the state of Karnataka in 2010, of 68,665 tuberculosis patients registered for 
treatment, 56,622 knew their HIV status and 8,485 were identified as HIV-infected13. Assuming 
existing operational efficiency, 67% (5,685) would be receiving ART and another 23% (1,951) 
would be eligible for ART as per current ART eligibility criteria, but not yet on ART due to 
operational challenges. Increasing the programme efficiency of ART initiation could place 
1,951 additional people on ART. About 10% (849) would be eligible for ART if new guidelines 
are implemented. Given that there were about 55,102 people alive and on ART in the state of 
Karnataka at the end of 2010, the annual addition of 849 (1.5%) people to the ART programme 
from ‘changed guidelines’, and 1,951 (3.5%) people from ‘improved programme efficiency’ 
would be modest. Improvements in programme efficiency of ART initiation for HIV-infected 
TB patients offers another important opportunity to improve ART coverage in HIV-infected 
TB patients, and in the larger context of ART provision would pose little additional burden on 
existing HIV treatment services.
This was the first state-wide study in India assessing the management of HIV 
diagnosis and care in TB patients under programmatic settings. The only other study to 
examine this issue in India found similar results in 2 districts of South India, in which about 
83% of HIV-infected TB patients were eligible for ART; but this finding suffered from very 
low completion of CD4 evaluation in that cohort6. Similar findings have been reported 
from sub-Saharan Africa, where 90% of HIV-infected TB patients had CD4 counts below 
350 cells/mm3  15. Our study covered the entire state of Karnataka and had very high rates 
of HIV case finding among TB patients and CD4 testing. Hence, these results are likely to be 
broadly generalizable. Given the similarity of results from various settings, we also believe 
that the results may be extrapolated to other high HIV prevalent states in the country, though 
more research is required to confirm this. The high rates of HIV testing among TB patients 
in this cohort could be attributed to the widespread availability of HIV testing services co-
located with the TB microscopy centres in the state. Since TB patients can be a high-yield 
WILL ADOPTION OF THE 2010 WHO ART GUIDELINES FOR HIV-INFECTED TB PATIENTS 
INCREASE THE DEMAND FOR ART SERVICES IN INDIA?
35
Ch
ap
te
r 2
source of HIV case finding, this calls for scale-up of co-located HIV testing and TB testing 
services across the country.
This study also emphasizes that in resource-poor settings, the majority of HIV-
infected TB patients who are not already on ART present to health services late and with low 
CD4 counts. The reasons for late presentation are many and include late diagnosis of HIV 
and the low CD4 threshold currently used for initiating ART among all HIV-infected persons. 
Hence, the national programmes should explore other opportunities of improved and earlier 
diagnosis of HIV-infected TB patients like PITC of TB suspects and strengthening intensified TB 
case finding activities at HIV care settings by the use of WHO-endorsed, new, rapid molecular 
technologies to diagnose TB16. The 2010 WHO ART guidelines which recommends initiation of 
ART for all PLHIV with CD4 count of <350/mm3 is a welcome change in this regard which may 
not only prevent TB cases from occurring but may also ensure that those who develop TB 
would have higher CD4 counts and consequently the likelihood of better clinical outcomes. 
NACP and RNTCP are considering all the above options in their next joint national strategic 
plan (2012-17) to achieve improved and earlier diagnosis of HIV-infected TB patients17.
This study also revealed operational weaknesses in ART services.  There were 
various reasons for poor ART uptake that included failure to reach the ART centre, not 
getting CD4 counts done, having a CD4 count > 350 cells/uL in the case of pulmonary 
tuberculosis and not returning to the ART centre after starting TB treatment. Some of these 
patients may have died or been too sick to reach the ART centre. Removal of the CD4 count 
hurdle as part of ART eligibility criteria may make it easier to start ART. More than one in 
five patients defined as ART eligible still failed to receive ART during TB treatment. As per 
NACP guidelines, patients were required to show proof of address and needed to make 2-3 
visits for baseline investigations and adherence counseling before initiation of ART. Though 
this was important to ensure long term adherence to treatment, it might have contributed 
to losing track of even those who were eligible for ART. An assessment of reasons for the 
lack of ART initiation for eligible patients was beyond the scope of the current study and 
this needs further investigation. On a positive note, the majority of patients who started ART 
did so within 8 weeks of commencing TB treatment in accordance with the NACP and WHO 
recommendations, with efavirenz-based ART regimens being those most commonly used 
as per current NACP guidelines. Early ART initiation for HIV-infected TB patients has been 
convincingly shown to save lives, and the timeliness of ART initiation should be monitored to 
ensure continued effective implementation. 
This study had some limitations mainly related to our reliance on data collected 
routinely by the national TB and HIV programmes, where high accuracy of recording is 
difficult to ensure. Although the 2010 WHO ART guidelines are justified as a public health 
approach, it is important to study the TB treatment outcomes among the subgroup of HIV-
infected TB patients with CD4 count of >350/mm3 and assess if they  actually benefit by early 
initiation of ART. A previous study from Cote d’Ivoire indicated that although mortality was 
less among HIV-infected TB patients with CD4 count of >200/mm³ when compared with those 
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whose CD4 count was <200/mm³, it still remained many times higher than in HIV-negative TB 
patients18. Information on mortality in HIV-infected TB patients whose CD4 counts of >350/
mm³ is limited and this needs further study. Further, we did not extend our research to do a 
costing exercise, but this can and should be a subject of further analysis.
In conclusion, this study indicates that about 90% of HIV-infected TB patients are 
eligible for ART as per 2006 WHO ART guidelines. Hence as a public health approach, this 
strongly justifies the adoption of 2010 WHO ART guidelines which recommends that all HIV-
infected TB patients should be initiated on ART irrespective of CD4 count; this policy change 
should have few additional resource implications for the national ART programme. However, 
systematic measures need to be taken by the national TB and HIV programmes to improve 
access of HIV-infected TB patients to ART and bridge the gap in ART uptake.
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Figure 1. Eligibility for and initiation of antiretroviral treatment in HIV-infected TB patients registered in 
Karnataka state, India, in June 2010.
*4 PTB patients were started on ART even though not eligible as per guidelines TB-Tuberculosis; HIV-Human 
immunodeficiency virus; PTB-pulmonary tuberculosis; EPTB-extrapulmonary tuberculosis; NACO-National 
AIDS Control Organization; ART-antiretroviral treatment; ARTC-ART centre
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Table 1: Characteristics of HIV-infected TB patients registered in Karnataka state, India, in June 
2010.
Category Sub-category Number (%)
All patients 710 (100)*
Sex Male
Female
465 (66)
245 (34)
Age group 0-14 years
15-24 years
25-35 years
35-44 years
45-54 years
55-64 years
> 65 years
33 (5)
23 (3)
214 (30)
283 (40)
114 (16)
38 (5)
5 (1)
Type of TB** Pulmonary TB
Extra-pulmonary TB
516 (73)
194 (27)
Smear status of Pulmonary TB (N=516) Smear Positive
Smear Negative
Smear Unknown
285 (55)
216 (42)
15 (3)
Site of Extra-pulmonary TB (N=194) Lymph Node
Pleura
Meninges/CNS 
Abdomen
Other
Not recorded
62 (32)
39 (20)
33 (17)
30 (16)
7 (3)
23 (12)
TB registration type New
Relapse
Treatment after Default
Treatment after Failure
Other
593 (83)
30 (4)
19 (3)
5 (1)
63 (9)
CD4 cell count < 50/mm3
50-200/mm3 
201-350/mm3 
> 350/mm3
Not available
72 (10)
291 (41)
149 (21)
109 (15)
89 (13)
*Percentages may not always add up to 100 due to rounding errors
** There were 10 patients who had both pulmonary and extrapulmonary TB; they have been classified under 
extrapulmonary TB as they belong to HIV stage 4 and are ART eligible 
TB-Tuberculosis; HIV-Human immunodeficiency virus; CNS-Central Nervous System
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Table 2: Timing of ART initiation and ART regimen in HIV-infected TB patients registered in 
Karnataka state, India, in June 2010.
Category Sub category Number (%)
All patients on ART 487 (100)
Timing of ART initiation Prior to TB diagnosis 146 (30)
<2 weeks of TB treatment 67 (14)
2-8 weeks of TB treatment 205 (42)
>8 weeks of TB treatment 69 (14)
ART regimen Zidovudine-Lamivudine-Efavirenz 224 (46)
Stavudine-Lamivudine-Efavirenz 235 (48)
Zidovudine-Lamivudine-Nevirapine 9 (2)
Stavudine-Lamivudine-Nevirapine 13 (3)
Other/Not recorded 6 (1)
TB-Tuberculosis; HIV-Human immunodeficiency virus; ART-antiretroviral treatment

3.
HIV prevalence among persons suspected of tuberculosis: 
policy implications for India
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Background
HIV testing of persons referred for tuberculosis diagnosis (TB suspects) is recommended 
by World Health Organization but is not a policy in India, where HIV prevalence among TB 
suspects has never been reported. The current Indian policy of offering HIV testing only to TB 
cases may limit opportunities for early HIV diagnosis and treatment.
Methods
All adult TB suspects examined for diagnostic sputum microscopy in Mandya district (2 
million population), in December 2010, were offered voluntary HIV counseling and testing. 
Participants were assessed for subsequent TB diagnosis.
Results
Of 1668 eligible TB suspects, HIV status was ascertained for 1539 (92%). Among these, 108 
(7%) were HIV positive. Of the 108, 43 (40%) were newly diagnosed as HIV (ie, not previously 
known to have HIV infection). To detect a new case of HIV infection, the number needed to 
screen among TB patients was 13, as compared to a number needed to screen of 37 among 
“TB suspects not diagnosed as TB”. Applied annually in 2010, HIV testing of TB suspects in 
2010 could have identiﬁed approximately 534 newly diagnosed HIV cases, a 51% increase in 
district HIV case ﬁnding.
Conclusion
Routine HIV testing of TB suspects was feasible and yielded a large number of HIV cases in 
absolute terms and would increase district HIV case ﬁnding by 51%. The number of patients 
needed to be HIV tested to ﬁnd a previously undetected HIV case among TB suspects was 
greater than for TB cases but was potentially acceptable. Given heterogeneity of HIV epidemic 
in India, broader surveillance is required before national policy decision.
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INTRODUCTION
Globally and in India, tuberculosis (TB) is the most common opportunistic infection and 
the most common cause of death among HIV-infected individuals.2-5 Unless HIV-infected TB 
patients are initiated on cotrimoxazole preventive therapy (CPT) and antiretroviral therapy 
(ART) in addition to TB treatment, mortality may remain high.5 The first step in this process 
is early identification of HIV-infected persons. Globally, less than half of those living with HIV 
know their HIV status6. To facilitate early HIV case-finding, World Health Organization (WHO) 
and International Standards for TB Care (ISTC) recommend provider initiated HIV testing 
and counseling (PITC) for people suspected and/or diagnosed to be having TB.7-8 India 
has adopted the policy of PITC for TB patients.9 The current policy of offering HIV testing 
only to TB cases may limit opportunities of early HIV diagnosis and treatment. Moving HIV 
testing upstream to include all persons suspected of having TB and referred for diagnostic 
evaluation (henceforth referred to as ‘TB suspects’), though recommended internationally, is 
not a policy in India and HIV prevalence in this population has never been reported. Previous 
studies on this topic are mostly from African countries where HIV epidemic is generalized; the 
findings from these studies cannot be generalized to Indian situation with a concentrated HIV 
epidemic.10-11 Indian policy makers seek evidence of the value of HIV testing of TB suspects 
for HIV case finding.12
We conducted this study in Mandya district of Karnataka, one of the highest HIV 
prevalent states in India, to assess the prevalence of HIV among persons referred to any 
microscopy center in the district for diagnostic evaluation. The specific objectives were, i) To 
determine the HIV prevalence among TB suspects examined for diagnostic smear microscopy, 
ii) To assess the number of HIV cases ‘newly’ diagnosed by testing all TB suspects, iii) To assess 
the number needed to screen (NNS) to find an additional case of HIV infected person among 
‘TB suspects’ in comparison to ‘TB patients’, and iv) to assess the potential contribution of 
this activity to HIV case finding.
METHODS
DESIGN
This was a cross-sectional study done by offering HIV counseling and testing to TB suspects 
attending the microscopy centres for TB diagnosis.
SETTING 
The study was done in Mandya district (population 2 million) of Karnataka state, India. In 
the district, tuberculosis control programme services are available through a decentralized 
network of primary health care facilities which provide general health services including 
diagnosis and treatment for TB. Any patient with a cough of 2 weeks or more is considered as 
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pulmonary TB suspect and referred to the microscopy centre for diagnostic evaluation. The 
sputum smear microscopy is done in 25 designated microscopy centres (DMC) of the district, 
which are RNTCP supported microscopy services embedded into the public health system 
clinics. Microscopy is supported by a district-wide system of external quality assurance. All 
TB patients diagnosed are treated with standardized fully intermittent thrice-weekly short-
course regimens (6-9 months) administered under direct observation and are registered 
at 1 of the 4 sub-district level TB programme management units according to Indian TB 
programme guidelines.13 
HIV counseling and testing services are offered through the National AIDS Control 
Programme-supported network of integrated counseling and testing centres (ICTC). There are 
about 24 ICTCs throughout the district, and these are co-located in the same health facilities 
as DMCs.  These service delivery sites under National AIDS Control Programme follow the 
national guidelines for counseling, testing, care and treatment of HIV-infected patients.14 
The current national policy is to offer routinely HIV counseling and testing to 
TB patients; those identified as HIV-infected are provided cotrimoxazole prophylaxis and 
referred to the nearest antiretroviral treatment (ART) centre for assessment of ART eligibility 
and initiation on ART—if found to be eligible. Free ART is provided through the district ART 
centre, where HIV-infected patients (including TB patients) are screened for ART eligibility and 
offered treatment and care. In the year 2010, 20,165 TB suspects were examined for sputum 
microscopy and 2,156 TB patients were registered in Mandya district. Of the TB patients 
registered, 74% were tested for HIV and 237 HIV-infected TB patients were identified.15
SAMPLE SIZE AND SAMPLING
Assuming 3% HIV seroprevalence (p) among TB suspects, an error margin (d) of 1%, 95% 
confidence limit (z=1.96) and a possible attrition rate of 10%, the sample size was calculated 
using the formula ((z2*p*(1-p))/d2) as 1280. Considering the TB suspect examination rate of 
2010, it was decided to examine all the TB suspects attending the microscopy centres in one 
month. 
STUDY POPULATION 
The study population consisted of all the TB suspects attending the 25 microscopy centres 
for diagnostic sputum smear examination in the month of December 2010. TB suspects less 
than 18 years of age were excluded from the study.
DATA COLLECTION, STUDY VARIABLES AND STUDY INSTRUMENT
All the TB suspects aged older than 18 years were provided a patient information sheet by 
the laboratory technician (LT) at the microscopy centre and enrolled into the study. After 
obtaining a written informed consent, they were further referred to the ICTC for HIV testing 
located mostly in the same premises. From one microscopy centre which did not have a 
HIV testing centre in its premises, the patients were referred to the nearby ICTC. At the ICTC, 
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the prevailing national guidelines for HIV testing were followed which includes a pre-test 
counseling, post-test counseling and referral to ART centre in case the patient is found to 
be HIV positive. TB suspects with an already known HIV status were not tested again as per 
the national protocol. ‘Known’ HIV status referred to those who were HIV positive or with 
a HIV negative result within the past 6 months. Those TB suspects who had a negative 
sputum smear result were tracked for one month to assess if they were diagnosed as smear 
negative pulmonary TB or extra-pulmonary TB. The results of sputum smear microscopy and 
HIV testing were informed to the client and offered TB treatment and HIV care and support 
accordingly. The data were collected by the LT into a pre-tested, structured questionnaire 
for all the eligible TB suspects; data collected included laboratory number, age, sex, sputum 
smear result, HIV status and type of TB. The completed questionnaires were collected once a 
week by the trained laboratory supervisor of the national TB programme and were checked 
for completeness and validated by the principal investigator. In addition, the data on total 
clients tested and diagnosed as HIV was collected from the local programme division to 
assess the potential of this strategy to improve HIV case finding. 
DATA ENTRY AND ANALYSIS
Data were double-entered into an EpiData software package16 by two data entry operators 
independently, databases were compared and discrepancies resolved through referral to the 
original questionnaire. Proportions of HIV positive patients among the TB suspects and TB 
patients with 95% confidence intervals were calculated. The proportion of all HIV-infected 
persons who were ‘newly diagnosed’ (after excluding previously known HIV cases) was 
calculated. To find one additional HIV case, the number needed to screen (NNS) among TB 
suspects and TB patients was determined. All variables have been described as proportions, 
and differences between groups were compared for statistical significance using the Chi-
square test or Fisher’s exact test, as applicable. A p-value less than 0.05 was considered 
statistically significant.
ETHICS APPROVAL
All study subjects provided written informed consent for study participation and HIV testing. 
The study protocol was reviewed and approved by the Ethics committee of National 
Tuberculosis Institute, India and the Ethics Advisory Group of the International union against 
TB and lung disease (The Union), France.
RESULTS
Of the 1,723 TB suspects who underwent diagnostic sputum smear microscopy, 1,668 
TB suspects were eligible to participate in the study. Out of those eligible, 1,539 (92%) 
participated and had HIV status ascertained and recorded (Figure 1). 
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The demographic and clinical characteristics of the 1,539 who participated and 
had a HIV test result and the 129 who declined to ascertain HIV status are shown in Table 1. 
TB suspects who did not have a HIV test result were more likely to belong to older age groups. 
Among 1,539 TB suspects with a known HIV status, 100 (6.5%) were eventually diagnosed as 
TB. Of the TB cases, 87 were sputum smear positive, 8 were sputum smear negative and 5 
were diagnosed as extra-pulmonary TB. 
HIV prevalence among TB suspects disaggregated by age, sex and TB status is 
shown in Table 2. Overall, HIV prevalence among TB suspects was 7% with significantly higher 
prevalence noted among those aged 25-54 years, females and the subset of TB suspects who 
were subsequently diagnosed as TB patients. 
To highlight the incremental effect of the policy change from ‘HIV testing of TB 
patients’ to ‘HIV testing of the larger group of TB suspects’, we calculated the difference 
in the number of instances of newly-detected HIV infections (i.e. excluding those persons 
with previously-known HIV infection) (Table 3). Of the 108 HIV positive patients, 65 (60%) 
knew their HIV status prior to the study. While the current policy of HIV testing of TB patients 
would have yielded 7 instances of newly-detected HIV infection, HIV testing of TB suspects 
added 36 instances of newly-detected HIV infection. To detect a new case of HIV infection, the 
number needed to screen (NNS) among TB patients was 13, compared to an NNS of 37 
among ‘TB suspects not diagnosed as TB’ (Table 4). Among the subset of TB suspects aged 
25-54 years who were not subsequently diagnosed as TB, the NNS to detect a new case of 
HIV infection was 21. 
Application of the prevalence of new cases of HIV infection among TB suspects to 
the overall number of TB suspects examined in 2010 suggested that a policy change could 
yield markedly increased HIV case-finding. Overall in 2010 in Mandya, 23,909 general clients 
(including TB patients) and 18681 antenatal mothers were tested, and respectively 999 (4.2%) 
and 57 (0.3%) were HIV positive. If all 19,070 TB suspects were also tested, then approximately 
534 cases of previously-undiagnosed HIV infection could be expected. This would represent a 
51% increase in district HIV case-finding relative to current practice.
DISCUSSION
Routinely testing TB suspects for HIV infection in Mandya detected large numbers of new 
cases of HIV infection, and may represent a major opportunity for increased HIV-case-
finding. Surveillance during our one-month study period found overall 15 cases of HIV 
infection among TB patients, including 8 (50%) with newly-diagnosed HIV infection; these 
would be detected by the existing policy. HIV testing among TB suspects, limited to those 
not subsequently diagnosed with TB, detected 93 cases of HIV infection, including 36 (39%) 
with newly-diagnosed HIV infection. In the overall district context, effective application of a 
policy of HIV testing of TB suspects in 2010 could have increased HIV case-finding by 51%. 
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TB suspects are an easily accessible group of population, already at health facilities with HIV 
testing. These findings suggest that HIV testing of TB suspects should be carefully explored 
in India, particularly in high HIV prevalence settings where HIV testing services are widely 
available and co-located with TB diagnostic services.
This is among the first studies to report HIV prevalence among TB suspects from 
India or any concentrated HIV epidemic setting globally. A similar study done during the 
same time period in Andhra Pradesh (India) showed HIV prevalence of 10.3% among TB 
suspects compared to 8.1% in TB patients (Shanta Achanta, MPH, Personal Communication, 
September 2011). Limited data from generalized HIV epidemics has also shown HIV prevalence 
in TB suspects to be similar to HIV prevalence among TB patients10,17-21. The World Health 
Organization has recommended that in generalized HIV epidemics, HIV testing be offered 
to all persons attending health care facilities, including TB suspects. While the magnitude 
of HIV prevalence among TB suspects and TB patients was substantially higher in those 
generalized HIV epidemic settings than found in our study, the principle of a comparable HIV 
case-finding yield remains. 
With more than 90% of TB suspects accepting HIV testing, this study showed 
that it was feasible to routinely implement PITC among TB suspects in the general health 
system with the existing staff. Availability of decentralized HIV testing services with 
co-location in the same facility as the TB microscopy centres might have facilitated such high 
levels of acceptance.
While ‘PITC among TB patients’ was clearly a more efficient strategy of HIV case 
finding than ‘PITC among TB suspects’, HIV testing of TB suspects remained reasonably 
efficient, and yielded major improvements in HIV-case finding. While the NNS to detect a 
case of HIV in the general ICTC client pool was 23, the NNS for TB suspects not diagnosed 
with TB was 37, and was 20 among those aged 25–54 years. Given the feasibility of HIV 
testing clients already in health care facilities for TB diagnosis and the high yield in terms of 
absolute numbers of HIV infections diagnosed, we believe that the strategy of ‘routine offer 
of HIV testing for TB suspects’ in high-HIV settings may be recommended by the National 
programme. The effective implementation of this strategy is highly dependent on the presence 
of a co-located HIV testing service in the same facility as TB diagnostic centre; hence it should 
not be recommended in areas where HIV testing services are not sufficiently decentralized. 
Additionally, this strategy is likely to be beneficial by resulting in earlier diagnosis of HIV 
among TB patients, earlier initiation of CPT and ART and consequent reduction in mortality.
The study had a few limitations. Firstly, about 8% of the study population could not 
be assessed for HIV due to various reasons; however, if we conservatively assume all of the 
untested patients were HIV-negative, then the minimum HIV prevalence among TB suspects 
would be 6.5%. Hence our interpretation of the findings would not change. Secondly, the HIV 
prevalence reported in our study was mainly among pulmonary TB suspects who attended 
the government-run sputum microscopy centres. We were not able to assess HIV prevalence 
among isolate extra-pulmonary TB suspects who were not eligible for sputum examination, 
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or TB suspects evaluated at private laboratories outside national programme. Though this 
will remain a limitation in assessment of true HIV prevalence among all TB suspects, we feel 
that information is not required to inform the policy question facing national TB and AIDS 
programmes. Thirdly, our study did not assess whether the strategy of moving HIV testing 
upstream to test all TB suspects instead of TB patients actually resulted in increased linkage 
to HIV care and support and reduced mortality among HIV-infected TB patients. This needs 
further research. Fourthly, though indicative, results from a single district is not sufficient to 
inform national policy decision as the HIV epidemic is heterogenic with varied HIV prevalence 
across states and districts of India.22 Hence, broader surveillance from across the country is 
required before national policy decision.
CONCLUSION
This study demonstrated that routine HIV testing of TB suspects was feasible in settings with 
decentralized availability of HIV testing services and yielded a large number of HIV cases in 
absolute terms. HIV testing of TB suspects was somewhat less efficient than current efforts 
for HIV case-finding among TB patients or then general ICTC population, but remained 
reasonably efficient in the context of a concentrated HIV epidemic. More importantly, in the 
context of overall district HIV case-finding efforts, a policy of HIV testing of TB suspects could 
substantially increase HIV case detection relative to existing practice. Though these findings 
are promising, given the heterogeneity of HIV in India broader surveillance of HIV among TB 
suspects is indicated to inform national policy decisions.
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Table 1: Demographic and clinical characteristics of the study population, Mandya district, 
India, December 2010.
Characteristic TB suspects who did not 
consent for ascertaining 
HIV status N (%)
TB suspects who consented 
for ascertaining HIV status 
N (%)
P value
Total 129 (100) 1539 (100)
Age (years)
<45
>45
31 (24)
98 (76)
616 (40)
923 (60)
<0.001
Sex
Male
Female
91 (71)
38 (29)
1060 (69)
479 (31)
0.69
TB status
TB patients
TB suspects without TB
5 (4)
124 (96)
100 (6)
1439 (94)
0.24
Table 2: HIV prevalence among TB suspects examined for diagnostic smear microscopy, 
Mandya district, India, December 2010.
Characteristic Number of TB suspects with 
HIV status ascertained 
Number (%) HIV Positive
Total 1539 108  (7.0)
Age (years)
18-24
25-34
35-44
45-54
55-64
>65 
117
247
252
260
283
380
4 (3.4)
38 (15.4)
41 (16.3)
11 (4.2)
11 (3.9)
3 (0.8)
Sex
Male
Female
1060
479
57 (5.4)
51 (10.6)
TB status
TB patients
TB suspects without TB
100
1439
15 (15.0)
93 (6.5)
Table 3: Newly detected instances of HIV infections among TB patients and TB suspects, 
Mandya district, India, December 2010.
Category Prior HIV status Known
Prior HIV status 
Unknown
Proportion of newly-
detected instances of 
HIV infections
HIV 
Positive 
[a]
HIV 
Positive 
[b]
HIV 
Positive 
[c]
HIV 
Positive 
[d]
[c]/[a+c]
TB patients (n=100) 8 2 7 83 47%
TB suspects without 
TB (n=1439)
57 51 36 1295 39%
Total 65 53 43 1378 40%
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Table 4: Number needed to screen to find an additional case of HIV, by strategy, Mandya 
district, India, December 2010.
Strategy Number with 
Prior HIV status 
Unknown
Number (%) HIV 
Positive
Number Needed to 
Screen (NNS)
HIV testing for all TB patients 90 7 (7.7) 13
HIV testing for TB suspects 
excluding TB patients 1331 36 (2.7) 37
HIV testing for all TB suspects 
including TB patients 1421 43 (3.2) 33
HIV testing of all TB suspects in 
the age group 25-54 years 664 31 (4.7) 21
Figure 1. TB suspects examined for sputum smear microscopy, Mandya district, India, December 2010
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4.
Feasibility and effectiveness of Provider initiated HIV testing 
and counseling of TB suspects in Vizianagaram district, 
South India
Achanta S, Kumar AMV, Nagaraja SB, Jaju J, Shamrao SRM, Uppaluri R, 
Tekumalla RR, Gupta D, Kumar AMVA, Satyanarayana S, Dewan PK. 
PLoS ONE. 2012;7(7):e41378.
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Background
Though internationally recommended, provider initiated HIV testing and counseling (PITC) 
of persons suspected of tuberculosis (TB) is not a policy in India; HIV seroprevalence 
among TB suspects has never been reported. The current policy of PITC for diagnosed TB 
cases may limit opportunities of early HIV diagnosis and treatment. We determined HIV 
seroprevalence among persons suspected of TB and assessed feasibility and effectiveness of 
PITC implementation at this earlier stage in the TB diagnostic pathway. 
Methods
All adults examined for diagnostic sputum microscopy (TB suspects) in Vizianagaram district 
(population 2.5 million), in November-December 2010, were offered voluntary HIV counseling 
and testing (VCT) and assessed for TB diagnosis. 
Results
Of 2918 eligible TB suspects, 2465(85%) consented to VCT. Among these, 246(10%) were HIV-
positive. Of the 246, 84(34%) were newly diagnosed as HIV (HIV status not known previously). 
To detect a new case of HIV infection, the number needed to screen (NNS) was 26 among ‘TB 
suspects’, comparable to that among ‘TB patients’. Among suspects aged 25-54 years, not 
diagnosed as TB, the NNS was 17.
Conclusion
The seroprevalence of HIV among ‘TB suspects’ was as high as that among ‘TB patients’. 
Implementation of PITC among TB suspects was feasible and effective, detecting a large 
number of new HIV cases with minimal additional workload on staff of HIV testing centre. 
HIV testing of TB suspects aged 25-54 years demonstrated higher yield for a given effort, and 
should be considered by policy makers at-least in settings with high HIV prevalence.
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INTRODUCTION
According to World Health Organization’s (WHO) global TB report 2010, Tuberculosis (TB) 
accounted for 25% of all deaths among people living with HIV/AIDS (PLHIV) in 20091. Unless 
HIV-infected TB patients are diagnosed early and linked to both TB and HIV treatment, 
mortality will remain high. To facilitate early and enhanced diagnosis of HIV-infected TB 
patients, WHO recommends intensified TB case finding at all HIV care settings and ‘provider 
initiated HIV testing and counseling’ (PITC) for patients with diagnosed and presumptive TB 2. 
The recommendation of PITC for all TB suspects is based on study findings from 
sub-Saharan African countries, which have shown a very HIV prevalence among persons 
being evaluated for TB (TB suspects), sometimes even higher than HIV prevalence among 
TB patients 3,4. These findings from HIV endemic settings cannot, however, be generalized 
to lower HIV burden settings such as India. With no previously published literature on this 
issue from India, it remains unclear if TB suspects indeed have a similar HIV prevalence as 
compared to diagnosed TB patients, or even if HIV prevalence among TB suspects is higher 
than that found in the general community. Hence, despite recommendations from WHO and 
International Standards of TB Care (ISTC) 5, in India routine HIV testing is offered only to ‘TB 
patients’ and not to all ‘TB suspects’. 
The strategy of routine HIV testing of all TB suspects offers the potential for early 
HIV diagnosis and treatment with consequent reduction of morbidity and mortality. Evidence 
showing that HIV prevalence among TB suspects is relatively high and PITC implementation 
among them is feasible might guide policy makers seeking to improve TB and HIV care 6. 
We conducted this study to assess the feasibility and effectiveness of routinely 
offering HIV counseling and testing to all TB suspects in a relatively high-HIV prevalence 
district of South India. The four specific objectives were: (1) to assess the proportion of ‘TB 
suspects’ and ‘TB patients’ tested for HIV and found HIV positive, (2) to assess the number of 
newly-detected cases of HIV infection detected as a result of this strategy, (3) to assess the 
number needed to screen (NNS) to find one new case of HIV among ‘TB patients’ and ‘TB 
suspects’, and (4) to assess the additional workload at HIV testing centers due to this strategy.
METHODS
STUDY DESIGN 
This was a cross sectional study conducted among TB suspects attending the designated 
microscopic centers (DMC) in the district for diagnosis of TB.
SETTING
The study was conducted in Vizianagaram, a coastal district in the state of Andhra Pradesh, 
India with a population of 2.5 million. This district has been prioritized for HIV services by 
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National AIDS Control Programme (NACP) as the HIV prevalence among antenatal clinic 
attendees has been consistently exceeding 1% over the past 5 years 7. HIV diagnostic and 
treatment services are offered free of cost through a network of 70 HIV testing centers and 
one Anti Retro-viral Therapy(ART) centre as per national guidelines 8. 
Under the ambit of Revised National TB Control Programme (RNTCP), TB diagnosis 
and treatment services are offered through the primary health care system of the district. 
TB suspects, defined as anybody with a cough of two weeks or more with or without other 
symptoms (For PLHIV, cough of any duration is considered as TB suspect) are examined at 
one of the 31 DMC for sputum smear microscopy. Those who are diagnosed as TB patients 
are treated with fully intermittent short course chemotherapy administered under direct 
observation (DOT) and registered in one of the six programme management units as per 
national guidelines 9. 
As per the national framework of joint TB/HIV collaborative activities 10, HIV testing 
is offered routinely to all the TB patients treated under RNTCP and those who are found HIV-
infected are provided cotrimoxazole prophylaxis and referred to ART centre for assessment 
of  ART eligibility and initiation. During 2010, 18,799 TB suspects underwent sputum smear 
microscopy and 3,760 TB patients were registered for treatment 11. Of the TB patients 
registered, 3,619 (96%) were ascertained for HIV status and 320 (9%) were found to be HIV-
infected 11.
STUDY POPULATION AND STUDY PERIOD
The study was conducted during the period from October 2010 to January 2011. All the adult 
TB suspects (more than 18 years of age) examined for diagnostic smear microscopy at the 
DMCs of Vizianagaram district from November 1 to December 31, 2010 formed the study 
population.
SAMPLE SIZE AND SAMPLING
Assuming 7% HIV prevalence among TB suspects, an absolute precision of 1% with 95% 
confidence, a possible attrition rate of 10%, the sample size was calculated to be 2744. 
Considering the number of TB suspects examined per month in the district, it was decided to 
enroll all the eligible TB suspects for a period of two months.
DATA COLLECTION AND DATA VALIDATION
All the adult TB suspects attending the DMC were provided information on the study by the 
laboratory technician (LT) trained for the purpose. Those who consented to participate in 
the study were referred to the co-located HIV testing centre for HIV testing and counseling. 
Those with a prior known positive HIV status or with a HIV negative result within the previous 
six months were not tested again as per national guidelines. The study participants were 
tracked for a month by the TB treatment supervisors of the programme, to assess if they 
were diagnosed as smear negative pulmonary TB or extra-pulmonary TB. The information 
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on the following variables – name of DMC, age, sex, sputum smear result, whether diagnosed 
as TB, type of TB, HIV status - were extracted into a pre-tested structured data collection 
format by LT in co-ordination with the counselor at HIV testing centre. All the data collection 
formats were checked for completeness and consistency by the TB laboratory supervisors of 
the programme once a week and by the principal investigator once in a fortnight. All the staff 
involved in data collection, data validation and data entry were trained in carrying out the 
respective procedures, using the study protocol and data collection formats. 
DEFINITIONS OF KEY OUTCOMES
We calculated the following key indicators – i) Proportions of ‘TB suspects’ and ‘TB patients’ 
with known HIV status, ii) Proportions of ‘TB suspects’ and ‘TB patients’ found HIV positive, 
iii) The number (proportion) of all HIV cases diagnosed newly as the result of the strategy of 
‘PITC of TB suspects’, iv) Number needed to screen (NNS) to diagnose an additional case of 
HIV, separately among ‘TB patients’ and ‘TB suspects not diagnosed as TB’, v) The average 
increase in daily workload at the HIV testing centers calculated centre wise by dividing the 
total number of TB suspects who underwent HIV testing by the average number of working 
days. 
DATA ENTRY AND ANALYSIS
The data were entered twice, independently by two data entry operators into a pre-
designed data entry form with inbuilt checks to minimize data entry errors using EpiData 
entry software12. Both the data bases were compared and discrepancies were resolved 
by referring to the original data collection formats. All analysis was done using EpiData 
analysis softwares13. NNS is the reciprocal of the proportion of newly-detected HIV infection, 
i.e. excluding those persons with previously-known HIV status. Chi-square tests were used 
for comparing proportions and ‘p’ value of less than 0.05 was considered as statistically 
significant.
ETHICS CONSIDERATIONS
Ethics clearance was obtained from Ethics Advisory Group of the International Union Against 
Tuberculosis and Lung Disease (The Union) and National Tuberculosis Institute, Bangalore. 
Administrative approvals were obtained from state and central authorities for conducting 
this study. A written informed consent was taken from each patient and confidentiality 
was assured as data collection formats were maintained securely by programme staff and 
electronic databases contained no personal identifiers.
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RESULTS
Of the 3,232 TB suspects examined for sputum smear microscopy, 314 were aged less than 
18 years and excluded from the study. Of the remaining 2,918 adult TB suspects, 2,465 (85%) 
consented for HIV testing. 
The demographic and clinical characteristics of study participants who consented 
for HIV testing as compared to those who did not are shown in Table 1. Those who did 
not consent for HIV testing were more likely to belong to older age groups and less 
likely to have HIV.
The proportions of TB suspects who were tested for HIV and found to be HIV 
infected are shown in Table 2. Of the 2465 (85%) of TB suspects tested for HIV, 246 (10%) were 
HIV infected. The HIV prevalence was found to be higher among the age-group 25-44, females 
and ‘TB suspects without TB’.
The newly detected number of HIV patients is shown in Table 3. Among the 246 HIV-
infected patients identified in the study population, 162 (67%) had their HIV status known 
prior to the study and 84 (34%) were diagnosed newly as part of the study. Of the 84 newly-
detected cases of HIV among the population of TB suspects, 70 (83%) were among those 
not ultimately diagnosed with TB, and only 14 (17%) were subsequently diagnosed with 
TB. These are the additional number of HIV cases detected by the strategy of offering HIV 
testing to all TB suspects. Excluding those with prior known HIV status, the number needed 
to screen (NNS) to find an additional HIV case was found to be 25 among ‘TB patients’ and 
was comparable to that among ‘TB suspects without TB’ (Table 4).
The average increase in daily workload at the HIV testing centers due to the 
implementation of this strategy is shown in Table 5.  Most of the centers (27/31) had minimal 
increase in workload with only 1-2 extra clients to be counseled and tested in a day.
DISCUSSION
PITC for TB suspects effectively detected a large number of additional HIV cases and could be 
feasibly implemented with the existing resources within the programme. About 33 % of the 
newly-diagnosed instances of HIV infection in the overall population of TB suspects would 
likely have been missed if HIV testing was applied after TB diagnosis, i.e. to TB cases only. 
We found that overall 10% of the TB suspects tested for HIV were HIV-infected, indicating 
that HIV prevalence among TB suspects is higher than that reported among general 
population in the state of Andhra Pradesh (0.96%) 14, comparable to HIV prevalence among TB 
patients (9%) 11. 
This is one of the first studies from India examining the effectiveness and feasibility 
of implementing the strategy of PITC of TB suspects under programmatic settings. Another 
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study conducted in Mandya district of state of Karnataka in South India showed a HIV 
prevalence of 7% among TB suspects with nearly 40% of the HIV cases newly diagnosed as 
a result of the strategy of routine offer of HIV testing 15. Similar studies from other parts of 
the world, mainly from African countries, indicate that HIV prevalence among TB suspects 
varied from 27% to 63% and was as high as or even higher than among TB patients 3,4,16,17,18,19. 
However, the very high levels of HIV among TB suspects in African countries are reflective of 
the high levels of HIV in their general population. 
Among the 246 HIV-infected patients identified in the study population, 84 (34%) 
were newly diagnosed during the study, but most of these (70) were among TB suspects not 
subsequently diagnosed as TB.  These 70 newly-detected instances of HIV infection reflect 
the additional increase in detection of HIV-infected cases because of offering HIV testing to 
all TB suspects. Clearly, PITC among TB suspects is a very effective strategy of HIV case finding 
in an easily accessible population. 
This study also demonstrated the feasibility of implementation of PITC among TB 
suspects. We found that a great majority of the TB suspects (about 85%) consented for HIV 
testing indicating very high acceptance levels for HIV testing among the TB suspects. Further, 
centre-wise workload analysis indicated that most of the HIV testing centers (27/31) had 
a minimal increase in additional workload with only 1-2 extra clients to be counseled and 
tested in a day. Hence this strategy can be implemented with the existing human resources 
and almost negligible additional burden on the health staff delivering services. If the resource 
investment were still felt to be too great, limiting HIV testing of TB suspects to adults could 
also be considered. A sub-analysis among TB suspects aged 25-54 years indicated that 
examining as few as 17 TB suspects in this age group would yield one additional case of 
HIV. Since, about 90% of all HIV-infected individuals were in this age group and could be 
detected by testing only 60% of TB suspects; selectively adopting the strategy of PITC among 
TB suspects aged 25-54 years would be highly resource-optimizing. 
There are two key considerations and reasons for policy makers to exercise caution 
before implementing this strategy more widely. Firstly, the high HIV testing rates among TB 
suspects in our study was hugely facilitated by the widespread availability of HIV testing 
services co-located with the DMCs. The easy availability of HIV-testing services has been 
shown to be closely associated with HIV testing uptake 20. Co-location of HIV testing services 
at all DMCs is seemingly a pre-requisite for successful implementation of this strategy. 
Secondly, the total number of HIV tests performed can increase substantially as a result of 
this strategy and national programme needs to plan for enhanced procurement and supply 
chain management of HIV testing kits before launching this strategy.
There are other positive implications of this strategy to consider. Firstly, the early 
diagnosis of HIV-infected TB patients and linkage to HIV care and support can potentially 
be life saving. Secondly, this strategy identifies HIV-infected individuals in whom TB has 
been ruled out and who are thus eligible for Isoniazid preventive therapy (IPT) as per WHO 
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guidelines; linking these individuals to early antiretroviral therapy (ART) and IPT can have a 
substantial impact in preventing TB in this vulnerable group.  
There were some limitations to this study. Firstly, about 15% of the TB suspects 
did not consent for HIV testing. Non-consenting TB suspects were more likely to belong 
to older age group who are in general less likely to be HIV infected; hence this could have 
overestimated the overall HIV prevalence. However, if we assume all the untested patients 
were HIV negative, then the minimum HIV prevalence among TB suspects would still be 8.5%. 
Thus our enrollment rate did not change the interpretation of study findings. Secondly, the 
study captured only pulmonary TB suspects attending state-run designated microscopy 
centres. We were not able to assess HIV prevalence among isolate extra-pulmonary TB 
suspects who were not eligible for sputum examination, or TB suspects evaluated at private 
laboratories outside national programme. Furthermore, it was beyond the scope of this 
study to evaluate if offering an early opportunity for HIV testing among TB suspects actually 
translated into early initiation of HIV care and support and the expected morbidity and 
mortality benefits; longer term HIV care outcomes should be the subject of future operational 
research.
TRANSLATING RESEARCH FINDINGS INTO POLICY
Acknowledging the strong evidence found as part of this study and another study conducted 
simultaneously in another district of South India 15, the National Technical Working Group 
(NTWG) of TB/HIV collaborative activities took a policy decision to implement PITC among TB 
suspects in high HIV settings (states of Karnataka, Andhra Pradesh, Tamil Nadu, Maharashtra, 
Manipur and Nagaland) in India. It was further recommended that PITC among TB suspects 
be piloted in 1-2 high prevalence states (and select districts in other high prevalent states, 
at all microscopy centres with co-located HIV testing facility) for a period of 3-6 months with 
mechanisms for recording and reporting to finalize the operational guidance before scale-up 
to other high HIV settings. 
Considering a high yield of HIV among TB suspects in high prevalent settings, 
which was hitherto unexpected in India, the national policy making body also opined that 
similar surveillance efforts should be conducted jointly by RNTCP and NACP in moderate and 
low HIV settings (states other than the ones mentioned above) of the country and findings 
presented before national policy decision. Given the heterogeneity of HIV epidemic in India 
across states/districts, it is not possible to define a cutoff value of HIV prevalence to decide if 
PITC among TB suspects is justified. Hence, it has been agreed that if the prevalence of HIV 
among TB suspects is as high as or greater than HIV positivity among the ICTC clients, then 
the strategy of PITC for TB suspects may be justified.
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CONCLUSION
Our study found that the prevalence of HIV among TB suspects was as high as that among 
TB patients and could be an important source of HIV case finding. The strategy of PITC in 
TB suspects was highly effective in detecting a large number of additional HIV cases and 
could be feasibly implemented with minimal additional workload on existing health staff. 
HIV testing of TB suspects aged 25-54 years demonstrated higher yield for a given effort. 
This study contributed towards making routine offer of HIV testing among TB suspects a 
policy in settings with high HIV prevalence. However, programme managers must scale up 
decentralized availability of HIV testing services and ensure availability of HIV testing kits in 
adequate numbers before launching this strategy.
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Table 1: Demographic and clinical characteristics of the study population, Vizianagaram 
district, India, November-December 2010.
Characteristic TB suspects who did not 
consent for HIV testing 
N (%)
TB suspects who consented 
for HIV testing 
N (%)
P value
Total 453 (100) 2465 (100)
Age (years)
18-24
25-34
35-44
45-54
55-64
>65 
43 (10)
71 (16)
86 (19)
79 (17)
87 (19)
87 (19)
220 (9)
417 (17)
569 (23)
561 (23)
473 (19)
225 (9)
<0.01
Sex
Male
Female
317 (70)
136 (30)
1648 (67)
817 (33)
0.19
TB status
TB patients
TB suspects without TB
27 (6)
426 (94)
381 (16)
2084 (84)
<0.01
TB – Tuberculosis; HIV – Human immunodeficiency virus
Table 2: HIV prevalence among TB suspects examined for diagnostic smear microscopy, 
Vizianagaram district, India, November-December 2010.
Characteristic Number of TB suspects 
examined for smear 
microscopy
Number (%) of TB suspects 
with known HIV status
Number 
(%) HIV 
Positive
Total 2918 2465 (84.5) 246  (10.0)
Age (years)
18-24
25-34
35-44
45-54
55-64
>65 
263
488
655
640
560
312
220 (83.7)
417 (85.5)
569 (86.9)
561 (87.7)
473 (84.5)
225 (72.1)
15 (6.8)
86 (20.6)
105 (18.5)
31 (5.5)
8 (1.7)
1 (0.4)
Sex
Male
Female
1965
953
1648 (83.9)
817 (85.7)
147 (8.9)
99 (12.1)
TB status
TB patients
TB suspects without TB
408
2510
381 (93.4)
2084 (83.0)
31 (8.1)
215 (10.3)
TB–Tuberculosis; HIV–Human immunodeficiency virus; CI-Confidence interval
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Table 3: Newly detected HIV infections among TB patients and TB suspects, Vizianagaram 
district, India, November-December 2010.
Category Prior HIV status Known
Prior HIV status 
Unknown
Proportionate increase 
in the number of new 
cases of  HIV
HIV 
Positive 
[a]
HIV 
Positive 
[b]
HIV 
Positive 
[c]
HIV 
Positive 
[d]
[c]/[a+c]
TB patients (n=381) 17 16 14 334 45%
TB suspects without TB
(n=2084)
145 85 70 1784 33%
Total 162 101 84 2118 34%
TB – Tuberculosis; HIV – Human immunodeficiency virus
Table 4: Number needed to screen to find an additional case of HIV, by strategy, Vizianagaram 
district, India, November-December 2010.
Strategy Number with 
Prior HIV status 
Unknown
Number (%) HIV 
Positive
Number Needed to 
Screen (NNS)
HIV testing for all TB patients 348 14 (4.0) 25
HIV testing for TB suspects 
excluding TB patients 1854 70 (3.7) 26
HIV testing for all TB suspects 
including TB patients 2202 84 (3.8) 26
HIV testing of all TB suspects in 
the age group 25-54 years 1331 75 (5.6) 17
TB –Tuberculosis; HIV –Human immunodeficiency virus; NNS-Number needed to screen
Table 5: Increase in workload at HIV testing centres due to strategy of ‘routine HIV testing of 
TB suspects’, Vizianagaram district, India, November-December 2010.
Average increase in number of clients 
tested for HIV per day
Number of ICTCs (N=31)
<3 27
3-5 3
6-10 1
HIV-Human immunodeficiency virus; ICTC-Integrated counseling and testing centre

5.
HIV Testing among Patients with Presumptive Tuberculosis: 
How do we implement in a Routine Programmatic Setting? 
Results of a large Operational Research from India
Kumar AM, Gupta D, Kumar A, Gupta RS, Kanchar A, Rao R, Shastri S, 
Suryakanth MD, Rangaraju C, Naik B, Guddemane DK, Bhat P, Nair AS, Harries AD, Dewan 
P. PLoS ONE. 2016;11(5):e0156487.
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Background
In March 2012, World Health Organization recommended that HIV testing should be 
offered to all patients with presumptive TB (previously called TB suspects). How this is best 
implemented and monitored in routine health care settings in India was not known. An 
operational research was conducted in Karnataka State (South India, population 64 million, 
accounts for 10% of India’s HIV burden), to test processes and learn results and challenges of 
screening presumptive TB patients for HIV within routine health care settings. 
Methods
In this cross-sectional study conducted between January-March 2012, all presumptive TB 
patients attending public sector sputum microscopy centres state-wide were offered HIV 
testing by the laboratory technician, and referred to the nearest public sector HIV counselling 
and testing services, usually within the same facility. The HIV status of the patients was 
recorded in the routine TB laboratory form and TB laboratory register. The laboratory register 
was compiled to obtain the number of presumptive TB patients whose HIV status was 
ascertained, and the number found HIV positive. Aggregate data on reasons for non-testing 
were compiled at district level. 
Results 
Overall, 115,308 patients with presumptive TB were examined for sputum smear microscopy 
at 645 microscopy centres state-wide. Of these, HIV status was ascertained for 62,847(55%) 
among whom 7,559(12%) were HIV-positive, and of these, 3,034(40%) were newly diagnosed. 
Reasons for non-testing were reported for 37,700(72%) of the 52,461 patients without HIV 
testing; non-availability of testing services at site of sputum collection was cited by health 
staff in 54% of respondents. Only 4% of patients opted out of HIV testing. 
Conclusion
Offering HIV testing routinely to presumptive TB patients detected large numbers of 
previously-undetected instances of HIV infection. Several operational challenges were noted 
which provide useful lessons for improving uptake of HIV testing in this important group. 
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INTRODUCTION
According to the World Health Organization (WHO) Global TB Report 2014, an estimated 1.1 
million people globally had HIV-associated tuberculosis (TB), and 360,000 died from HIV-
associated TB in 2013. 1 Three important reasons have been given for this unacceptably high 
death rate: i) in persons with HIV/AIDS, TB was not diagnosed and treated; ii) in patients with 
TB, HIV was not diagnosed and thus co-infected patients were not referred to HIV care and 
treatment; and iii) when the two diseases were diagnosed and treated, this often happened 
far too late to be effective.2 
In March 2012, WHO launched its updated policy on collaborative TB/HIV activities 
to reduce the burden of TB and HIV. This policy uses the same framework as the 2004 WHO 
Policy of TB/HIV collaborative activities, but includes some important new recommendations, 
one of which is that routine HIV testing and counselling should be offered not only to patients 
diagnosed with TB, but also to those with presumptive TB (previously called TB suspects).3 
This recommendation was based on the findings from studies done predominantly in 
sub-Saharan African countries, which show a high HIV prevalence among patients with 
presumptive TB ranging from 27%-64%, sometimes even higher than HIV prevalence among 
TB patients.4-10 However, these findings from HIV endemic settings were not generalizable 
to India, a country with a ‘concentrated’ HIV epidemic (meaning HIV prevalence in general 
population remains lower than 1%).11 Hence, despite recommendations from WHO, routine 
HIV testing had been offered only to ‘TB patients’ and not to all ‘patients with presumptive 
TB’ in India. Operational research conducted in two districts of South India in 2010 showed 
that the HIV prevalence among presumptive TB patients can be as high as that among TB 
patients ranging from 7%-10%, and that ‘Provider initiated HIV testing and counselling’ (PITC, 
a term used when health care providers actively offer the HIV testing to certain patient groups) 
among presumptive TB patients can be feasibly implemented in settings with decentralized 
HIV testing facilities with potential for increased HIV case finding, early treatment initiation 
and reduction in mortality and morbidity.12, 13 
The National Technical Working Group (NTWG) for joint TBHIV collaborative 
activities in India acknowledged the strong evidence and took a policy decision to implement 
PITC among presumptive TB patients in high HIV settings in India.14  However, how this is best 
implemented and monitored in routine health care settings, especially when implemented at 
large scale, was not known, and this implementation-knowledge gap needed to be addressed. 
The roles and responsibilities of the different staff officers were unclear, and mechanisms for 
recording and reporting in routine settings had not been tested. So, NTWG recommended the 
pilot implementation of PITC in one State of India for a period of 3-6 months to finalize the 
operational guidance before scale-up to other high HIV settings.14 Accordingly, a pilot study 
was implemented in the entire state of Karnataka (South India, population 64 million, high 
HIV prevalence). Karnataka State was chosen for two main reasons: 1) Large state enabling 
to test operational feasibility of the strategy when PITC is implemented to scale 2) relatively 
CHAPTER 5
74
high HIV prevalence and better TB-HIV related health infrastructure compared to other 
states in India. Duration of three months was chosen for the pilot so as to understand the 
operational challenges.
This paper describes the screening procedures deployed (including mechanisms 
for recording, reporting and monitoring), the experience of implementation, results and 
challenges of screening presumptive TB patients for HIV within routine health care settings 
of Karnataka State, India. 
The specific objectives were to assess
1. the proportion of patients with presumptive TB whose HIV status was ascertained, disaggregated 
district-wise
2. the proportion HIV positive among those who had their HIV status ascertained, disaggregated 
district-wise
3. the reasons for not ascertaining the HIV status, from the perspective of the health care-provider 
4. the number of HIV cases “newly” diagnosed and the number eligible for antiretroviral therapy (ART 
eligibility was assessed using WHO-2013 ART guidelines [all TB patients irrespective of CD4 count 
and for presumptive TB patients without TB, a CD4 count <500/mm³ was considered ART eligible] 
in line with the recent decision of national AIDS control organisation in India)15, 16
5. The number needed to screen (NNS) to find an additional case of HIV-infection among “patients 
with presumptive TB ” in comparison to “confirmed TB patients” and those in reproductive age 
group (25-54 years).
6. The average increase in daily workload at the HIV testing centers  as a result of using this strategy 
(obtained by dividing the total number of Presumptive TB patients who underwent HIV testing by 
average number of working days in each centre)
MATERIALS AND METHODS
ETHICS APPROVAL
Approval of the competent national (Central TB Division and National AIDS Control 
Organization) and state authorities (State TB Cell and Karnataka State AIDS prevention 
and control society) was obtained for conducting this pilot. Ethics approval was obtained 
from Institutional Ethics Committee of the National Tuberculosis Institute, Bangalore, India. 
Individual written informed consent from each patient was not taken separately for the 
study as this was intended to be a pilot programme implementation and standard operating 
procedures of National AIDS Control Programme (NACP) were followed for counselling and 
HIV testing, which included obtaining written consent. The same was approved by the ethics 
committee including waiver of a separate informed consent. Given the programmatic nature 
of the study and availability of local ethics approval, the Ethics Advisory Group of International 
Union Against Tuberculosis and Lung Disease waived the need for ethics review. Data was 
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maintained securely by programme staff and electronic databases contained no personal 
identifiers. 
DESIGN 
This was a cross-sectional, implementation research study conducted among patients with 
presumptive TB examined for diagnostic smear microscopy within the routine health services 
of the state of Karnataka, India.
SETTING
Karnataka has an estimated 0.21 million people living with HIV in 2011 and accounts for 
about 10% of country’s HIV burden.11 Hence, the state has been classified as ‘high priority’ 
for HIV interventions by the National AIDS Control Organization (NACO) in India on the basis 
of consistently high HIV sero-prevalence rates of >1% among antenatal women and >5% in 
other high risk groups. 17, 18 In the state, tuberculosis control programme services are available 
through a decentralized network of peripheral health institutions which provide general 
health services including diagnosis and treatment for TB. 
Patients with presumptive TB (defined as people with cough for two weeks or more 
with or without other symptoms suggestive of TB) are identified at the peripheral health 
centres and referred for sputum smear microscopy to Designated Microscopy Centres (DMCs), 
which are geographically distributed, each covering a population of 0.05 to 0.1 million. In 
situations where the patient is unable to physically visit the DMC, the sputum is collected and 
transported by the health care workers in the general health system or non-governmental 
organizations. The diagnosis of TB is made in accordance with national guidelines, and all 
diagnosed TB patients are treated with standardized fully intermittent thrice-weekly short-
course regimens (6-9 months) administered under direct observation. Such patients are 
registered at one of the 125 sub-district level TB programme management units (which are 
administrative and supervisory units for every 10-15 peripheral health institutions) according 
to Indian programme guidelines. 19 
As per national policy, HIV status is routinely ascertained for TB patients, and HIV-
infected TB patients are provided Cotrimoxazole Preventive Therapy and referred to Anti-
Retroviral Treatment (ART) centres for initiation on ART. 20 TB patients are referred for free HIV 
counselling and testing to one of the 1637 ‘integrated counselling and HIV testing centres’ 
(ICTC, these are peripheral health institutions with HIV testing services) throughout the state. 
At the time of the study, about 90% of DMCs had co-located HIV testing services. Free ART is 
provided through a network of 44 ART centres (with at-least one ART centre in every district), 
where HIV-infected patients (including TB patients) are started on treatment and care. Once 
patients were clinically stable on ART, they were referred to one of 121 Link-ART centres in 
the state, closer to the patient’s residence for continuing on ART. These service delivery sites 
under NACP follow the national guidelines for counselling, testing, care and treatment of 
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HIV-infected patients. 21 In line with the higher burden of HIV, there is a higher density of HIV 
testing and care centres in the northern parts of the state. 22
STUDY POPULATION
All patients with presumptive TB examined for diagnostic smear microscopy at the DMCs of 
Karnataka state from January-March 2012 formed the study population.
SAMPLE SIZE AND SAMPLING
Since this was a pilot study intended to be implemented under programmatic conditions 
to answer questions of feasibility, it was decided to enrol all patients with presumptive TB 
(including children aged 0-14 years) examined for smear microscopy during the pilot period 
in all the 31 districts of the state. No patients were excluded. For this reason, sample size 
calculations were deemed not relevant for the study.
PLANNING AND IMPLEMENTATION
Following the decision of NTWG and based on the official government orders from the 
Revised National Tuberculosis Control Programme (RNTCP) and NACP, joint-meetings were 
organized between the state level programme managers for planning and rolling out the 
activities, training of the staff and ensuring supply chain management of HIV test kits. 
All staff involved in data collection, data validation and data entry were trained in 
carrying out the respective procedures. The District TB Officers, District nodal officer of HIV/
AIDS and WHO Consultants of the respective study district were trained at state level as master 
trainers who then trained the district level staff and oversaw the smooth implementation of 
study. The trainings were conducted jointly for the implementing staff (TB field supervisors, 
Laboratory technicians of DMCs and HIV testing centres, Counsellors of HIV testing centres) 
by programme managers of the state level with support from WHO consultants. 
Regular supervisory visits were conducted by the state level programme managers 
(once a month), WHO Consultants (once a fortnight) and district programme managers (once 
a fortnight). Periodic review meetings were conducted to assess the progress of the pilot and 
address any implementation issues.
The screening procedures and the patient flow in the health system are shown in 
Fig 1-3 and described in Table 1. 
Since this was a pilot study and the objective was also to study the processes, 
separate data collection forms were used to capture individual patient information which 
included information on presence or absence of a co-located ICTC, age, sex, sputum smear 
result, HIV status, prior HIV status and CD4 count. These variables were extracted into a pre-
tested structured data collection format by the Senior TB laboratory supervisor (STLS) in co-
ordination with the LT and the counsellor at the HIV testing centre. STLS then coordinated 
with the district TB/HIV supervisor and referred to the HIV patient records maintained at the 
ART centre to obtain information on the baseline CD4 count. Aggregate data on reasons for 
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non-testing were extracted from the remarks column of the laboratory register and compiled 
at district and state level. Once the pilot period (January-March 2012) was over, the separate 
data collection formats were discontinued.
DATA VALIDATION 
The STLSs were trained in extracting data from the laboratory register accurately and 
expected to visit the DMCs under their purview once a week to ensure that activities were 
implemented as per protocol including recording of HIV status in the laboratory register. This 
was in turn monitored by District TB Officer and the WHO field consultant once in a fortnight.
DATA ENTRY & ANALYSIS
In this multi-centre study, we used a method of coordinating data capture by utilizing a 
combination of three open access sources (EpiData for data entry, Dropbox for sharing data 
and TeamViewer for trouble-shooting remotely).23 All data entry was done by the district-
level data entry operators working for RNTCP. The technique has been detailed elsewhere.23 
Double data entry, validation and analysis were done using EpiData software (version 3.1 for 
entry and version 2.2.2.182 for analysis, EpiData Association, Odense, Denmark). Given the 
large numbers in the study, it is expected to find statistical significance even when the actual 
differences between groups are small. Hence, we have refrained from showing results of any 
statistical tests and make all the interpretations from programmatic point of view. 
RESULTS
Data was obtained from all the 31 districts in the state. This included 645 microscopy centres, 
among which 573(89%) had HIV testing services available in the same facility. A total of 
115,308 patients with presumptive TB [40% female, mean age of 44 years] were examined for 
sputum smear microscopy. HIV status was ascertained for 62,847 (55%) among whom 7,559 
(12%) were found to be HIV positive. 
The proportion whose HIV status was ascertained along with HIV positive results, 
disaggregated by age, sex and smear-positivity, is shown in Table 2. HIV testing varied little 
[ranged between 50% and 57%] across age groups and sexes. HIV testing rates were two 
times higher among patients visiting microscopy centres with co-located HIV testing facilities 
as compared to those without. Patients with confirmed smear-positive TB were more likely to 
be tested for HIV as compared to those with other types of TB. HIV testing rates varied between 
15% and 95% across districts with districts in the northern part of the state performing better 
as compared to southern part (Table 3, Fig 4). 
HIV positivity tended to be lower among elderly age groups, marginally higher 
among females as compared to males and varied between 3% and 28% across districts – 
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with a higher positivity in districts located in the northern part of the state. HIV positivity was 
similar among smear-positive and smear-negative patients (Table 3, Fig 5).
Of all presumptive TB patients in the study, 4525 were already diagnosed as HIV 
positive prior to the study. Of the remaining 110783 patients with unknown status prior to the 
study, HIV status could be ascertained for 53627 (48%) patients, in whom an additional 3034 
HIV positive patients were identified.  Thus, of a total of 7,559 HIV-positive patients identified, 
3,034 (40%) were newly diagnosed with HIV infection as a result of this screening effort. 
Among 3,034 newly diagnosed HIV cases, ART eligibility could be assessed for 2,244 (74%) 
of whom 1,992 (89%) had CD4 count <500 and were found to be eligible for ART initiation. 
(Table 4)
When hypothetically comparing potential policies for HIV testing, the option of 
limiting HIV testing to adults in 25-54 years was most efficient. In this analysis, we excluded 
patients with previously known HIV status and examined the yield of HIV among those with a 
previously unknown HIV status. (Table 5)
The reasons for non-ascertainment of HIV status, collected from 37,300 (72%) of 
the 52,461 patients without HIV testing, is shown in Table 6. The key reason for non-testing 
was related to the fact that sputum samples were collected at peripheral health institutions 
and transported to microscopy centres instead of referring patients. 
A workload assessment indicated that the median [inter quartile range] increase in 
the number of clients to be tested for HIV per day as a result of this intervention was 2 [1-2]. 
About 90% of the HIV testing centres had an increase of less than or equal to five clients per 
day (Table 7).
DISCUSSION
The study showed that the strategy of HIV testing among patients with presumptive TB could 
be feasibly and effectively implemented within the routine health system. We consider the 
intervention was feasible for the following reasons: 
1. All the interventions including recording and reporting were implemented in a large state by the 
existing staff and resources. One of the major strengths of this study is that it was done with complete 
engagement of the national programmes from the stage of planning to execution, monitoring, 
recording and reporting. The existing programme resources were used for implementing all the 
activities without the need for any extra budget. There was a total increase in the need for HIV test 
kits which in turn needed optimisation of supply chain management and we need to factor-in this 
aspect in future procurement cycles. 
2. There was minimal additional workload in the HIV testing centres. Barring a small proportion of 
tertiary care institutes with high patient load, the average daily increase in number of patients 
requiring to be tested was low at more than 95% of HIV testing centres. In centres which had an 
increase of more than 10 clients tested per day, additional staff may need to be deployed. 
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3. Only 4% of the patients opted out of HIV testing indicating high acceptability of this intervention 
among the patient population. 
We consider the strategy to be effective as it led to finding thousands of new HIV-
positive patients who were ART eligible. Nearly 40% of the 7559 HIV-positive cases were ‘newly 
diagnosed’ as a result of this strategy with almost 90% of them eligible for ART as per the 
existing criteria for starting ART. Nearly half of all presumptive TB patients were tested for HIV, 
although district-wise analysis indicated large variability. This is probably due to variation in 
availability of HIV testing facilities and their co-location at the sputum microscopy centres. 
There are several important points that merit discussion. First, while WHO now 
recommends routine HIV testing of all presumptive TB patients, the operational guidance as 
to how to do this is lacking. This is among the first studies to fill that gap and addresses an 
area of global priority. This was also a national priority and addressed a specific request from 
the NTWG of Government of India.14 Previous studies on this issue have focussed on assessing 
prevalence of HIV among presumptive TB patients rather than testing implementation 
models in routine programme settings. 4-10 These findings were presented back to NTWG 
and a decision to nationally scale up this intervention across all high HIV settings was made. 
Changes in recording and reporting have already been adopted by the national TB and 
HIV programmes in India. While we cannot attribute it directly, we note that some of these 
changes are now reflected in global guidance. 24 
Second, this is one of the largest studies on the issue of HIV testing among 
presumptive TB patients with more than 0.1 million patients screened in a period of three 
months across one of the HIV priority states of India. Being carried out in the routine health 
care setting, this study gives valuable information of the ground realities and challenges in 
implementing a new strategy within the general health system. 
Third, we found that nearly 90% of HIV-infected presumptive TB patients (without 
TB) were eligible for ART. This is similar to the findings of two recent studies from Zimbabwe 
and India.25, 26 As a public health approach, this is another subset of patients (similar to HIV-
infected persons having active TB disease, hepatitis B virus infection with severe chronic 
liver disease, being pregnant or breast feeding, being aged under five years, and living in 
a sero-discordant relationship) in whom ART should be recommended irrespective of CD4 
count. This strengthens the argument about moving towards a HIV ‘test and treat’ strategy 
for presumptive TB patients. This is in line with the recent guidance from WHO which calls for 
starting all HIV patients on ART irrespective of CD4 count.27
Fourth, about half of the presumptive TB patients were not tested for HIV. Not 
surprisingly, HIV testing was more likely in DMCs with co-located HIV testing facilities. This 
justifies the ongoing efforts of the national programmes to prioritise setting up of new HIV 
testing facilities at hospitals having sputum microscopy facilities. This, however, will not 
address the major reason for non-testing in a substantial proportion of presumptive TB 
patients in whom sputum samples were collected and transported from peripheral health 
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institutions to DMCs – such patients will miss the opportunity to get HIV tested at DMC. 
This calls for further decentralization of the HIV testing services to all the peripheral health 
institutions and sputum collection centres and national programmes should seriously 
consider this strategy to improve the uptake of HIV testing. We suggest scaling-up the use of 
rapid HIV screening tests at all the PHIs and those who are screened positive may be referred 
for further testing and confirmation at the ICTCs. The other programmatic challenge is to 
improve the procurement and supply chain management of HIV test kits to enhance HIV 
test uptake. Unavailability of laboratory technician or counsellors at DMC and/or ICTC was 
another reason for lack of HIV testing. This can be addressed by training the other staff within 
the general health system and motivating them to perform HIV testing in line with the overall 
approach to integrate NACP into the general health system and this would be sustainable in 
the long term.
 Fifth, we captured data in an innovative manner using the freely available resources 
for data entry, storage, sharing and trouble shooting. This approach to ensuring quality of 
data capture in multicentre operational research in resource-constrained settings has been 
a great lesson.23 
There were some limitations to our study given the operational nature of the 
study and reliance on routinely collected data. In this pilot, we could not capture the data 
among smear negative presumptive TB patients as to how many were eventually diagnosed 
with smear negative pulmonary TB and extrapulmonary TB. In assessing ART eligibility, 
information on whether the person was living in a sero-discordant relationship would 
have been useful, but was not captured. Including these criteria would have increased the 
number of people eligible for ART and hence the numbers obtained in this study are an 
underestimate. Furthermore, CD4 cell count data were missing in 30% of the HIV positive 
patients. Information on how many newly diagnosed HIV infected presumptive TB patients 
were put on ART and Cotrimoxazole Prophylactic Therapy later was also not documented. 
Information such as this would be very useful to assess if this strategy indeed increased the 
overall number of HIV-infected persons placed on ART and if it reduced the delay in initiating 
ART. Further studies are required to assess this and the impact on reducing overall HIV-TB 
associated mortality. While there could be multiple reasons in an individual for non-testing of 
HIV, only one predominant reason was captured and that too from the provider’s perspective. 
In about one-third of patients, reason for non-testing was not mentioned and this is a serious 
limitation. Further, we do not have any information if this sub-group is similar to the rest in 
whom we know the reason for non-testing. Future research involving qualitative methods 
should be undertaken to understand patients’ perspectives for not getting tested for HIV. 
WHO and Joint United Nations Programme on HIV/AIDS (UNAIDS) have both 
embraced a bold new vision of “90-90-90” strategy which emphasizes the need to detect 90% 
of all HIV infected patients in the community, treat 90% of those detected with antiretroviral 
therapy (ART) and achieve viral suppression in 90% of those treated, and this has been 
reinforced by a similar 90-90-90 vision for TB control from the global STOP TB partnership.28, 29 
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Achieving these ambitious targets will require innovative efforts to find previously undetected 
HIV cases in the community. Testing presumptive TB patients in Karnataka proved to be an 
efficient means of HIV case-finding, and may complement that effort.  
In conclusion, this operational research demonstrated a feasible way to make 
HIV testing among presumptive TB patients a reality in routine health settings. Several 
operational challenges were noted which provide useful lessons for moving forward. 
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Table 1: Operational procedures in provider-initiated HIV counselling and testing among 
patients with presumptive TB in Karnataka state, India, January-March 2012.
Operational 
Procedure
Steps
Procedure at 
Designated 
Microscopy 
Centre 
(DMC)
1. All Presumptive TB patients (including those coming for a repeat sputum 
examination) attending the designated microscopy centre (DMC) for diagnosis of 
TB were offered HIV counselling and testing by the DMC laboratory technician 
(DMC LT). 
2. DMC LT after receiving the first sputum sample, referred the patient to the 
nearest, preferably the co-located HIV testing facility.
a. If the patient was known to be HIV positive (in case of referral from ART centres, 
ICTCs or blood banks), the information regarding the HIV status was recorded 
in the laboratory register and the patient was not referred any further. The date 
of HIV testing was extracted from the ART patient booklet; if not available, the 
approximate date of HIV testing was documented as per patient’s history. The 
information regarding ‘HIV status’ and ‘date of HIV testing’ was documented in 
the RNTCP laboratory register (in a new column added for the purpose).
b. In the case of presumptive TB patients whose HIV status was not known or HIV 
negative, LT referred them to the nearest or co-located HIV testing facility.
3. In cases where only the sputum samples reached the DMC (in the absence of the 
patient), it was recorded in the remarks column of the laboratory register. No active 
effort to track and offer an HIV test to such patients was undertaken. However, 
if there was a HIV testing facility at the peripheral health facilities (as in some 
districts like Bagalkot and Belgaum), HIV testing was offered to all presumptive 
TB patients whose sputum was collected at the collection points. The information 
regarding HIV status and date of HIV testing was then collected by DMC LT 
from the collection centres and this was updated in the laboratory register.
4. The counsellor at the HIV testing centre provided the feedback regarding HIV 
status (Positive/Negative/Indeterminate/Opted out) and date of HIV testing in 
the RNTCP laboratory form for sputum examination. A new field to capture 
HIV status and date of HIV testing was created in the RNTCP laboratory form 
for sputum examination. DMC LT updated the laboratory register based on the 
feedback on the laboratory form. Alternatively, the DMC LT discussed with the 
counsellor at the end of the day and updated the HIV status in the laboratory 
register – this is as per the national guidelines of shared confidentiality among 
health care providers for providing optimum care for the patient. 
5. The predominant reason for not ascertaining the HIV status, wherever known, was 
recorded in the remarks column.
Procedure at 
the Integrated 
Counselling 
and HIV 
Testing Centre 
(ICTC)
1. Presumptive TB patients coming to the ICTCs were offered counselling and 
testing as per the norms and standard operating procedures of the NACP. 
2. All referrals were recorded in the ICTC counselling register as referrals from 
RNTCP. 
3. Presumptive TB patients who were known to be HIV positive and patients who 
had tested HIV negative within last 6 months were not re-tested. Patients who had 
an indeterminate result were re-offered the HIV test.
4. For patients with HIV positive results, the counsellor linked these patients to the 
nearest ART centre available in the district/state. This was done by giving a referral 
form and explaining to the patient about how to access the centre. The patient was 
given the contact details of the district programme managers for any assistance.
5. The counsellor then documented the HIV status in the RNTCP laboratory form 
as feedback to DMC LT. The counsellor also assisted the DMC LT to update the 
laboratory register with information on HIV status. 
CHAPTER 5
86
Recording 1. RNTCP laboratory form for sputum examination (Fig 2): A new field was created 
to capture the HIV status and date of HIV testing which was completed by the 
counsellor/LT at the HIV testing centre wherein one of the following options was 
noted – Positive, Negative, Indeterminate, Opted out.
2. RNTCP laboratory register (Fig 3): A column to capture HIV status was added in 
the laboratory register (Positive, Negative, Unknown)
Reporting The following indicators were added in the monthly report submitted by each DMC 
to RNTCP 
1. Of Presumptive TB patients examined for diagnosis, number with known HIV 
status
2. Of above, number HIV positive 
This information was then compiled quarterly in the district and State level 
programme management reports and reported in routine RNTCP surveillance.
Table 2: Ascertainment of HIV status and HIV positivity among patients with presumptive TB 
in Karnataka state, India, January-March 2012.
Parameter Number examined 
for sputum smear 
microscopy
Number (%) with HIV 
status ascertained
Number 
(%) HIV 
Positive
Total 115308 62847 (55) 7559 (12)
Age (years)
00-14
15-24
25-34
35-44
45-54
55-64
>65 
Unknown
3808
12804
19595
20707
20336
18808
18857
393
1887 (50)
7326 (57)
11276 (57)
11738 (57)
11080 (55)
10022 (53)
9448 (50)
70 (18)
252 (13)
514 (7)
2157 (19)
2580 (22)
1333 (12)
510 (5)
205 (2)
8 (11)
Sex
Male
Female
Transgender
Unknown
69189
46068
7
44
37498 (54)
25335 (55)
6 (86)
8 (18)
4088 (11)
3465 (14)
5 (83)
1 (13)
Sputum Smear status
Smear Positive
Smear Negative
9789
105519
7071 (72)
55776 (53)
802 (11)
6757 (12)
HIV testing facility
Not co-located
Co-located
6248
109060
1784 (29)
61063 (56)
114 (6)
7445 (12)
TB–Tuberculosis; HIV–Human immunodeficiency virus
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Table 3: Ascertainment of HIV status and HIV positivity among patients with presumptive TB, 
district-wise, in Karnataka state, India, January-March 2012.
Parameter Number examined 
for sputum smear 
microscopy
Number (%) with HIV 
status ascertained
Number 
(%) HIV 
Positive
Bagalkot
Bangalore City
Bangalore Rural
Bangalore Urban
Belgaum
Bellary
Bidar
Bijapur
Chamarajanagar
Chikkaballapur
Chikmagalur
Chitradurga
Dakshina Kannada
Davanagere
Dharwad
Gadag
Gulbarga
Hassan
Haveri
Kodagu
Kolar
Koppal
Mandya
Mysore
Raichur
Ramanagara
Shimoga
Tumkur
Udupi
Uttara Kannada
Yadgiri
3351
9524
2054
5311
8569
3533
2987
2801
2735
2523
2928
2365
4116
3156
3899
2237
4348
4938
2223
1317
2733
2435
5026
6962
3201
3052
3576
5955
2455
3783
1215
3021 (90)
2330 (25)
591 (29)
816 (15)
8122 (95)
2827 (80)
2540 (85)
1873 (67)
899 (33)
1307 (52)
1169 (40)
1613 (68)
2761 (67)
1070 (34)
3261 (84)
1321 (59)
1835 (42)
2374 (48)
877 (40)
661 (50)
1841 (67)
2032 (83)
2327 (46)
2407 (35)
2595 (81)
1463 (48)
1788 (50)
3391 (57)
1187 (48)
1573 (42)
975 (80)
812 (27)
251 (11)
39 (7)
61 (8)
959 (12)
380 (13)
137 (5)
530 (28)
117 (13)
91 (7)
84 (7)
71 (4)
170 (6)
250 (23)
451 (14)
216 (16)
193 (11)
156 (7)
113 (13)
33 (5)
283 (15)
446 (22)
187 (8)
180 (8)
444 (17)
38 (3)
209 (12)
405 (12)
84 (7)
97 (6)
72 (7)
Table 4: Antiretroviral therapy (ART) eligibility in newly diagnosed HIV among patients with 
presumptive TB, Karnataka state, India, January-March 2012.
Characteristic TB patients Presumptive TB 
patients without TB
Total
Number of newly diagnosed HIV cases 
Number (%) assessed for ART eligibility
Number (%) ART eligible 
Median (IQR) CD4 count
395
395 (100)
395 (100)
149 (74-290)
2639
1849 (70)
1597 (87)
195 (89-361)
3034
2244 (74)
1992 (89)
189 (87-355)
Table 5: Number needed to screen (NNS) to find one new (previously undiagnosed) case of HIV, 
by hypothetical strategy, Karnataka state, India, January-March 2012.
Strategy Number with 
previously unknown 
HIV status tested for 
HIV
Number (%) 
HIV Positive
NNS
HIV testing for all smear-positive TB patients 
HIV testing for all presumptive TB patients 
HIV testing of all presumptive TB patients in  
 the age group 25-54 years
6035
53627
27769
395 (6.5)
3034 (5.7)
2408 (8.7)
15
18
11
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Table 6: Reasons for non-ascertainment of HIV status among presumptive TB patients, 
Karnataka state, India, January-March 2012.
Reasons for non-ascertainment of HIV status Number Percentage
Sputum specimens reaching microscopy centre instead of presumptive TB 
patients
Non-availability of HIV test kits
Non-availability of staff (Laboratory Technician, Counsellor) at the time 
of referral (due to leave, outreach duty, travel to attend meetings)
HIV testing facility not co-located at microscopy centres
Opted out of HIV testing
Other reasons (lack of awareness among staff, gaps in recording, refusal to 
test due to workload, non-referral due to misconceptions of the staffs, 
death)
20,454
7,179
3,681
2,332
1,659
2,395
54%
19%
10%
6%
4%
7%
Total 37,700* 100%
* Data about reasons for non-testing was available from 37,300 (72%) of the 52,461 patients 
Table 7: Increase in workload at HIV testing centres due to strategy of ‘routine HIV testing of 
presumptive TB patients’, Karnataka state, India, January-March 2012.
Average increase in number of 
clients tested for HIV 
Number (%)
(based on actual numbers 
tested for HIV)
Number (%)
(assuming all TB suspects will 
be tested for HIV)
1-2 clients per day
3-5 clients per day
6-10 clients per day
>10 clients per day
396 (69.5)
141 (24.7)
31 (5.4)
2 (0.4)
252 (44.2)
224 (39.3)
79 (13.9)
15 (2.6)
HIV-Human immunodeficiency virus;  
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Figure 1. Flow Chart depicting the patient flow and the recording and reporting mechanism, PITC among 
presumptive TB patients, Karnataka, India, 2012
PITC-Provider initiated HIV testing and counselling; HIV-Human immunodeficiency virus; TB-tuberculosis; 
RNTCP-Revised National Tuberculosis Control Programme; PHI-Peripheral Health Institutions; TU-Tuberculosis 
Unit; LT-Laboratory Technician; DMC-Designated Microscopy Centre; PMR-Programme Management Report
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Figure 2. Modified format of laboratory form for sputum examination, PITC among presumptive TB patients, 
Karnataka, India, 2012.
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME 
Laboratory Form for Sputum Examination 
Name of Referring Health Facility: ____________________ Date: ___________ 
Name of patient: _______________________________ Age: ____ Sex: M �  F �  
Complete address: ________________________________________________ 
________________________________________________ 
Contact Phone number / Mobile No.:  __________________________________ 
Type of suspect / disease:    �  Pulmonary 
         �  Extra-pulmonary  Site: ______________ 
Reason for examination: 
�  Diagnosis   
�  Repeat Examination for Diagnosis 
�  Follow-up examinations  
� For new and previously treated cases - Month of follow-up ………………….  
� For MDR-TB cases – Month of follow-up ……………………… 
Treatment Regimens (tick ü appropriate box):  
�   New cases   �  previously treated   �   MDR-TB  
 
 Patient’s TB No. ____________    
 (Name and signature of referring person/ official) 
 
If sputum samples are being transported: 
Specimen identification No.: __________ Date of sputum collection: __________ 
Specimen Collector’s name and signature ______________________________ 
 
Sputum microscopy results (To be completed in the laboratory of DMC) 
Name of DMC: ___________________________________________________ 
Lab. Serial No.: __________________________________________________ 
 
Date of 
examination Specimen 
Visual 
appearance  
(M, B, S)* 
Results 
(Neg or 
Pos) 
Positive (grading) 
 
3+ 2+ 1+ Scanty** 
 A       
 B       
* M = Mucopurulent, B = Blood stained, S = Saliva 
** Write actual count of AFB seen in 100 oil immersion fields 
Date: ______________                                 Signature of Lab. Technician 
HIV test results (To be completed by counselor / LT at HIV testing centre) 
HIV Test result: �   Negative   �  Positive   �  Indeterminate   �  Opted out  
Date of HIV testing:    PID Number: 
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Figure 3. Modified format of laboratory register, PITC among presumptive TB patients, Karnataka, India, 
2012.
R
EV
IS
ED
 N
AT
IO
N
A
L 
TU
B
ER
C
U
LO
SI
S 
C
O
N
TR
O
L 
PR
O
G
R
A
M
M
E 
LA
B
O
R
A
TO
R
Y	
R
EG
IS
TE
R
	
La
b.
 
Se
ri
al
	
N
o.
 
D
at
e 
N
am
e	
in
	F
ul
l 
A
ge
 
Se
x	
M
/F
 
 
Co
m
pl
et
e	
ad
dr
es
s	
(f
or
	n
ew
	p
at
ie
nt
s)
	
Ph
on
e	
N
o.
 
N
am
e	
of
	
re
fe
rr
in
g	
H
ea
lt
h	
Fa
ci
lit
y 
R
ea
so
ns
	f
or
	E
xa
m
in
at
io
n*
 
R
es
ul
ts
 
H
IV
	
st
at
us
	
(P
,N
,U
)	
Si
gn
 
R
em
ar
ks
 
D
ia
gn
o
si
s 
Fo
llo
w
-u
p 
A
 
B
 
TB
 
N
o.
 
R
eg
im
en
 
N
T/
PT
 
M
on
th
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
� 
If
	s
pu
tu
m
	is
	e
xa
m
in
ed
	fo
r	
di
ag
no
si
s,
	p
ut
	a
	t
ic
k	
(P
)	m
ar
k	
in
	t
he
	s
pa
ce
	u
nd
er
	“
D
ia
gn
os
is
”	
sp
ut
um
	is
	e
xa
m
in
ed
	fo
r	
re
pe
at
	d
ia
gn
os
is
,	p
ut
	‘R
E’
	in
	t
he
	s
pa
ce
	
un
de
r”
	D
ia
gn
os
is
”	
	
� 
If
	s
pu
tu
m
	is
	fo
r	
fo
llo
w
-u
p	
of
	p
at
ie
nt
s	
on
	t
re
at
m
en
t,
	w
ri
te
	t
he
	p
at
ie
nt
’s
	T
B
	N
o.
	in
	t
he
	s
pa
ce
	u
nd
er
	“
Fo
llo
w
	u
p”
,	t
re
at
m
en
t	
re
gi
m
en
	a
nd
	m
on
th
	o
f	f
ol
lo
w
	u
p	
� 
Po
in
ts
	t
o	
be
	m
en
ti
on
ed
	in
	t
he
	r
em
ar
ks
	c
ol
um
n:
	d
at
e	
of
	s
ta
rt
in
g	
tr
ea
tm
en
t,
	t
re
at
m
en
t	
re
gi
m
en
,	T
B
	N
o,
	R
ef
er
ra
l	d
et
ai
ls
,	M
D
R
-T
B
	s
us
pe
ct
	id
en
ti
fie
d	
an
d	
re
m
ar
ks
	o
n	
un
bl
in
de
d	
re
ch
ec
ki
ng
	o
f	s
lid
es
	d
ur
in
g	
O
SE
	v
is
it
s	
by
	t
he
	S
TL
S,
	e
tc
.	
� 
H
IV
	s
ta
tu
s:
	P
-P
os
it
iv
e;
	N
-N
eg
at
iv
e;
	U
-U
nk
no
w
n	
CHAPTER 5
92
Figure 4. Ascertainment of HIV status among patients with presumptive TB, district-wise, in Karnataka state, 
India, January-March 2012.
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Figure 5. HIV positivity among patients with presumptive TB, district-wise, in Karnataka state, India, January-
March 2012.

6.
Efficient quality-assured data capture in operational research 
through innovative use of open-access technology
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Summary
Ensuring quality of data during electronic data capture has been one of the most neglected 
components of operational research. Multicentre studies are additionally challenged with 
issues about logistics of travel, training, supervision, monitoring and troubleshooting 
support. Allocating resources to these issues can pose a significant bottleneck for operational 
research in resource-limited settings. In this paper, we describe an innovative and efficient 
way of coordinating data capture in multicentre operational research using a combination 
of three open access technologies – EpiData for data capture, Dropbox for sharing files and 
TeamViewer for providing remote support.
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INTRODUCTION
‘Quality-assured data entry’ has been aptly described as the ‘Cinderella’ of medical research, 
the most neglected one.1  Though there are several ways of reducing data entry errors, 
‘double data entry and validation’ has been considered the definitive gold standard2 – where 
data are entered independently twice and value pairs compared for discordances, followed 
by resolution of discordances by referral to the original data source.3  However, a review of all 
publications in the International Journal of Tuberculosis and Lung Disease in the year 2008 
indicated that only 2/43 published articles related to tuberculosis (TB) epidemiology actually 
mentioned achieving this standard while more than half did not even mention anything 
about data quality.4 This tendency to unquestioningly presume data quality in published 
research is highly questionable!  Despite the easy availability of high-quality open-access 
tools for quality-assured data capture, the concept has seemingly been grossly neglected 
from academic curricula in medical and public health schools. The challenge to assure 
data quality gets compounded if the context is a multi-centric research study involving 
multiple study sites and personnel; costs of travel for training, supervision, monitoring and 
troubleshooting support are often substantial. These costs can become a significant barrier 
to assuring data quality while conducting high-quality operational research, especially in 
resource-limited settings. In this paper, we describe a model that innovatively used multiple 
open-access tools in a multi-centric operational research project with efficient use of 
resources. 
CONTEXT
The subject of this operational research project was the implementation of provider-initiated 
HIV counselling and testing for patients with presumptive TB under routine programmatic 
conditions in the State of Karnataka, India.  This State has a population of about 62 million 
and is divided into 31 districts spread across ~192,000 km2 and extends to about 750 km from 
north to south and about 400 km from east to west.  The study took place between January 
and March 2012. As part of this intervention, every patient with presumptive TB attending 
the microscopy centre was assessed for HIV status by the laboratory technician.  Those with 
unknown HIV status were referred to the nearest HIV testing facility. HIV test results were 
captured by trained staff in a structured paper-based data collection form with measures 
built in to ensure data validity. Once the data were on paper, the forms were brought to the 
district TB centre for compilation and electronic capture. This meant that data entry would 
occur at 31 sites across the state and the responsibility was assigned to the data entry 
operator of the district under National Tuberculosis Programme. 
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INNOVATION: SETTING UP THE DATA CAPTURE SYSTEM FOR EACH SITE
We used three tools to set up the system for data entry.
First, we used EpiData Entry version 3.1 (EpiData Association, Odense, Denmark, 
http://www.epidata.dk) to design the data capture instrument. In addition to being open-access, 
this tool offers several advantages: small size of the software and the data files, non-interference 
of the software with the operating system of the user’s computer during installation, excellent 
capabilities for inbuilt checks during data entry to reduce the frequency of data entry errors and a 
simple option that allows double data entry and validation.  Most importantly, it is user-friendly, 
making it easy to teach and learn. 
Second, we used Dropbox (http://www.dropbox.com) to share the folders with each 
other over the web (See Box). The principal investigator (PI) designed the data capture formats in 
EpiData and placed them in a district-specific Dropbox folder (thus 31 folders, one for each district) 
and an invitation was sent by email to each district data entry operator to join the shared folder. 
Once the user accepted the invitation and had installed Dropbox, the software created the shared 
folder on their local computer. This provided the powerful, simultaneous option of both offline 
data entry and online file synchronization. The option of offline data entry ensured that continuous 
internet connectivity is not required during data entry. Online synchronization meant near real-
time sharing of data with the PI and data safety through online backup. Any need to change the 
structure of data capture instrument to suit needs of an individual site could be achieved very 
easily by manipulating the files in the shared folder by the PI. Without this instrument, a physical 
visit would have been required or considerable time expended in back-and-forth emailing of files.
Third, we used TeamViewer (http://teamviewer.com) to provide support remotely to the 
individual sites for initial set-up and troubleshooting (See Box). We used this software to connect 
to the district computers and set up the data capture system including software installation. This 
was also utilised as a training opportunity. After establishing telephone contact, the PI explained 
and demonstrated the use of the data capture system. The user was then allowed to enter data of 
a few records under PI supervision, allowing resolution of any early problems. Thereafter, if the user 
encountered any problem during data entry, he or she would connect with the PI on TeamViewer 
to actually show the error and get it resolved almost immediately. A problem that required an in-
person visit to resolve hitherto could now be solved very easily and efficiently over a TeamViewer 
session!
DATA ENTRY
Once the system for data capture was set up, the data entry operators entered the data twice in files 
designated for the purpose already placed in the shared Dropbox folder. Once they finished data 
entry, this was communicated to the PI over email. Then the PI performed a ‘data validation’ (‘data 
compare’) between the two databases and generated a validation report listing discrepancies 
between the two databases, placing the report in the Dropbox folder. The data entry operator was 
informed and requested to refer to the original data for corrections and finalization.
EFFICIENT QUALITY-ASSURED DATA CAPTURE IN OPERATIONAL RESEARCH THROUGH INNOVATIVE 
USE OF OPEN-ACCESS TECHNOLOGY
99
Ch
ap
te
r 6
WHAT WAS ACHIEVED? WHAT RESOURCES WERE REQUIRED?
In a span of three months, data on nearly 115,000 study participants were electronically 
captured while ensuring the highest standards of data quality coordinated across 31 sites. 
The PI was assisted by three colleagues working for the TB control programme in the state 
in ensuring that the data capture system was set up in their respective districts. These three 
colleagues also had access to the shared folders on Dropbox. They together co-ordinated 
data capture in a period of three months beyond and above their routine job responsibilities. 
DISCUSSION
This is an innovative use of open-access technology to coordinate data capture in a multi-
centric operational research project across 31 sites. While internet connection is decisive 
for success, the system does not require a large bandwidth nor ‘always-on’ capability: since 
EpiData file sizes are small (1000 records required 216 kilobytes only!), bandwidth is of minor 
importance; since Dropbox has the option of offline access to shared folders, uninterrupted 
internet connection is not required for data entry, a major pre-requisite in web-based data 
capture systems. Telephone costs can be circumvented, if required, by using Skype™ (http://
www.skype.com), which was used for periodic video conference calls among the PI and 
co-investigators for monitoring the project. A recent study5 has shown that an alternative 
to double entry could be ‘Automatic Forms Processing’ (a method by which one can 
‘automatically’ capture information entered into data fields by scanning, and converting it 
into an electronic format through techniques like ‘Optical Mark Recognition’ or ‘Intelligent 
Character Recognition’), but this is applicable only in highly structured questionnaires with 
only check boxes, numbers and no dates.5 Further this would also require relatively expensive 
equipment and computer expertise, often not available in resource-limited settings.
Overall, this model for data capture proved highly efficient in terms of optimum 
utilization of resources including time and we feel that it can be easily replicated in any 
resource-limited setting for operational research.
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BOX
WHAT IS DROPBOX?
Dropbox is a file hosting service operated by Dropbox Inc. that offers cloud storage and 
file synchronization. Dropbox uses a ‘Freemium’ business model, where users are offered 
a free account with a set storage size (2 Giga Bytes in this case) and paid subscriptions 
for accounts with more capacity. Dropbox allows users to create a special folder on each 
of their computers, which Dropbox then synchronises so that it appears to be the same 
folder (with the same contents) regardless of the computer it is viewed on. Files placed 
in this folder are also accessible through a website and mobile phone applications. Such 
folders can be shared with others for mutual access. 
More information at www.dropbox.com 
WHAT IS TEAMVIEWER?
Team Viewer is a secure software package for remote control, desktop sharing, online 
meetings, web conferencing and file transfer between computers. TeamViewer is a tool 
that makes it incredibly easy to set up and use a Virtual Private Network connection 
that lets you take complete control of another computer from your own computer via 
internet. It enables two-way connections in which users can flip control back and forth. 
While TeamViewer is proprietary, it is free to non-commercial purposes. 
More information at www.teamviewer.com 
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Setting
Puducherry, a low HIV prevalence (<1% among antenatal women) district in South India.
Objectives
(1) Among presumptive TB patients, to (i) estimate the proportion whose HIV status was 
ascertained and found HIV positive (ii) describe the demographic and clinical characteristics 
of those whose HIV status was not ascertained; (2) To assess the additional workload at HIV 
testing centers.
Design
Cross-sectional study – consecutive presumptive TB patients attending microscopy centers 
for diagnosis during March-May 2013 were asked if they knew their HIV status. Patients with 
an unknown HIV status were offered voluntary counseling and HIV testing.
Results
Of 1886 presumptive TB patients, HIV status was ascertained for 842 patients (44.6%) and 
28(3.3%) were HIV positive. The uptake of HIV testing was significantly higher in younger age 
groups, males, residents of Puducherry and smear positive TB patients. The median (range) 
increase in number of clients tested for HIV per day per testing center was 1 (0-6). 
Conclusion
The uptake of HIV testing was low. HIV prevalence was higher among presumptive TB patients 
than antenatal women and as high as in TB patients. With minimal increase in workload at 
HIV testing centers, HIV testing could be feasibly implemented using existing resources.
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INTRODUCTION
Globally, in the year 2011, there were an estimated 0.43 million deaths from tuberculosis (TB) 
among people who were human immunodeficiency virus (HIV)-positive.1 This high number 
of deaths is unacceptable given that HIV is manageable, though with life-long anti-retroviral 
therapy, and drug-sensitive TB is curable. 
The World Health Organization (WHO) in the year 2012, updated its policy on TB/HIV 
collaborative activities recommending provider initiated HIV testing and counseling (PITC) of 
not only TB patients but also ‘patients with presumptive tuberculosis’ (erstwhile referred to 
as TB suspects) to enable early diagnosis of HIV and linkage to structured HIV care.2, 3  The 
strategy of routinely offering HIV testing to patients with presumptive TB offers the potential 
for early HIV diagnosis and treatment which may reduce morbidity and mortality. Studies 
in sub-Saharan Africa and India have shown that the HIV prevalence among persons with 
presumptive TB is as high as among those with diagnosed TB, with prevalence rates varying 
according to the epidemiological context. 4-7 
Acknowledging the strong evidence, 6, 7 the National TB and HIV programs in India 
took a joint policy decision to implement PITC among patients with presumptive TB in high 
HIV settings (HIV prevalence >1% among pregnant women and >5% among High risk groups), 
namely the states of Karnataka, Andhra Pradesh, Tamil Nadu, Maharashtra, Manipur and 
Nagaland, and further recommended that similar surveillance efforts should be conducted 
in moderate and low HIV settings (HIV prevalence <1% among pregnant women and/or <5% 
among High risk groups) to inform national policy decision.8 
To address this knowledge gap, we undertook a study with the aim of assessing HIV 
test uptake and HIV positivity among presumptive TB patients in Puducherry, a district with 
low HIV prevalence in South India. The specific objectives were (1) to estimate the proportion 
of presumptive TB patients whose HIV status was ascertained and found HIV positive (2) to 
describe the demographic and clinical characteristics of presumptive TB patients whose HIV 
status was not ascertained (3) to assess the additional workload at HIV testing centers due 
to PITC strategy.
METHODS
STUDY DESIGN
 This was a health facility based cross-sectional study.
STUDY SETTING
The study was conducted in the Puducherry district, one of the four districts in the Union 
Territory of Puducherry with a population of ~1 million. Puducherry district is bordering 
a high HIV prevalence district (Cuddalore and Villupuram districts in Tamil Nadu state) 
and health facilities in Puducherry, including its eight medical colleges, have attracted 
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patients from neighboring districts for TB diagnostic services. Under the Revised National 
Tuberculosis Control Programme (RNTCP), TB diagnosis and treatment services are offered 
through the existing primary health care system. ‘Patients with presumptive TB’, defined as 
anybody with a cough of two weeks or more with or without other symptoms are examined at 
Designated Microscopy Centers (DMCs) in the district.  All diagnosed TB patients are treated 
free of charge with fully intermittent, thrice weekly short course chemotherapy administered 
under direct supervision (DOTS) as per the national guidelines. HIV diagnostic and treatment 
services are offered free of charge as per the national guidelines through a network of eight 
stand-alone HIV testing centers and one anti-retroviral therapy (ART) center.9 Of 18 DMCs 
in the district, 13 DMCs have HIV testing facility located in the same facility. As part of TB/
HIV collaborative activities, HIV testing is routinely offered to all TB patients treated in the 
RNTCP.  Those who are found to be HIV positive are referred to the ART center for further 
evaluation and management, including initiation of ART. During 2012, 96% of TB patients 
were ascertained for HIV and 2% were found to be HIV-infected in Puducherry district. 
The corresponding figure for the neighboring districts of Cuddalore and Villupuram was 5% 
in both districts. 10 
STUDY POPULATION AND STUDY PERIOD
Adult patients (aged 18 years and above) with presumptive TB attending designated 
microscopy centers (DMC) for diagnostic sputum smear microscopy between 15th March, 
2013 and 10th May, 2013 constituted the study population. Of a total of 18 DMCs in the district, 
7 DMCs were excluded. Of 7 DMCs, 5 DMCs didn’t provide HIV testing services and 2 DMCs 
didn’t give administrative permission to conduct the study. Presumptive TB patients who 
didn’t come to the DMC but had their sputum collected and transported were excluded. 
DATA COLLECTION PROCEDURE
Patients were asked if they already knew their HIV status by the RNTCP laboratory technician 
(LT) trained for the purpose. Those with unknown HIV status were referred to HIV testing 
center and offered voluntary counseling and HIV testing as per national guidelines.9 RNTCP 
laboratory technicians and staff of HIV testing centres received training on HIV testing and 
counseling six months before the study as part of their routine in-service training.
STUDY VARIABLES AND SOURCE OF DATA
The data variables related to the study objectives were captured in a structured data 
collection proforma. The original sources of data were RNTCP laboratory registers and the 
records at the HIV testing centers. To assess the workload of each HIV testing center, the total 
number of clients counseled during the study period was collected and compared with the 
increase in the number of clients counseled due to the PITC strategy.
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DEFINITIONS OF KEY OUTCOMES
We calculated the following key indicators – i) Proportions of ‘presumptive TB patients’ 
ascertained for HIV status, ii) Proportions of ‘presumptive TB patients’ found HIV positive, 
iii) The number (proportion) of all HIV cases diagnosed newly as the result of the strategy of 
‘PITC of presumptive TB patients’, iv) Number needed to screen (NNS) to find an additional 
case of HIV, v) The average increase in daily workload at the HIV testing centers calculated 
center wise by dividing the total number of presumptive TB patients who underwent HIV 
testing by the average number of working days during the study period.
DATA ENTRY AND ANALYSIS
Dual data entry, validation and analysis was done using EpiData entry software (Version 3.1 
for entry and 2.2.2.180 for analysis, EpiData Association, Odense, Denmark).11 We used chi‐
square tests for comparing proportions and a p-value of < 0.05 was considered as statistically 
significant.
ETHICS CONSIDERATIONS
We obtained informed consent from study participants and standard operating procedures 
(SOPs) of the National AIDS Control Programme (NACP) were followed for counseling and HIV 
testing.9 Ethics approval was obtained from the Ethics Advisory Group of the International 
Union Against Tuberculosis and Lung Disease, Paris, France and the Institutional Ethics 
Committee (IEC) of Indira Gandhi Medical College, Puducherry.
RESULTS
Of 2135 patients who underwent diagnostic sputum smear microscopy, 67 were excluded 
because sputum samples were transported instead of patients. Of the remaining 2068, 1886 
(91.2%) were ≥ 18 years and eligible for the study. Of these, the HIV status was ascertained 
for 842 patients (44.6%) and 28 (3.3%) were HIV positive (Table 1). Of the 28 HIV cases, 13 
(46%) knew their HIV status and 15 (54%) were newly identified due to the PITC strategy. 
The number needed to screen (NNS) to find one new HIV positive patient was 56. The NNS 
was relatively lower among patients in the 35-44 year age group, males and those 
with a positive smear.
The demographic and clinical characteristics of study participants according to the 
uptake of HIV testing are shown in Table 2. The uptake of HIV testing was significantly lower 
in older age groups, females, patients residing outside Puducherry (study area) and smear 
negative TB patients. 
Due to the implementation of the PITC strategy, in most (8/11) of the HIV testing 
centers 1–2 extra clients per day were counseled and tested. In the remaining three centers, 
the increase in workload was 3-5 clients per day. The median (range) increase in the number 
of clients tested for HIV per center per day was 1 (0-6).
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DISCUSSION
This is one of the first studies from India examining the effectiveness and feasibility of 
implementing the PITC strategy for presumptive TB patients in a low HIV prevalence setting 
under routine programmatic conditions. Overall, the HIV testing uptake was low with less 
than half of presumptive TB patients getting their HIV status ascertained.  The uptake was 
higher among smear positive TB patients which could be attributed to the existing national 
policy of PITC among TB patients. The uptake was lower in older age groups, females and 
those who were smear negative. As smear negative patients form a larger group with a higher 
contribution to overall number of new HIV cases detected and given higher likelihood of HIV 
positive individuals being smear negative, this group should not be missed.  Reasons for the 
low uptake are unknown but possible reasons could be a low self-perceived risk of HIV in 
older age groups, hesitation among providers in offering an HIV test, losses in the referral 
process and deficiencies of recording and reporting.  In comparison to our findings, the 
uptake of HIV testing was higher in the states of Karnataka and Andhra Pradesh at 92% and 
85% respectively.6,7 These states have a high HIV prevalence and the high uptake could be 
due to greater awareness among the patients and providers about the need for HIV testing.
The other important finding was a relatively high HIV prevalence (3.3%) among 
presumptive TB patients who got tested as compared to antenatal clinic attendees (<1%), TB 
patients (2%) and  clients attending HIV testing centres excluding pregnant women (1.6%).10, 
12 Nearly 60% of HIV cases identified were newly diagnosed as a result of PITC. This confirms 
the findings from other studies that ‘presumptive TB patients’ could be a target group for 
PITC. 6,7 Failing to test for HIV in this group represents a missed opportunity in diagnosing HIV 
infection. The number needed to screen (NNS) to find one new HIV positive patient was 56 
overall and 81 among presumptive TB patients whose sputum smear was negative. The NNS 
was lower among the age group 25-54 years and nearly 80% of all new HIV patients diagnosed 
were in this age group. To optimize the use of existing resources, the national programme 
may selectively offer HIV testing to patients in the age group 25-54 years. As expected, the 
HIV positivity was higher among patients of neighbouring states, with a relatively higher HIV 
prevalence. This is another group that could be targeted for HIV testing.
The implementation of the PITC strategy did not pose a burden to the staff of the 
HIV testing centres according to our study findings. The additional workload at most of the 
HIV testing centres increased by two extra clients per day, even after assuming a 100% uptake. 
Hence HIV testing for presumptive TB patients is feasible and could be implemented using 
existing human resources. However, the overall requirement for HIV test kits would increase 
substantially and the HIV programme should properly plan procurement and supply chain 
management to ensure the uninterrupted supply of HIV test kits. 
The study had a few limitations. First, the study could not be implemented in five 
DMCs due to the absence of HIV testing services, a pre-requisite for the implementation of 
PITC. Second, nearly 50% of patients were not tested for HIV with higher proportions among 
older age groups who were likely to have a lower HIV prevalence. This could have led to an 
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overestimation of HIV prevalence in our study. Third, we could not ascertain the reasons 
for non-testing; well-designed qualitative studies are required for a better understanding. 
Fourth, we could not assess CD4 counts of HIV positive patients and linkage to care services. 
This would be essential to assess if the PITC strategy actually impacts on mortality and 
morbidity of HIV-positive patients and could be a topic of future research. 
CONCLUSION
Though the uptake of HIV testing was low, the HIV prevalence was higher compared to antenatal 
clinic attendees and as high as in TB patients. The PITC strategy could be implemented with 
existing resources with a minimal increase in workload at HIV testing centers. We recommend 
that HIV testing should be routinely offered to presumptive TB patients, especially those in 
age-group 25-54 years and the reasons for non-testing needs detailed evaluation. Further 
studies in similar settings across India are required to confirm these findings before wider 
scale-up decisions.
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Table 1: HIV test uptake, HIV positivity and number needed to screen among presumptive TB 
patients, Puducherry, South India, March – May 2013.
Characteristic Total 
Number
Number (%) 
HIV status 
ascertained
Number (%)
HIV Positive
Number (%)
New cases of 
HIV Positive
NNS
Total 1886 842 (44.6) 28 (3.3) 15 (1.8) 56
Age (years)*
18‐24
25‐34
35‐44
45‐54
55‐64
>65
215
332
336
378
335
277
118 (54.9)
187 (56.3)
149 (44.3)
175 (46.3)
129 (38.5)
82 (29.6)
1 (0.8)
7 (3.7)
10 (6.7)
5 (2.9)
4 (3.1)
1 (1.2)
0 (0.0)
3 (1.6)
6 (4.0)
3 (1.7)
3 (2.3)
0 (0.0)
NA
62
25
58
43
NA
Sex
Male
Female
1138
748
534 (46.9)
308 (41.2)
20 (3.7)
8 (2.6)
12 (2.2)
3 (1.0)
45
103
Residence
Puducherry
Other states
1327
559
617 (46.5)
225 (40.3)
16 (2.6)
12 (5.3)
6 (1.0)
9 (4.0)
103
25
Sputum Smear
Positive
Negative
192
1694
114 (59.4)
728 (43.0)
7 (6.1)
21 (2.9)
6 (5.3)
9 (1.2)
19
81
HIV–Human immunodeficiency virus; NNS-Number needed to screen; NA-Not applicable;
*Age missing for 13 study participants.
Table 2: Factors associated with HIV test uptake among presumptive TB patients, Puducherry, 
South India, March - May 2013.
Characteristic Number (%) HIV 
status ascertained
Number (%) HIV 
status not ascertained
P value
Total 842 1044 
Age (years)*
18‐24
25‐34
35‐44
45‐54
55‐64
>65
118 (14.0)
187 (22.3)
149 (17.7)
175 (20.8)
129 (15.4)
82 (9.8)
97 (9.4)
145 (14.0)
187 (18.1)
203 (19.7)
206 (19.9)
195 (18.9)
<0.001
Sex
Male
Female
534 (63.4)
308 (36.6)
604 (57.9)
440 (42.1)
0.01
Residence
Puducherry
Other states
617 (73.3)
225 (26.7)
710 (68.0)
334 (32.0)
0.01
Sputum Smear result
Positive
Negative
114 (13.5)
728 (86.5)
78 (7.5)
966 (92.5)
<0.001
HIV–Human immunodeficiency virus  
*Age missing for 13 study participants.
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Summary
For certain subgroups within people living with HIV (active tuberculosis, pregnant 
women, under-five children and sero-discordant couples), the World Health Organization 
recommends antiretroviral therapy (ART) irrespective of CD4 count. Another subgroup which 
has received increased attention is ‘HIV-infected presumptive TB patients without TB’. In this 
study, we assess the proportion of HIV-infected presumptive TB patients eligible for ART in 
Karnataka State (population 60 million), India. This was a cross-sectional analysis of data 
of HIV-infected presumptive TB patients diagnosed in May 2015 abstracted from national 
TB and HIV programme records. Of 42,585 presumptive TB patients, 28,964(68%) were 
tested for HIV and 2262(8%) were HIV positive. Of the latter, 377(17%) had active TB. Of 1885 
‘presumptive TB patients without active TB’, 1100(58%) were already receiving ART. Of the 
remaining 789 who were not receiving ART, 617(79%) were assessed for ART eligibility and of 
those, 548(89%) were eligible for ART. About 90% of ‘HIV-infected presumptive TB patients 
without TB’ were eligible for ART. This evidence supports a public health approach of starting 
all ‘HIV-infected presumptive TB patients without TB’ on ART irrespective of CD4 count in line 
with global thinking about ‘test and treat’.
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INTRODUCTION 
With an estimated 36.9 million people living with HIV (PLHIV), 2.0 million new HIV infections 
and 1.2 million deaths in 2014, HIV continues to be the most common infectious cause of 
mortality in the world and has claimed more than 34 million lives so far.1 Anti-retroviral 
treatment (ART) is life-saving for PLHIV and, by the end of March 2015, about 15 million 
PLHIV were receiving ART. HIV is the only infectious disease where treatment is initiated only 
after it becomes clinically severe (assessed using CD4 counts). There have been various reasons 
for this strategy which include prioritizing toxic drugs for those with highest risk of 
progressing to AIDS, concerns about non-adherence and risk of drug resistance if treatment 
is started too early. However, this situation is fast changing with the availability of newer and 
safer antiretroviral medicines and the evidence that early ART is beneficial even in 
asymptomatic PLHIV.2, 3 
WHO and the Joint United Nations Programme on HIV/AIDS (UNAIDS) have both 
embarked on an ambitious vision of “90-90-90”: to detect 90% of all HIV infected patients in 
the community, treat 90% of those detected with antiretroviral therapy (ART) and achieve 
viral suppression in 90% of those treated.4 Given this, there is an increased demand from 
civil society organizations and patient groups to move towards a ‘test and treat’ strategy. 
WHO in 2013 raised the threshold for ART initiation to a CD4 count ≤ 500 cells/uL in adults, 
adolescents and children aged five years and above. For certain patient groups like PLHIV 
having active TB disease, hepatitis B virus infection with severe chronic liver disease, 
pregnant and breast feeding women, children aged under five years, and those living in a 
sero-discordant relationship, ART is recommended irrespective of CD4 count (akin to a ‘test 
and treat’ strategy) (Table 1).5 Another such subgroup which has caught global attention is 
‘presumptive TB patients’ (previously called TB suspects and defined as people with cough 
for two weeks or more with or without other symptoms suggestive of TB), but without TB. 
Several studies from sub-Saharan African countries and Asia, show a high HIV prevalence 
among patients with presumptive TB ranging from 10%-64%, sometimes even higher than the HIV 
prevalence among TB patients prompting WHO to recommend routine HIV testing in such patients.6-14 
A prospective study from Zimbabwe showed that HIV-infected presumptive TB patients are a 
neglected group with only 15% getting ART, while about 85% had CD4 cell counts < 350 cells/uL and 
were eligible for ART at the time.4 However, no study has systematically assessed this aspect in India. 
Hence, in this study, we aim to determine the number of HIV-infected presumptive 
TB patients eligible for ART in a large south Indian state of Karnataka. The specific objectives 
were to determine among a cohort of presumptive TB patients (stratified by whether they 
have TB or not) attending the microscopy centres of Karnataka in May 2015, 
1. Number (proportion) ascertained for HIV status and found HIV positive
2. Among HIV-infected patients, 
 a. number assessed for ART eligibility and found ART eligible
 b. number (proportion) initiated on ART
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MATERIALS AND METHODS
STUDY DESIGN 
This was a cross-sectional study involving secondary analysis of data routinely recorded 
under the Revised National TB Control Programme (RNTCP) and National AIDS Control 
Programme (NACP). 
SETTING
India is considered a country with a concentrated HIV epidemic and contributes to about 
10% of the global burden in absolute terms.1 The HIV epidemic in India is showing a declining 
trend and in 2011, about 2.1 million people were living with HIV in India with an estimated 
0.12 million new infections and 0.15 million deaths.15 
Karnataka state has an estimated 0.21 million people living with HIV in 2011 and 
accounts for about 10% of country’s HIV burden.15 Hence, the state has been classified as 
‘high priority’ for HIV interventions by the National AIDS Control Organization (NACO) in 
India on the basis of consistently high HIV sero-prevalence rates of >1% during sentinel 
surveillance at antenatal clinics.16, 17 In the state, tuberculosis control programme services 
are available through a decentralized network of peripheral health institutions which provide 
general health services including diagnosis and treatment for TB. 
Patients with presumptive TB are identified at the peripheral health institutions 
and referred for sputum smear microscopy to Designated Microscopy Centres (DMCs), 
which are geographically distributed, each covering a population of 0.05 to 0.1 million. In 
situations where the patient is unable to physically visit the DMC, the sputum is collected 
and transported using existing systems and health care workers in the general health 
system or non-governmental organizations. The diagnosis of TB is made in accordance with 
national guidelines. Presumptive TB patients are first tested using sputum smear microscopy 
and if found to be positive for acid-fast bacilli, patients are diagnosed as ‘smear-positive 
pulmonary TB’ and initiated on treatment. Patient with negative smears are given antibiotics 
for a 7-10 days and are tested for smear microscopy again if symptoms persist. If smears 
are negative in repeat sputum microscopy, patient undergoes chest radiography. A diagnosis 
of smear-negative pulmonary TB is made if lesions consistent with TB are found on chest 
radiograph. Patients with a normal chest x-ray and/or whose symptoms were subsided by 
the trial of antibiotics were categorized as ‘presumptive TB without TB’. All diagnosed TB 
patients are treated with standardized fully intermittent thrice-weekly short-course regimens 
(6-9 months) administered under direct observation. Such patients are registered at one of 
the 177 sub-district level TB programme management units according to Indian programme 
guidelines. 18
As per national policy, HIV status is routinely ascertained for all presumptive TB 
patients, and HIV-infected TB patients are referred to Anti-Retroviral Treatment (ART) centres 
for initiation on ART and Cotrimoxazole Preventive Therapy (CPT).19 HIV status is ascertained 
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at ‘integrated counselling and HIV testing centres’ (ICTC) spread throughout the state, which 
are usually co-located with sputum microscopy services. HIV is diagnosed based on three 
positive rapid tests as per national guidelines.20 Free ART is provided through a network of 
64 ART centres (with at-least one ART centre in every district), where HIV-infected patients 
(including TB patients) are offered treatment and care. There are 194 Link-ART centres in 
the state which offer follow-up services at decentralized locations for HIV patients who are 
clinically stable on ART. These service delivery sites under NACP follow the national guidelines 
for counselling, testing, care and treatment of HIV-infected patients. 21 In line with the higher 
burden of HIV, there is a higher density of HIV testing and care centres in the northern parts 
of the state.22
STUDY POPULATION AND STUDY PERIOD 
All patients with presumptive TB examined for diagnostic smear microscopy at the DMCs of 
Karnataka state in May 2015 constituted the study population. Patients attending for ‘Re-
examination’ and follow-up examination were not included.
DATA COLLECTION PROCEDURE AND DATA VARIABLES 
For objective 1, we collected aggregate data on number of presumptive TB patients examined 
for smear microscopy, number tested for HIV and number HIV positive. For the HIV-infected 
presumptive TB patients, individual patient data was collected using a structured, pre-tested 
data collection proforma. The data variables included laboratory number, age, sex, TB 
diagnosis (smear positive TB / smear negative TB / extra-pulmonary / No TB), TB treatment 
(Yes/No), WHO clinical staging, latest CD4 lymphocyte count (at the time of registration for 
newly detected HIV patients or latest available count for patients already receiving ART), 
ART status (Already on ART before visiting DMC/started on ART after DMC visit/Not started 
on ART). These variables were extracted from the TB laboratory register and TB treatment 
register of RNTCP and pre-ART patient register, patient ART card and HIV-TB register of NACP. 
Information on whether the patient is diagnosed as smear-negative TB or extra-pulmonary 
TB was extracted by referring to the TB register.
Data was collected by the ‘district PMDT/TBHIV co-ordinators’ working for RNTCP 
and trained in the study protocol under the supervision of WHO consultants and state-level 
government programme officers working for the TB and HIV programmes.
DATA ENTRY AND ANALYSIS 
Aggregate information from each district was collected using an Excel format. For capture of 
patient-wise data, we used a combination of three open access sources (EpiData for data entry, 
Dropbox for sharing data and TeamViewer for trouble-shooting remotely). The technique has 
been detailed elsewhere.23 Data entry was done by the data entry operators of the respective 
districts, trained for the purpose. Double data entry, validation and analysis was done using 
EpiData software (version 3.1 for entry and version 2.2.2.182 for analysis, EpiData Association, 
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Odense, Denmark). ART eligibility was assessed using WHO-2013 ART guidelines (CD4 count 
of <500, WHO clinical staging 3 and 4, children under the age of 5, all HIV-TB patients) as the 
NACP in India has agreed in principle to adopt the recommendations.24, 25 In addition, if a 
patient was documented as ‘ART eligible’ in the records and started on ART (even though 
there was no full documentation of CD4 counts and/or WHO clinical staging), we considered 
such patients to be eligible for ART for this analysis. 
ETHICS 
Administrative approval to conduct the study and access the data was obtained from the 
State Tuberculosis Cell of Government of Karnataka. Ethics approval was obtained by the 
Ethics Advisory Group of International Union Against Tuberculosis and Lung Disease, Paris, 
France. Since the study involved a secondary analysis of routine programme records, the 
need for individual patient consent was waived by the ethics committee.
RESULTS
A total of 42,585 presumptive TB patients underwent sputum smear microscopy in 680 DMCs 
of 31 districts of Karnataka State, of whom 28,964 (68%) were ascertained for HIV status and 
2262(8%) were found to be HIV positive. (Figure 1) The median (interquartile range, IQR) age 
of HIV-infected patients was 38 (30-45) years and about half of them were males.
TB DIAGNOSIS, TB TREATMENT AND ART
Of 2262 HIV-infected presumptive TB patients, 377(17%) were diagnosed to have active TB 
and of them, 370(98%) were initiated on TB treatment. Of 377 TB patients, 194(52%) had 
smear positive pulmonary TB, 122(32%) had smear negative pulmonary TB and 61(16%) had 
extra-pulmonary TB. Of the TB patients, 210 (57%) were receiving ART prior to TB diagnosis. 
Of the remaining 167, 122(73%) were started on ART after TB diagnosis. Thus, a total of 332 
(88%) were receiving ART during TB treatment. 
PRESUMPTIVE TB PATIENTS WITHOUT ACTIVE TB: ART ELIGIBILITY AND ART INITIATION
Among the 1885 ‘presumptive TB patients without active TB’, 1100(58%) were already 
receiving ART prior to the current visit. Among the remaining 789 who were not receiving ART, 
617 (79%) were assessed for ART eligibility and among them, 548 (89%) were found to be 
ART eligible as per WHO 2013 ART guidelines. Patients who were assessed for ART eligibility 
were similar to those not assessed by age (median age 39 and 40 years respectively, p=0.95) 
and sex (proportion male 49% and 51% respectively, p=0.54). The CD4 distribution and WHO 
clinical staging information of 548 patients who were found to be eligible for ART is shown in 
Table 2. Of those found to be ART eligible, 405 (74%) were initiated on ART. (Figure 1) 
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MEDIAN CD4 COUNTS
Of 2262 patients, 1998 (88%) had information on CD4 counts. The median (IQR) CD4 count 
among patients with active TB was 194 (100-333) as compared to 264 (123-438) among 
‘presumptive TB patients without active TB’ (p <0.001). Among those without active TB, 
median (IQR) CD4 count was significantly higher (p<0.001) among those receiving ART at 281 
(147-450) cells / uL as compared to those not on ART at 226 (92-399) cells / uL.
DISCUSSION
These findings confirm our hypothesis and showed that nine out of ten HIV-infected 
presumptive TB patients (without TB) are eligible for ART as per current WHO guidelines. 
This too is an underestimate as we did not assess all the criteria of ART eligibility in our study. 
For example, we did not have any information about whether the patients in our study had 
co-existing Hepatitis-B infection with severe liver disease or if they were pregnant or if they 
were living in a sero-discordant relationship. Some studies have indicated that nearly 75% 
of PLHIV in India are sero-discordant.26, 27 If we apply this figure to our cohort, then nearly all 
HIV-infected presumptive TB patients would be eligible for ART. Hence, as a public health 
approach to ART initiation, there is a strong case to be made for recommending that all HIV-
infected presumptive TB patients should be initiated on ART irrespective of CD4 count. 
There are a number of advantages with adoption of this recommendation. First, 
this is likely to improve uptake of ART (possibly by removing barriers associated with CD4 
testing) in this vulnerable group. We have observed this in the past with HIV-infected TB 
patients when after adopting a ‘test and treat’ strategy for TB patients, there was a significant 
increase in uptake of ART. The proportion of HIV-infected TB patients receiving ART in India 
increased from 41% in 2008 to 91% in 2014.22 This is observed in our study sample too – 
nearly 90% of HIV-infected TB patients received ART as compared to only 74% among those 
without TB. Despite high uptake of ART among HIV-TB patients in India, mortality remains 
high at 13% emphasizing the need for early diagnosis and ART initiation.22
Second, this is likely to lead to early diagnosis and treatment of HIV, thus preventing 
avoidable mortality, morbidity and improving the quality of life in the long term. HIV testing 
among presumptive TB patients implies moving the HIV testing intervention to an upstream 
level in the TB diagnostic pathway and hence, patients are diagnosed earlier on in the natural 
course of disease. This is substantiated by higher median CD4 counts in our study, among 
presumptive TB patients (without TB) as compared to those with active TB. If active TB can 
be confidently ruled out using more sensitive diagnostic tools such as Xpert MTB/RIF or 
mycobacterial culture, such patients could be potentially eligible for isoniazid preventive 
therapy, which is known to act synergistically with ART in preventing TB. A recent randomized 
controlled trial has shown that early ART along with IPT is likely to provide maximum benefit 
to PLHIV in terms of preventing mortality and morbidity including TB.2 It is essential to rule 
out active TB confidently before starting ART as not doing so might pose a higher risk of 
developing immune reconstitution inflammatory syndrome.
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Third, starting these patients earlier on ART is likely to improve their immune 
status. As observed in our study, the median CD4 counts were higher among ‘HIV-infected 
presumptive TB patients without active TB’ already receiving ART prior to the current visit as 
compared to those who were not on ART. A previous study from Zimbabwe showed that not 
starting these patients on ART led to high mortality and morbidity.4 In addition to individual 
benefits, early ART is also likely to have public health benefits – ART reduces the risk of 
transmission of HIV to partners28 and avoids the operational problem of poor retention in 
pre-ART care.29, 30 
Fourth, as only about 10% of presumptive TB patients were not eligible as per 
current guidelines, adopting this strategy is not likely to place a large additional burden on 
the national ART programme in India. From a public health perspective, this is a step towards 
‘immediate and universal ART’ for every person with HIV in line with the vision of NACP phase-
IV for the period 2012-17. 24
Our study had several strengths. This is the first study from India examining the 
issue of ART eligibility among HIV-infected presumptive TB patients. Since the data come 
from a large and comprehensive sample of patients in a large state in India, the results are 
likely to reflect ground realities and are generalizable to similar high-HIV settings in India. 
However, we need more evidence, especially from low-HIV settings in India before a national 
policy decision can be considered. We used an innovative method of quality-assured data 
capture and this model is likely to be useful in co-ordinating data collection in multicentre 
research studies in resource-constrained settings. 
There were a few limitations mainly related to our reliance on data collected 
routinely by the national TB and HIV programmes. However, we think this is not a major 
limitation as both TB and HIV programmes in the state of Karnataka are well supervised and 
monitored and hence the quality of data is likely to be high. Information on ART eligibility 
(CD4 counts and/or WHO clinical staging) was missing in about one-fifth of the patients. 
Since those assessed for ART eligibility were similar to those not assessed by age and sex, 
we think the results can be extrapolated to those not assessed for ART eligibility. We did not 
have any information on presumptive extra-pulmonary TB patients in our study and this 
should be a topic of future research. Although our recommendations are justified as a public 
health approach, it is important to study the long-term outcomes among the subgroup of 
patients with CD4 count of >500/mm3 and assess if they actually benefit by early initiation of 
ART. We however think early ART will be beneficial based on the evidence of two randomized 
controlled trials which have confirmed the benefit of early ART in preventing death and/or 
AIDS related events.2, 3 These trials have also confirmed that there was no or minimal increase 
in adverse events due to early ART initiation, thus allaying any fears that early ART initiation 
could be detrimental. 
Finally, as the adage goes, ‘what gets monitored gets done’. Hence we need to think 
about ways of monitoring the ART uptake among HIV-infected presumptive TB patients. We 
propose the addition of an extra column in the existing TB laboratory register to capture ART 
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initiation status. From this, two indicators can be calculated: 1) Proportion of presumptive TB 
patients ascertained for HIV 2) Proportion of HIV-infected presumptive TB patients receiving 
ART. These indicators could then be compiled and reported in the quarterly reports of the TB 
programme from the peripheral level to district to state to national levels, finally finding a 
place in global TB and HIV reports. Future operational research should test this and/or other 
models of recording and reporting to find out the most optimal way forward. 
CONCLUSION
In conclusion, about 90% of ‘HIV-infected presumptive TB patients without active TB’ were 
eligible for ART as per WHO-2013 guidelines. As a public health approach, ‘HIV-infected 
presumptive TB patients without TB’ is a vulnerable subgroup qualifying for ‘test and treat’ 
strategy akin to HIV-infected TB patients.
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Table 1: Comparison of WHO guidelines for ART initiation among people living with HIV in the 
year 2010 and 2013.
Population Target Population 2010 ART guidelines 2013 ART guidelines
Adults and 
adolescents
HIV infected 
individuals
CD4 count ≤350 cells/mm3 or 
WHO clinical stage 3 or 4 
regardless of CD4 cell count
CD4 count ≤ 500 cells/mm3  
or 
WHO clinical stage 3 or 4 
regardless of CD4 cell count
HIV infected 
pregnant and 
breastfeeding 
women
CD4 count ≤350 cells/mm3 
regardless of clinical symptoms
or
WHO clinical stage 3 or 4 
regardless of CD4 cell count
Regardless of CD4 cell count or 
WHO clinical stage
HIV infected 
partners in 
serodiscordant 
couple 
relationship(s)
No recommendation 
established
HIV/TB 
co-infection 
HIV/HBV 
co-infection
Presence of active TB disease, 
regardless of CD4 cell count
Evidence of chronic active 
HBV disease, regardless of 
CD4  cell count
No change
Evidence of chronic HBV 
disease with advanced stage 
liver disease (e.g. cirrhosis), 
regardless of CD4  cell count 
Children HIV infected 
children ≥5 years 
old
CD4 ≤350 cells/mm3 
or 
WHO clinical stage 3 or 4 
regardless of CD4 cell count
CD4 count ≤500 cells/mm3  
or 
WHO clinical stage 3 or 4 
regardless of CD4 cell count
HIV infected 
children 1–5 years 
old
1. Between 12 and 24 
months of age, regardless 
of CD4 count or WHO 
clinical stage. 
2. Between 24 and 59 
months of age with CD4 
count of ≤750 cells/
mm3 or CD4% ≤25, 
or whichever is lower, 
regardless of WHO 
clinical stage.
Regardless of CD4 cell count 
and clinical stage
HIV infected 
infants <1 year old
All infants, regardless of CD4 
cell count and clinical stage
No change
WHO-World Health Organization; ART-antiretroviral therapy; HIV-Human immunodeficiency virus; TB – 
Tuberculosis; HBV – Hepatitis B Virus.
CHAPTER 8
126
Table 2: CD4 counts and WHO clinical staging of ‘HIV-infected presumptive TB patients 
without TB’ eligible for ART in May 2015, Karnataka State, India.
WHO Clinical staging
Baseline CD4 
count [cells / 
uL]
Stage 1
N (%)
Stage 2
N (%)
Stage 3
N (%)
Stage 4
N (%)
Unknown
N (%)
Total 
N (%)
<50
50-200
201-350
351-500
501 and above
Unknown
Total 
15 (7)
68 (32)
67 (31)
47 (22)
14 (7)*
3 (1)*
214
19 (10)
86 (44)
52 (27)
24 (12)
13 (7)*
1 (1)*
195
17 (22)
34 (45)
13 (17)
7 (9)
3 (4)
2 (3)
76
9 (60)
5 (33)
1 (7)
0 (0)
0 (0)
0 (0)
15
24 (50)
8 (17)
7 (15)
8 (17)
0 (0)
1 (2)*
48
84 (15)
201 (37)
140 (26)
86 (16)
30 (5)
7 (1)
548
 * These patients (n=32) were documented as ‘ART eligible’ in the programme records and started on ART 
even though the CD4/WHO staging criteria were either not documented or did not match eligibility criteria. 
They were considered ‘ART eligible’ for the purpose of this analysis.
WHO-World Health Organization; ART-antiretroviral therapy; HIV-Human immunodeficiency virus;
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Figure 1. ART eligibility among HIV-infected presumptive TB patients in Karnataka, India, 2015
TB-Tuberculosis; ART-Antiretroviral therapy; HIV-Human Immunodeficiency Virus; On prior ART-Person who 
was receiving ART prior to the current visit to sputum microscopy centre (TB Clinic);
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Setting
‘Structured Operational Research and Training Initiative’(SORT IT) courses are well-known for 
their outputs – nearly 90% participants complete the course and publish in scientific journals. 
Objective
We assessed the impact of research papers on policy/practice that resulted from six SORT IT 
courses initiated between July 2012 and March 2013.  
Design
A cross-sectional study involving email-based, self-administered questionnaires and 
telephone/skype/in-person responses from first and/or senior co-authors of course papers; 
a descriptive content analysis of responses was performed and categorized into themes. 
Results
Of 72 participants, 63(88%) completed the course and course outputs included 81 submitted 
papers, of which 76(94%) were published. Of the 81 papers assessed, 45(55%) contributed 
to a change in policy and/or practice: these included 29 contributing to government policy/
practice change (20 at national, four at sub-national and five at hospital level), 11 to non-
government organizational policy change and five reinforcing existing policy. The changes 
ranged from modifications to monitoring and evaluation tools to redrafting of national 
guidelines to scaling-up existing policies. 
Conclusion
Over half of SORT IT course papers contributed to a change in policy and/or practice. Future 
assessments should include more robust and independent verification of the reported 
change(s) with all stakeholders to improve their rigour/richness. 
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INTRODUCTION
A vital element to assess the success of operational research (OR) is to measure its impact on 
policy and/or practice.1 The International Union Against Tuberculosis and Lung Disease (The 
Union) and  Médecins sans Frontières (MSF) have developed a training model in operational 
research that is well-known for its outputs – nearly 90% of participants successfully complete 
the course and publish in peer-reviewed journals.2 Both The Union and MSF are members of 
the ‘Structured Operational Research and Training Initiative’ (SORT IT), a global partnership 
led by the Special Programme for Research and Training in Tropical Diseases (TDR) at the 
World Health Organization (WHO). The Union/MSF courses are accredited as SORT IT courses.
Two follow-up studies published in 2014 assessed the impact of SORT IT - 74% of 
course papers contributed to changes in policy and practice and participants from the first 
eight SORT IT courses continued to conduct and publish OR after the course.3, 4 A limitation 
of the studies was that the follow-up period was variable, ranging from nine months to three 
years after course completion.3 Since then, we have been more systematic and now contact 
participants eighteen months after course completion to assess the impact of their OR on 
policy and/or practice. In this paper, we describe the self-reported impact of SORT IT course 
papers on policy/practice.  
METHODS
This was a cross-sectional mixed-methods study design with both quantitative and qualitative 
components. This involved email-based, self-administered questionnaires and telephone/
Skype/in-person responses from first and/or senior co-authors. The study population 
included all participants of six SORT IT courses started between July 2012 and March 2013 
and first author and/or senior co-authors of viewpoints that were written in conjunction 
with the courses. These courses were run in Chennai-India (1), Paris-France (1), Luxembourg-
Luxembourg (1), Addis Ababa-Ethiopia (1), Nadi-Fiji (1) and Kathmandu-Nepal (1). 
The questionnaire was sent to course participants as part of routine follow-up, 
about 18 months after the course completion, between December 2014 and March 2015 with 
three months’ time to respond as previously described.(3) A specific question asked whether 
their course-related research contributed to change in policy/practice. If the answer was ‘Yes’, 
participants were asked to provide the details and similarly, if the answer was ‘No’, participants 
were asked to provide the reasons. Where responses were unclear, the first author and/or one 
of the senior co-authors of the paper (who were mentors in the course) were contacted via 
email, telephone and/or skype communication and clarifications were obtained. The verbal 
responses over Skype/telephone/in-person were transcribed in an email and validated for 
their accuracy by respondents. This constituted validation of responses by the respondents. 
In case of viewpoints led by course faculty, either the first author or one of the 
senior co-authors was contacted to find out if the work (usually shared between faculty 
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and participants) contributed to policy change. For every viewpoint, we (AK, RZ and ADH) 
debated if it had impacted policy and arrived at a consensus. 
Claims of policy change were verified by referring to the policy documents or 
minutes of meetings available in the public domain or by contacting the first authors of the 
paper participants, wherever feasible. 
DATA ENTRY AND ANALYSIS
Data were entered into an MS Excel file (Microsoft, Redmond, WA, USA) and a descriptive 
content analysis of responses was performed. The e-mail responses satisfied the criterion 
of ‘low inference descriptors’ as participants did their own transcribing and the responses 
were used directly for content analysis.5 Content analysis was performed manually, given 
the small dataset, by three authors trained in qualitative research methods. The responses 
were classified into the following broad themes: change in government policy and/or 
practice (which is subdivided into national, sub-national and hospital level depending on 
the level of impact) and change in non-government organizational policy and/or practice 
(when decisions were made by non-governmental organizations like MSF or The Union).4 The 
categorization of responses into themes was done by three authors (AK, HS, JP) together for 
enhancing interpretive credibility. Any disagreement between the three authors was resolved 
by consensus after consultation with two senior authors (ADH and RZ). A conservative stance 
was adopted in assessments – whenever there was doubt, the study was deemed not to 
have impacted policy/practice. The Ethics Advisory Group of The International Union Against 
Tuberculosis and Lung Disease, Paris, France, determined that neither ethics clearance nor 
participant informed consent were required for this type of study.   
RESULTS AND DISCUSSION
There were 72 (31 female) participants enrolled in the six courses, of whom 63 (88%) 
successfully completed the course and submitted one or more papers to a scientific journal. 
Selected participants came from 36 countries (34 in Asia with 20 from India, 24 in Africa, 
12 in the South Pacific and one each from Latin America and Europe). The majority of the 
participants were medical doctors (48) followed by research officers (6), nurses (3) and other 
paramedical staff including M&E officers (6). Most were working for government (28) followed 
by non-governmental organizations (24), academia (10) and donors (1). 
OUTPUTS: PUBLICATIONS AND IMPACT ON POLICY/PRACTICE
A total of 81 papers (including nine viewpoints) were submitted for publication, of which 
76 (94%) were published by June 30, 2015. The topics covered included tuberculosis (47%), 
HIV (15%), non-communicable diseases (10%), operational research (10%), maternal and 
child health (7%) and others (tobacco control, neglected tropical diseases, health system 
issues).  All the 72 research papers were led by the course participants of which 67(93%) were 
published. This is in line with the previously published reports of high publication outputs 
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and might be related to strict selection criteria, adherence to timelines and milestones 
coupled with strong hands-on mentorship offered by the programme faculty.3, 4, 6 Of the nine 
viewpoints, two were led by course participants, one by a former SORT IT participant and 
current faculty, one by the course administrator and the rest were led by the course faculty 
and all were published. Very few capacity-building programmes track for outputs, although 
this is fast changing7, and SORT IT creates a benchmark in this area.8 
All study participants responded and of the 81 papers which were assessed, 
45(55%) reported to have contributed to a change in policy and/or practice (Figure). 
This is encouraging and can be attributed to several factors including policy-relevance of 
the research question which was often based on constraints faced by the programmes, 
engagement of policy makers as co-investigators, ownership of results especially when 
programme managers were principal investigators of the research project and other windows 
of opportunity available to individual researchers by virtue of them being in national/state 
level committees.  
However, the outputs are relatively fewer than reported in the previous study 
which reported nearly three-fourths of the studies having impacted policy.4 We speculate 
three reasons: 1) increased rigour and conservative stance in our assessments; 2) change in 
denominator – we used ‘all submitted papers’ as the denominator in this study as compared 
to only ‘published studies’ in the previous assessment. This amendment was made in order 
to mirror the SORT IT course targets and our belief that policy change can happen even 
without/before publication; and 3) Varied profile of course participants – a lower proportion 
of course participants tended to be senior people (including decision makers and national 
programme managers) in the current cohort as compared to previous cohorts, hence less 
likely to act on the research findings. 
Of the 45 papers having an impact, 29 contributed to a change in government 
policy or practice (20 at national level, four at sub-national level and five at hospital level),11 
contributed to a change in non-governmental organizational policy or practice and five added 
additional evidence to existing policies and helped to make national scale-up decisions. The 
changes ranged from taking new policy decisions to redrafting of national technical and 
operational guidelines to scaling-up existing policies to changes in recording and reporting 
leading to improved programme monitoring. Some projects had a policy impact even before 
publication, possibly indicating the ownership of results by the policy makers engaged as 
part of the study. 
CHANGES IN GOVERNMENT POLICY/PRACTICE
CHANGES IN NATIONAL POLICY/PRACTICE
Three papers from the India SORT IT course generated evidence to support shifting from two 
sputum samples to one sputum sample during follow-up sputum microscopy among drug-
sensitive TB patients.9-11 To quote the participant from India, 
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“Yes, there has been a national policy change to switch to one specimen from 
two specimens during follow-up sputum microscopy”
This was verified by referring to the policy documents and government orders issued by the 
National TB Programme in India. 
Two participants from India12,13 mentioned change in national guidelines for screening 
malnourished children for TB, 
“Yes. The new Strategy document being published for elimination of TB 2020, 
has taken in to account the screening of all undernourished children in NRCs 
[Nutritional Rehabilitation Centres]”
A participant from Mongolia reported that her research led to redrafting of national guidelines 
for MDR-TB.14
CHANGES IN SUBNATIONAL POLICY/PRACTICE CHANGE
Some studies contributed to improvements in record keeping, leading to improved 
programme implementation at the district level. A participant from Gazeera State in Sudan 
reported that her study led to modification of monitoring and evaluation tools, including 
introduction of some new variables in the Asthma card and register, and regular monitoring 
for completeness of record keeping.15 A study from Sri Lanka led to the creation of a mid-level 
programme officer post at sub-district level.16
CHANGE IN HOSPITAL LEVEL POLICY/PRACTICE
There were several instances of change in policy at the level of the hospital or institution. A 
study from China led to prolongation of the treatment of TB patients with co-existing diabetes 
mellitus in their hospital.17 In a tertiary hospital in Kenya, management decided to improve 
care of tuberculosis among health workers by providing dedicated space for treatment, 
access to new diagnostics and more budgetary allocation for care.18
In another experience from Rwanda,19 the participant mentioned,
“A few things that we learned from this evaluation have impacted our 
newest offering [of research workshops]: 1) Clinical staff were less likely to 
complete, we believe due to difficulties leaving clinical duties if in the middle 
of consultations/procedures. Solution - we developed online modules to 
complement the course. Individuals who missed could make up sessions (up 
to two out of the 10) using these online modules. 2) Few women enrolled, and 
were less likely to complete. Solution - we allocated 50% of training slots for 
women, and online modules added flexibility for their competing demands. 
3) Assessment targets were not set. The course was changed to require that 
participants had an average of 80%+ on all assessments to graduate.”
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CHANGE IN NON-GOVERNMENT ORGANIZATIONAL POLICY/PRACTICE
A study from Somalia by MSF on telemedicine led to changes in organizational policy for its 
wider application in MSF-assisted health care facilities in rural Kenya and Syria.20 A participant 
from Ukraine referring to her study21 reported, 
“..This research has shown relatively low levels of HIV testing and re-testing 
among most at-risk populations. A new testing mechanism called “Self-
assisted testing” was developed and introduced in 2015 by HIV/AIDS Alliance 
Ukraine.”
Viewpoints were also reported to have led to policy change – particularly at organizational 
level. A paper on open access publications led MSF to take an institutional stance.22 As quoted 
by the lead author of the author in an email, 
“MSF has taken an institutional position to support Open Access. Funds have 
been made available as part of routine country level budgets to cover open 
access costs. This applies for all SORT IT course publications and also those 
from routine operational projects.”
Another viewpoint helped in formalizing changes to the structure and content of SORT IT 
courses run by The Union and MSF.23
LACK OF POLICY CHANGE AND REASONS
Most participants (n=22) who reported ‘no policy change’ did not elaborate on the reasons. 
Those mentioned by a few participants (n=14) could be classified into the following themes: 
lack of priority by the national programmes and institutions, need for more time and more 
evidence for policy change, turnover of decision makers in the ministry and ineffective 
dissemination. One participant from the South Pacific region mentioned that his research 
was not policy-relevant and he did not expect any policy change to happen as a result. This 
underlines the importance of choosing the right research question from a policy perspective. 
A participant from China24 mentioned, 
“No, one reason is that maybe the voice did not reach out to those policy 
makers enough, another reason is that  our policy makers have been focusing 
on setting up a new standard treatment procedure in the health insurance 
system which will regulate clinical practice and thus solve the problem 
brought out by my paper.”  
Some course participants were conservative in their assessment as mentioned previously 
and mentioned a ‘no’ despite some evidence of impact. A participant from China quoted,25 
“No, not sure about the direct effect on policy and/or practice…  But being one 
of the first large cohort studies among the injection drug users who attended 
methadone maintenance programme (MMP) in China, our research added the 
strong and important evidence to the effectiveness of health education in the 
MMP.”
CHAPTER 9
136
One participant from India attributed the lack of policy change to his inability to actively 
follow-up with the national programme,26 
“No. Possible reasons: the findings of my research work were not perceived as 
a priority issue under the national programme. Other reason, I didn’t pursue it 
further as I am not working directly with the programme.”
One of the viewpoints called for uniformity in referencing styles and in particular criticised 
PLoS journals and Tropical Medicine and International Health journal for their challenging 
reference styles in the paper.27 Though the two journals have changed their referencing styles 
and aligned themselves with generic Vancouver style, the authors of the viewpoint were not 
sure if it was due to their paper. Hence they took a conservative stance and decided that their 
view point did not contribute to policy change.  
STRENGTHS AND LIMITATIONS
This study is one of the few attempts to systematically track the effects of operational 
research on policy and practice.4  We believe this type of follow up should be the way forward 
to minimize creation of ‘research waste’ (research that stops at publication and does not 
benefit the populations).28,29  We also call upon journals and researchers to operationalize 
this process and track their publications for policy impact.30 We had a 100% response rate 
and clarifications were sought whenever responses were ambiguous – thus achieving 
participant validation. Three authors did the content analysis and disagreements were 
resolved in consultation with two senior authors – this helped to minimize the subjectivity 
in assessments and to enhance interpretive credibility. An important limitation relates to 
self-reporting of impact by the authors of the papers. This is especially important in case of 
viewpoints led by course faculty who are also involved in assessing for policy impact in this 
paper. While we have tried to mitigate this by verifying official policy documents wherever 
possible and by adopting a conservative stance in our assessments, responder bias cannot 
be completely ruled out. It is also important to note that these assessments were for changes 
in policy and practice, and the further step of determining whether the changes improved 
the health of the population was not part of this study. Finally, we highlight two important 
challenges below which may be of use in future assessments.  
CHALLENGES IN EVIDENCE-POLICY LINKAGE
While many of the SORT IT studies and viewpoints appear to have contributed to policy 
change, it was challenging to find documentary evidence linking the evidence to the policy 
decision. It is one of the limitations of self-reported data. A participant from Swaziland 
mentioned that the policy decision would have happened based on analysis of routine data 
irrespective of its publication in a journal, though the publication increased credibility of 
findings.31 To quote the participant, 
“This is a really an issue of how literally you expect respondents to take the 
question. If I answer the question as it was phrased, then the answer is no 
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- it was not the study per se that led to policy change, but rather the use of 
routine data to feed the advocacy efforts of MSF and CHAI - this would have 
happened regardless of the study. However, it could be argued that the fact 
that we intended to write up the routine data analysis for publication, meant 
that we paid increased attention to data quality which made our analysis 
more reliable, thus improving our advocacy work. In that way, the study could 
be argued to have had policy impact. So, I guess you know what the question 
was trying to get at - if you feel that my answer constitutes a 'yes', then that is 
fine by me.”
In line with our conservative approach to assessment, we took this as ‘no’. The response from 
a participant from Nepal, also highlighted the difficulty in attributing a link between evidence 
and challenge of evidence-policy change,32
“Yes - practice changed to screen all retreatment cases and expand Xpert…  
I am not sure it is because of the study and paper published but there is 
improvement in situation as it was recommended in the paper. The policy 
has been changed to screen all retreatment TB patients for MDR TB as much 
as possible and the Gene Xpert service has been expanded to more places.”
CHALLENGES RELATED TO VARIED INTERPRETATIONS
Different participants interpreted the question of impact differently leading to varied 
interpretations of the effects of their research on policy. Five participants responded that 
their studies provided additional evidence for existing policies which led to national scale-
up decisions. One example was from India where the study provided additional evidence to 
scale-up existing policy - use of LED-FM [light emitting diode fluorescent microscopy] in high 
workload settings of India.33 Another participant from Bangladesh mentioned,34 
“Yes. It had a great effect on policy and practice. Bangladesh NTP [National 
Tuberculosis Programme] gave permission to extend the programme in a 
larger scale.”
In contrast, some participants interpreted that their study did not impact change in policy/
practice even though it supported an existing change. For example, a participant from 
Zimbabwe interpreted the same situation as not having impacted policy change,35 
“No, it provided local evidence to scale up integration of ART in antenatal 
clinics which was already taking place in Zimbabwe”. 
In another instance, a participant from India mentioned his study having impacted policy 
change even though the study simply reinforced existing policy and did not change 
practice.36, 37 On further clarification and discussion over email and phone, he mentioned, 
“Our study findings called for a need to revisit the WHO recommendation of 
switching to same-day diagnosis [in tuberculosis]. With the dissemination of 
this study result, the National TB Control Programme in India took a policy 
decision not to change its current policy as per WHO recommendation.” 
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We agreed with this reasoning and considered the study to have had an impact on policy. 
In conclusion, over half of course outputs resulting from recent SORT IT OR courses 
had contributed to a change in policy and/or practice. Given the complexities in interpreting 
policy impact assessment, future assessments should focus beyond self-reporting of 
data and use more robust and independent verification of the reported change(s) with all 
concerned stakeholders to enhance the richness and rigour of the assessments.
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Figure 1. Outputs from six completed SORT IT operational research courses run in Europe, Africa, Asia and the 
South Pacific during 2012-13ª. 
ª The six courses were run in Chennai-India (1), Paris-France (1), Luxembourg-Luxembourg (1), Addis Ababa-
Ethiopia (1), Nadi-Fiji (1) and Kathmandu-Nepal (1); Outputs were assessed as of June 30, 2015
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SUMMARY
 
In 2009, The International Union Against Tuberculosis and Lung Disease (The Union) 
and Médecins Sans Frontières (MSF) jointly developed a new paradigm for operational 
research capacity building and started a new process of appointing and supporting 
operational research fellows in the field.  This case study describes i) the appointment of two 
operational research fellows in The Union South-East Asia Office (USEA), New Delhi, India, 
ii) how this led to the development of an operational research unit in that organization, iii) 
the achievements over a five year period from June 2009 to June 2014 and iv) challenges 
and lessons learned. In June 2009, the first operational research (OR) Fellow in India was 
appointed on a full-time basis and the second was appointed in February 2012 - both had 
limited previous experience in OR. From 2009 to 2014, annual research output and capacity 
building initiatives rose exponentially and included: i) facilitation at 61 operational research 
training courses / modules; ii) publication of 96 papers, several of which had a lasting impact 
on national policy and practice; iii) providing technical assistance in promoting operational 
research; iv) building capacity of medical college professionals to manage data; v) support 
to programme staff for disseminating their research findings; vi) reviewing 28 scientific 
papers for national or international peer-reviewed journals; and vii) developing 45 scientific 
abstracts for presentation at national and international conferences. The reasons for this 
success are highlighted along with on-going challenges. This experience from India provides 
good evidence for promoting similar models elsewhere.
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OPERATIONAL RESEARCH AND IT’S ROLE IN PUBLIC HEALTH 
From a public health perspective, operational research can be defined as research into 
strategies, interventions, tools or knowledge that can enhance the quality, coverage, 
effectiveness or performance of the health system or disease programme in which the research 
is being conducted.¹  It can be viewed as a spectrum of activities that encompasses reviews 
of data already collected in patient registers, treatment cards, patient files or electronic data 
sets, evaluations of operational practices or assessments of the implementation of new 
strategies and technologies.  
Operational research is often observational in nature, and can involve descriptive 
or cross-sectional studies, retrospective or prospective cohort studies and sometimes 
case-control studies. Recent guidelines for the reporting of observational studies (the 
STROBE statement) provide a logical structured roadmap for this type of research, thereby 
improving its scientific credibility.² In addition, pragmatic, cluster-randomized trial designs 
and qualitative research methods are also being increasingly viewed as within the ambit of 
operational research. Operational research also needs to be conducted within a sound ethics 
framework that includes the principles of informed consent and data confidentiality, and 
in all cases study results should be fed back to the local communities in an accessible and 
understandable manner.³ 
The key role of operational research in improving health programme performance 
is well-recognized, and consequently the subject is strongly promoted by donors and 
technical agencies. For example, The Global Fund Against AIDS, Tuberculosis and Malaria 
(GFATM) recommends an allocation of up to 10% of country grants towards monitoring and 
evaluation including operational research. Given that this is provision is not explicit and 
hidden under ‘monitoring and evaluation’, potential users are often unaware and do not make 
use of this excellent opportunity for programme strengthening. Further, the implementation 
of operational research is weak in many low- and middle-income countries in most need of 
it, and lack of operational research capacity is one of the main reasons behind this.  
THE UNION’S CENTRE FOR OPERATIONAL RESEARCH 
Operational research has always been a priority for the International Union Against 
Tuberculosis and Lung Disease, Paris, France (The Union) owing to visionary leadership of 
great public health leaders like Annik Rouillon, Karel Styblo and Don Enarson who served 
The Union. The initial efforts of OR capacity building included development of a guide,4 
and a training programme that started in 1997 with support of the United States Center 
for Disease Control’s Division of TB Elimination.⁵ The vision at the time was to identify and 
train participants from different countries in quality-assured data capture and analysis and 
research protocol development and encourage them to conduct multi-centric collaborative 
operational research projects. There were several challenges including high attrition among 
the participants and few outputs in terms of publications,6,7 and the initiative could not be 
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sustained mainly due to lack of continued funding. Despite these limitations, this initiative 
sowed the first seeds of OR in the minds of several people who went on to become leaders of 
organizations and marks the first efforts of The Union in OR capacity building. 
On January 1st, 2009, The Union received financial support from Bloomberg 
Philanthropies to establish the Centre for Operational Research and Strategic Information. 
One of the objectives was on promoting operational research and was supported by two 
principal activities: i) to establish a new paradigm for operational research capacity building 
and ii) to appoint and support operational research fellows in the field.  
OPERATIONAL RESEARCH CAPACITY BUILDING:
In March 2009, The Union and Medecins Sans Frontieres Luxembourg (MSF) met in Paris to 
develop a new course for integrated operational research and training that not only teaches 
the principles of the “what, why and how of operational research”, but also incorporates the 
development, implementation and writing up of a research project as an integral part of 
the course.⁸ Training is combined with “doing”, akin to an apprenticeship. The success of a 
participant is judged on whether or not a research project has been designed and completed, 
with a paper submitted to a peer-reviewed journal within the stated time frame of the course. 
The two organizations also track whether these papers have been published, whether the 
research has had any impact on policy and practice,9-11 and whether the skills imparted to the 
participants and their organizations are used after the course to further develop, implement, 
write up and publish other relevant studies.12 
After running courses together for three years, The Union and MSF joined forces 
with the Special Programme for Research and Training in Tropical Diseases (TDR), which is 
based at the World Health Organization (WHO), Geneva, Switzerland. In July 2012 the three 
organizations developed a formal blueprint for training public health programme staff under 
the Structured Operational Research Training Initiative (SORT IT) and has been described 
elsewhere.13  
OPERATIONAL RESEARCH (OR) FELLOWS: 
The Union instituted this new cadre of staff called the “operational research fellow”, whose 
task is to strengthen operational research capacity and implementation in the field (Box 1). 
Fellows are appointed using strict selection criteria and they work within disease control 
programmes or supportive non-governmental organizations in their countries. They work 
full-time or part-time for The Union and are given support and time to carry out relevant 
operational research. Fellows must successfully complete one of the operational research 
courses within their first year of appointment and they are expected to initiate, complete 
and publish their own operational research as well as drive country-based operational 
research. They are on one- or two-year performance based contracts, with one of the key 
milestones being the submission of two papers to peer-reviewed journals by the end of a 
12-month period, failure to achieve this resulting in termination of the contract. Fellows start 
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in junior fellowships, and after two years progress to senior fellowships. After four years, with 
at least eight papers submitted, fellows may be considered for PhD programmes that allow 
submission of published papers to count towards the final degree.  Following this successful 
model, MSF also appointed operational research fellows under the same conditions that 
pertain in The Union. 
PURPOSE OF THE CASE STUDY
The main purpose of this manuscript is to describe i) how the appointment of two operational 
research fellows in the South-East Asia Union Office, Delhi, India, led to the development of 
an operational research unit in that organization, ii) the achievements and their reasons over 
a five year period from June 2009 to June 2014 and iii) challenges and lessons learned. 
DEVELOPING THE OPERATIONAL RESEARCH UNIT IN INDIA:
OR as a strategic direction was always part of the vision of the leadership of the Union South-
East Asia (USEA) Regional office, New Delhi, India and the office of the Executive Director of 
The Union, Paris and several efforts were being made since 2008 to procure funding for OR 
capacity building. In June 2009, the first OR Fellow (SS) in India was appointed on a full-time 
basis. A decision had been made several months earlier between the regional director of The 
Union South-East Asia (USEA) office, Delhi, India, and the director of operational research 
in Paris (ADH) to appoint an OR fellow in India. SS was working as a WHO-RNTCP Medical 
Consultant in the Indian Revised National Tuberculosis Control Programme (RNTCP), was 
keen to learn about operational research. The national programme manager of Indian 
RNTCP and the WHO Medical Officer for Tuberculosis displayed exemplary leadership by 
supporting this appointment, despite human resource constraints at the Central TB Division 
of Ministry of Health and Family Welfare of Government of India. SS submitted his curriculum 
vitae along with references, was interviewed and appointed, with the generic terms of 
reference underpinning the job (Box 1). His previous experience with operational research 
was limited. He had published two papers in peer-reviewed journals, one in 2005 on dengue 
fever as third author and one in 2008 on initial default in tuberculosis patients in India in 
which he was eleventh author.14, 15 He had also had one successful abstract submission for the 
Annual Conference of the Indian Academy of Preventive and Social Medicine in 2005. He had 
never acted as a peer reviewer for a scientific paper and had never been a facilitator on an 
operational research training course. The financial support for his position was through the 
Bloomberg Philanthropies. This appointment marked the formal beginning of operational 
research initiatives in the USEA office. 
In September 2011, the Department for International Development (DFID), UK, also 
started to provide support to enhance operational research capacity building at the Union. 
One of their areas of support was for a regional operational research course for South-East 
Asia along with an additional OR fellow to support SS in India. At the time, there was a WHO-
RNTCP Medical Consultant (AMVK) attending the operational research capacity building 
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course in Paris. He had proven his competence and enthusiasm for operational research 
during the course, and following the same procedures as with SS, he was formally appointed 
in February 2012, with the same generic terms of reference underpinning his tasks. He also 
had no previous experience with operational research. He had published one paper as sole 
author on confidence intervals,16 and had presented a paper at the 22nd Annual conference of 
the Indian Society for Medical Statistics on prevention of parent to child transmission of HIV/
AIDS. He also had never acted as a peer reviewer for a scientific paper and had never been a 
facilitator on an operational research training course.
At the same time that AMVK was undertaking his operational research training, two 
senior staff officers of the USEA Office underwent the same operational research training in 
Paris and this helped in the creation of an enabling environment for operational research 
in the office. A research associate position was also established and filled to support a 
tuberculosis knowledge, attitude and practice survey funded by the Global Fund Against 
AIDS, Tuberculosis and Malaria in 2012. Thus, a small team began to be established in the 
office. These factors ensured that operational research featured as one of the six strategic 
goals of the “Vision 2020” document which details the plan, goals and strategic directions for 
the USEA office for the period 2012-20.
ACHIEVEMENTS AND REASONS FOR SUCCESS:
The achievements are summarised below:
SUCCESSFUL COMPLETION OF THEIR OPERATIONAL RESEARCH COURSES:
SS completed the first ever operational research capacity building course held at The Union 
Headquarters in Paris with two operational research projects on paediatric tuberculosis and 
recurrent tuberculosis in India, both of which were published.17, 18 AMVK similarly completed 
the second operational research capacity building course in Paris with one project on 
antiretroviral therapy in HIV-infected TB patients in India.19
FACILITATION AND MENTORSHIP ON FURTHER OPERATIONAL RESEARCH COURSES:
Both OR Fellows went on to facilitate at modules of other operational research courses, with 
SS starting his facilitation career in June 2010 and AMVK in February 2012. The details of the 
modules at which each fellow facilitated each year are shown in Table 1. Up to June 2014, SS 
facilitated at 21 modules and AMVK facilitated at 40. 
In addition to the operational research modules and courses, the OR fellows were 
invited as resource persons to teach at other capacity building workshops conducted by the 
World Health Organization, the RNTCP, the National AIDS Control Programme (NACP) and the 
medical colleges. In May 2012, AMVK and SS were invited by WHO and RNTCP to build data 
management capacity for about 65 WHO-RNTCP consultants working in India. Following this 
training, a data management module using the open access software “EpiData” (EpiData 
Association, Odense, Denmark) was developed by AMVK for the RNTCP to enable the 
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structured capture of the data collected during the ‘programme evaluations’ conducted 
across the country. To institutionalize this mechanism, the Central TB Division of the Ministry 
of Health of the Government of India issued official directives to train all the data entry 
operators (more than 650) in using EpiData and how to use the specific data management 
module to capture the data of Internal Evaluations of RNTCP. The information thus captured 
is now compiled nationally and used for programme reviews, decision making and research. 
Several of these WHO-RNTCP consultants, who were instrumental in DOTS expansion in 
India, became participants in the OR courses and developed as trainers and leaders in OR.20
PUBLISHED PAPERS:
The number and details of published papers each year for the two OR fellows are shown in 
the Supplementary Annex 1 and Figure 1. It should be noted that several of these research 
projects were mentored by the two OR fellows together. The number of publications 
increased exponentially between 2009 and 2013, indicating the value of a critical mass of 
people involved full time in operational research. Altogether over the five years, the OR 
fellows were co-authors on 75 published research papers and 21 opinion and review papers 
with a total number of 96 published papers. Of these, 71 (74%) were published in journals 
offering immediate and free open-access to their readership, with most of the remainder 
being published in journals offering free open-access after a period of time. In the six years 
before the OR fellows joined the USEA Office, there was one published paper. 
IMPACT OF OPERATIONAL RESEARCH ON POLICY AND PRACTICE:
Several of the operational research studies conducted or mentored by the OR fellows 
contributed to changes in national policy and practice. Some examples of this impact are 
highlighted in Table 2.
TECHNICAL ASSISTANCE IN PROMOTING OPERATIONAL RESEARCH:
The two OR fellows became known as leaders in operational research by partners and other 
stakeholders and were invited to be a part of national level technical committees which 
assist and recommend the national programme. SS participated as a member of the National 
Standing Committee on Operational Research for the RNTCP, while AMVK participated as a 
member of National Technical Working Group on TB/HIV for the NACP and as a member of 
the State level Operational Research Committee of Karnataka State, India. In addition, they 
provided technical assistance to states in the country for conducting operational research, 
analysing data and publishing papers. In addition, several research projects (including 
nationally representative Knowledge, Attitude and Practice surveys on Tuberculosis and 
projects related to tobacco control) initiated by other departments within USEA office were 
supported technically by the two OR fellows from design to analysis to publication. 
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BUILDING CAPACITY OF MEDICAL COLLEGE PROFESSIONALS IN DATA MANAGEMENT:
A collaborative framework was formed between the Karnataka State RNTCP, the Medical 
Colleges and The Union in 2013 to build the capacity of public health professionals in medical 
colleges to conduct operational research. One of the first initiatives of this collaboration was 
to engage with public health professionals in medical colleges and academic institutions 
in India and conduct a two-day course on EpiData for the residents and faculty of public 
health departments of medical colleges in and around Bangalore. This workshop, funded by 
Eli Lilly, was organised by the USEA Office (led by AMVK) in collaboration with the Department 
of Community Medicine in the Bangalore Medical College and Research Institute (BMCRI), 
and the Karnataka State Tuberculosis Cell of the RNTCP of the Government of India. A 
second initiative was replicated in Puducherry in collaboration with Jawaharlal Nehru 
Institute of Postgraduate Medical Education and Research (JIPMER), one of the premier 
medical institutions in India, catering to the medical college faculty and scientists of Indian 
Council of Medical Research from Puducherry. The feedback from the participants suggests 
that they have begun to use EpiData in their research work and have included it in their 
teaching curriculum for post-graduate and under-graduate medical students. The sessions 
in these courses were video-captured, edited and have been posted on YouTube (http://
www.youtube.com/watch?v=1SoxNpj-Ncw) to be used as self-learning resource materials by 
interested public health professionals worldwide. These online learning materials were also 
shared with the participants of the online virtual operational research training initiated by 
The Union in North America. 
SUPPORT TO PROGRAMME STAFF FOR DISSEMINATING THEIR RESEARCH FINDINGS:
The operational research unit in the USEA office has supported several programme staff 
officers who are working with the RNTCP and national HIV programme to draft and submit 
scientific abstracts to national and international conferences. Several abstracts have been 
accepted for oral or poster presentations. To facilitate dissemination of research findings, a 
national dissemination workshop was conducted in 2013 by the USEA Office in collaboration 
with the RNTCP, and this was attended by representatives of all stakeholders working for TB 
control in India. Such workshops provide a great opportunity for the researchers to share their 
findings directly with the national programme managers and advocate for policy change.
SCIENTIFIC PAPERS REVIEWED FOR NATIONAL OR INTERNATIONAL PEER-REVIEWED 
JOURNALS:
The number of papers that each OR fellow reviewed each year is shown in Figure 2. Although 
the OR fellows were invited to review many papers, they could not accept all the offers given 
their busy schedules. Altogether, 28 papers were reviewed. 
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SCIENTIFIC ABSTRACTS PRESENTED AT NATIONAL AND INTERNATIONAL CONFERENCES:
The number of abstracts accepted for presentation with OR fellows as co-authors at 
conferences each year is shown in Figure 3. Altogether, 45 conference abstracts were written. 
CREATION OF A NATIONAL POOL OF RESOURCE PERSONS:
In the initial courses co-ordinated by the OR fellows, support was provided by external 
facilitators. Once the fellows became independent facilitators, they started identifying 
outstanding participants in their operational research courses and provided them with an 
opportunity to co-facilitate in future courses. This helped in grooming young committed 
participants as future facilitators. As a result of this facilitator-grooming initiative, there is 
now a pool of independent, national facilitators in India who can be drawn into facilitating 
national and regional courses without the need for external (out-of-country) expertise. 
Several of these facilitators are now able to adapt and replicate the SORT IT model in their 
own networks. Notable efforts include those made by the Postgraduate Institute of Medical 
Education and Research, Chandigarh, India, to advance locally relevant research in tobacco 
control and that of National Institute for Research in Tuberculosis in Madurai, India, to build 
capacity of medical college professionals in TB research. It augurs well for future sustainability 
of this model of capacity building.
 
LESSONS AND CHALLENGES:
There are several important lessons and take home messages from this initiative. First, the 
fellows had both worked in national disease control programmes before taking up their 
OR fellowship positions and understood the importance of identifying programmatically 
relevant operation research questions and ensuring completion of the studies that 
were initiated.  
Second, this experience, combined with their operational research training which 
focused on study completion and movement of research findings to policy and practice, has 
ensured that programme managers are engaged at all stages of the operational research 
(protocol development, data collection, data analysis, data interpretation, paper writing 
and dissemination). Engagement with programme managers has had a cascading effect in 
promoting and developing a culture of OR within the national programmes.
Third, an enabling environment for operational research has developed at the 
USEA office with the regional director strongly supportive of this form of research. In addition 
to the OR fellows, three senior staff members of the office and one consultant from the Central 
TB Division of the Ministry of Health and Family Welfare, Government of India, were trained 
in operational research at Paris, one of whom went on to become the national professional 
officer for TB control at the WHO-India office. This has enabled strong links to be developed 
with the key partners, the WHO-country office and the Indian RNTCP. 
Fourth, these initiatives have led to the creation of a national pool of resource 
persons capable of independently facilitating operational research courses without the need 
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for external international facilitators. The role of the WHO-RNTCP consultant network and 
the support of WHO-country office lead for tuberculosis in contributing to this resource pool 
needs special mention. 
Finally, there has been strong, on-going and regular mentorship support from the 
Director of the Centre for Operational Research, Paris, which has included frequent visits to 
the USEA office. This has provided additional motivation and enthusiasm for the fellows to 
perform to their full potential.  
Despite these lessons, there are on-going challenges. First, even in a country like 
India, with ample resources of its own, external financial support is needed in the short and 
medium term to start and sustain this initiative. Donor money is needed both to support 
OR fellows and the capacity building courses until such time as the national government 
appreciates the benefits and value of such domestic support. There has, and continues to be, 
great support from several donor institutions such as Bloomberg Philanthropies, the Global 
Fund for AIDS, Tuberculosis and Malaria, United States Aid for International Development 
and the Department for International Development of the United Kingdom for OR capacity 
building, without which these initiatives could not have been sustained. 
The OR fellows have not been successful in tapping into the operations research 
funds earmarked within the national TB control programme because the latter are 
cumbersome and time consuming to access. This needs re-thinking as utilising national 
funds earmarked for operations research may help in undertaking programmatically relevant 
and challenging operational research studies that require prospective study designs. 
Second, building operational research capacity and conducting operational 
research is a continuous process, with its success and sustainability depending on repeating 
the process over and over again and again, often due to staff turnover. It is vital for OR fellows 
to also identify promising individuals at operational research courses and engage them 
rapidly as facilitators for future courses so that momentum can be maintained. 
Third, it is vital that enthusiastic and driven OR fellows are supported in their 
career paths so that they can attend skills building courses, develop their own capacity and 
submit their work for masters and PhD degrees. In this regard, adequate and appropriate 
remuneration is needed to retain such people within their institutions. Fortunately, the 2013 
World Health Report explicitly acknowledges the need to strengthen research endeavour not 
only in academic centres but also in public health programmes, close to the supply of and 
demand for health services.21 Important donors, such as the Department for International 
Development (DFID), UK, recognise this need and are prepared to give the necessary support, 
provided that value for money is achieved.  
CONCLUSION:
This case study testifies to the huge research output that resulted from placing one and then 
two OR fellows in the USEA Office, Delhi, India. Of particular note, in the six years before the 
fellows joined there was one published paper from the office while in the first five years since 
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the fellows joined the cumulative number of published papers reached nearly one hundred. 
Research publications are an objective way to measure research output, an indicator that 
the research has been properly designed, implemented, analysed and written up to a high 
enough standard to get through peer-review and be published in a respectable international 
journal.22 Published papers are also a crucial way to disseminate research findings to a wide 
audience, especially if open-access journals are used as the media for publication. 
Before joining as OR fellows, the two individuals had little engagement in 
operational research. They learnt and subsequently taught their craft as they developed, 
with a number of factors facilitating this process such as their own enthusiasm and passion 
for the subject, a supportive and enabling environment and strong mentorship from the 
leadership. Selecting the right individuals for the job is an essential determinant of success, 
but the performance-related contracts that The Union offers to all OR fellows allow a way out 
if a mistake is made in selection and individuals fail to deliver. 
Currently, the situation is that one OR fellow is pursuing a PhD training programme 
in McGill University, Montreal, Canada, and during this time can only spend four months of 
the year in India. The USEA Office therefore has one full-time resident OR fellow, and although 
this is not reflected in a decrease in the volume of publications in the first six months of 
2014 (24 published papers by 30th June 2014), it nevertheless puts undue strain on the one 
individual. In an enabling environment in a busy country office, we believe that there should 
be a minimum of two full-time OR fellows at any one time, and if resources permit this 
number should be increased to three. We are convinced that in this situation that the whole 
is greater than the sum of its parts, and total research output will be maximised as good OR 
fellows will feed off and stimulate each other.
We believe that our experience in India provides good evidence for promoting 
similar models elsewhere. We need to select highly motivated individuals and, provided they 
are well supported, mentored and given performance-related contracts, they can facilitate 
high quality research that impacts not only locally but also at national and international 
level. Furthermore, it is essential to have a critical mass of OR fellows, with two at any one 
time being a minimum. We hope that public health institutions and donors will read and 
learn from this story.   
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BOX 1: TERMS OF REFERENCE FOR OPERATIONAL RESEARCH FELLOWS: 
BACKGROUND:
Low and middle income countries of the world, particularly in sub-Saharan Africa, are 
overburdened with three serious communicable disease epidemics (HIV/AIDS, tuberculosis 
and malaria) as well as silent, growing epidemics of non-communicable diseases. Many of 
these countries have very weak health management information systems and are unable 
to track cases, quality of care, outcomes or results of treatment, or the impact of prevention 
and treatment. In addition, the use of data that are available to lead directly to actions and 
policies to promote health (termed operational research) is lacking because few professionals 
in developing countries have access to appropriate training and mentorship in operational 
research and resources for this type of research have been largely unavailable. Hence, there 
is a need for both better collection and tracking of health information and better use of data 
to improve the health of people in low and middle income countries.  
To address these two critical gaps, a new Centre for Strategic Health Information and 
Operational Research (SCHIOR) has been established within the Union. The work of the 
Centre will be organised around:-
• developing improved data collection and tracking systems for key infectious and non-
communicable disease based on the highly successful model used in international 
tuberculosis control
• using electronic data systems to accurately supplement, and, where indicated, to 
replace paper records, based on a successful model that has been used in Malawi for 
the past 7 years.
• increasing capacity for operational research through in-country training programs and 
operational research fellowships
• enhancing and expanding vital registration systems  (i.e., birth and death registries) 
which will enable the population impact of health interventions to be assessed
• developing an evaluation component to track the influence of operational research and 
strategic information in changing policy and practice
• engaging with the World Health Organization to maximise the benefits of this approach 
to improving health in the developing world
OVERALL ROLE OF AN OPERATIONAL RESEARCH FELLOW:
Operational Research Fellows will conduct and publish research into strategies, interventions, 
tools and new knowledge that will help to improve health care delivery either in programme 
settings or important health-related problems.
SPECIFIC RESPONSIBILITIES 
Research fellows will specifically:-
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• undertake mandatory attendance of the training for all 3 modules conducted by the OR 
Centre
• develop protocols for research projects under the mentorship of staff at the Centre or 
within The Union and in collaboration with country colleagues who shall act as local 
mentors
• submit such proposals to ethical review to ensure that the highest standards are being 
met
• ensure that protocols, once approved, are implemented in the field within a reasonable 
time frame 
• be responsible for the collection, filing, management and storage of all data, with 
appropriate back-up strategies, and quality-assured data entry and validation with 
technically suitable and appropriate electronic application software
• conduct data analysis under the mentorship of staff at the Centre or within The Union 
and with local mentors
• ensure that within 3 months of completion of any research project that a paper is 
prepared and ready for submission to an international peer-reviewed journal
• be responsible for the submission, management and follow-up of all papers submitted 
electronically to journals
• present the results of published work at relevant national and International conferences
• submit each year at least two papers to peer-reviewed journals (see below regarding 
annual performance assessments)
• attend targeted training on protocol development, data entry, data analysis and paper 
writing skills and participate / facilitate in Union-sponsored training courses
SKILLS, COMPETENCIES, REQUIREMENTS AND SUPPORT:
Research fellows will be local health care personnel (doctors, paramedical staff or nurses) or 
health care analysts working in TB or HIV programmes, Ministries of health or larger health 
care institutions that assist in the national effort to improve the health of ordinary people. 
They will be enthusiastic and committed to the concept of operational research. They will be 
fluent in spoken and written English, as this is the most common language of paper writing.
Research fellows will be appointed as Union Fellows a result of recommendations from 
senior colleagues, an excellent curriculum vitae, an interview process and two satisfactory 
referee reports. They will have an annual contract for up to 2 years around a programme of 
work, with an annual assessment of performance. In particular, failure to submit at least 
2 papers to peer-reviewed international journals within each 12-month period will 
result in failure to renew the annual contract.
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Research fellows will receive financial and other support (for example, lap-top computers) to 
enable them to undertake research projects in the field.
Research fellows will periodically undertake targeted training on research protocol 
development, data analysis and paper writing skills, and every attempt will made to include 
them in Union-conducted training courses or symposia.
Table 1: Operational Research Courses and other training workshops at which the OR fellows 
facilitated, 2009-14.
Year OR Fellow (SS) OR Fellow (AMVK)
2009 None None
2010 Module 1 PHFI OR Course
Module 1 Paris OR 2 Course
Module 1 of the India (Bangalore 1) OR 
course 
Operational Research Skills in one day 
(World Lung Conference 2010)
None
2011 Module 1 Paris OR course
Module 1 Luxembourg OR course
Module 3 India (Bangalore 1) OR course
Operational Research Skills in one day 
(World Lung Conference 2011)
None
2012 Module 3 Paris OR course
Module 3 Luxembourg OR course
Module 1 of  India (Bangalore 2) OR course
Modules 1, 2 and 3 of South-Asian OR 
course 2012
Operational Research Skills in one day 
(World Lung Conference 2012)
Modules 1, 2 and 3 of South-Asian OR 
course 2012
Module 2 of African OR course
Advanced EpiData course in Paris
Module 1 of India (Bangalore 2) OR course
Module 2 of the Pacific OR course
Modules 1 and 2 of Paris OR course
Modules 1 and 2 of India (Chennai 1) OR 
course
EpiData course for WHO-RNTCP 
consultants in India
Operational Research Skills in one day 
(World Lung Conference 2012)
Workshop on “Operational Research” 
conducted by National AIDS Control 
Programme in India
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2013 Module 1 Luxembourg OR course
Module 3 of 2nd Indian OR course
Module 1 Luxembourg OR course
Paper writing workshop for the staffs of 
USEA office
Paper writing workshop for the staffs of TB-
DM pilot project sites (WDF supported)
Operational Research Skills in one day 
(World Lung Conference 2013)
Short course on “Efficient, Quality-assured 
Data Capture using EpiData” (Bangalore 
and Puducherry)
Workshop on “Operational Research” 
for medical college professionals working 
in close collaboration with National TB 
Programme in Gujarat, India
Paper writing workshop for the staffs of 
USEA office
Modules 1, 2 and 3 of South-Asian OR 
course 2013
Modules 2 and 3 of India (Bangalore 2) OR 
course
Short course on “Efficient, Quality-assured 
Data Analysis using EpiData” (Bangalore)
Advanced EpiData course in New Delhi
Paper writing workshop for the staffs of TB-
DM pilot project sites (WDF supported)
Advanced EpiData course in Paris
Module 3 of India (Chennai 1) OR course
Module 3 of Paris OR course
Module 1 of Estonia OR course
Module 1 of Luxembourg OR course
EpiData Module for the online virtual OR 
training (Treat TB)
Module 3 of African OR course
Modules 1 and 2 of India (Chennai 2) OR 
course
Operational Research Skills in one day 
(World Lung Conference 2013)
2014 
(till 
June)
None (Joined PhD programme at McGill 
University, Montreal, Canada)
Modules 1 and 2 of South Asia OR course 
2014
Module 3 of Estonia OR Course
Module 3 of Luxembourg OR course
OR course on tobacco control in 
collaboration with PGIMER Chandigarh, 
India
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Table 2: Examples of operational research projects co-ordinated and mentored by OR fellows 
which contributed to changes in policy and practice: 2009-13.
Title and details of the Paper Policy change sought Impact 
Sachdeva KS, Srinath S, Dewan 
PK, Nair SA, Reddy R, Kundu 
D, Chadha SS, Venkatachalaiah 
AKM, Parmar M, Chauhan LS. 
Source of previous treatment for 
re-treatment TB cases registered 
under the National TB Control 
Programme, India, 2010. 
PLoS ONE 2011; 6: e22061.
Enhanced efforts towards 
extending treatment support 
and supervision to patients 
treated by private sector 
treatment providers are urgently 
required to improve the quality 
of treatment and reduce the 
numbers of patients with 
recurrent tuberculosis.
These two studies highlighted 
the large numbers of TB patients 
treated in the huge private sector 
in India. These studies have 
contributed to the estimation of 
the TB burden in the country 
(as suggested by the WHO’s 
onion peel model). They have 
also triggered a large number of 
studies/ models that will help 
to enhance the notification of 
TB cases in the country. The 
Government of India eventually 
declared TB to be a nationally 
notifiable disease, mandating 
all health care providers in the 
country to inform the RNTCP 
about the TB cases that they are 
managing.
Srinath S, Nair SA, Chadha 
SS, Shivashankar R, Sharma G, 
Yadav S, Mohanty S, Kamineni 
V, Wilson NC, Harries AD, 
Dewan PK. From where are 
tuberculosis patients accessing 
treatment in India? Results from 
a cross-sectional community 
based survey of 30 districts.
PLoS ONE 2011; 6: e24160.
1) Reviewing and revising the 
scope of the India tuberculosis 
notification system; 2) 
Strengthening and monitoring 
health care delivery systems 
with periodic assessment of 
the reach and utilisation of the 
India RNTCP services especially 
among rural communities
Kumar AMV, Gupta D, Rewari 
BB, Bachani D, Mohammed S, 
Sharma V, Lal K, Reddy HRR, 
Naik B, Prasad R, Yaqoob M, 
Deepak KG, Shastri S, Srinath 
S, Harries AD, Chauhan LS, 
Dewan P. Will adoption of the 
2010 WHO ART Guidelines 
for HIV-infected TB patients 
increase the demand for ART 
services in India?
PLoS ONE 2011; 6: e24297.
Antiretroviral therapy (ART) 
could be extended to all HIV 
infected TB patients irrespective 
of the CD4 count with relatively 
little additional burden to the 
national ART programme.
National Policy was changed 
based on this study to initiate 
ART for all HIV-positive TB 
patients irrespective of the 
CD4 count. The number and 
proportion of HIV-infected 
TB patients receiving ART has 
increased over the years.
Chadha SS, Sharath BN, 
Reddy K, Jaju J, Vishnu PH, 
Rao S,Parmar M, Srinath S, 
Sachdeva KS, Wilson N, Harries 
AD. Operational challenges in 
diagnosing multi-drug resistant 
TB and initiating treatment in 
Andhra Pradesh, India.
PLoS One 2011; 6: e26659
Amongst patients who are 
eligible for multidrug-resistant 
TB (MDR-TB) services, a 
significant proportion is lost 
during the diagnostic and 
treatment initiation pathway 
due to a variety of operational 
challenges. The programme 
needs to urgently address these 
challenges for effective delivery 
and utilisation of the MDR-TB 
services.
The study highlighted the need 
for a) line listing all patients who 
are suspected to have MDR-
TB and b) for tracking sputum 
collection, transportation and 
ensuring that the patients do not 
get missed out in the journey 
from identification to diagnosis. 
The process outlined in the 
paper has now become a routine 
practice under the RNTCP.
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Naik B, Kumar A, 
Kumaraswamy L, Doddamani 
S, Krishnappa M, Indander 
V, Satyanarayana S, Gupta D, 
Dewan PK. HIV prevalence 
among persons suspected of 
tuberculosis: policy implications 
for India.
J Acquir Immune Defic Syndr 
2012; 59: e72-76.
HIV testing should be routinely 
offered to all TB suspects in high 
HIV settings
A policy decision has been 
taken that HIV testing should 
be offered routinely to all 
patients who are suspected as 
having tuberculosis in high HIV 
settings of India
Achanta S, Kumar AM, 
Nagaraja SB, Jaju J, Shamrao 
SR, Uppaluri R, Tekumalla 
RR, Gupta D, Kumar A, 
Satyanarayana S, Dewan PK. 
Feasibility and Effectiveness 
of Provider Initiated HIV 
Testing and Counseling of 
TB Suspects in Vizianagaram 
District, South India.                                            
PLoS One 2012; 7: e41378.
HIV testing should be routinely 
offered to all TB suspects in high 
HIV settings
Kumar AMV, Gupta D, Gupta 
RS, Satyanarayana S, Wilson N, 
Zachariah R, Lawn SD, Harries 
AD. HIV testing in people with 
presumptive tuberculosis: time 
for implementation. 
Lancet Respiratory 
Diseases 2012, October 
24: doi: 10.1061/S2213-
2600(12)70050-4. 
HIV testing should be routinely 
offered to all TB suspects in high 
HIV settings
India Tuberculosis – Diabetes 
Study Group. Screening of 
patients with tuberculosis for 
diabetes mellitus in India
Tropical Medicine and 
International Health 2013; 18: 
636 – 645
TB patients should be routinely 
screened for Diabetes Mellitus
These studies contributed 
towards a national policy 
decision that all TB patients 
in India should be screened 
routinely for Diabetes Mellitus. 
Treatment cards and registers for 
the country were amended to 
accommodate the recording and 
reporting necessary for policy 
implementation. 
Balakrishnan S, Vijayan S, 
Nair S, Subramoniapillai J, 
Mrithyunjayan S, Wilson N, 
Satyanarayana S, Dewan PK, 
Kumar AMV, Karthickeyan D, 
Willis M, Harries AD, Nair SA. 
High diabetes prevalence among 
tuberculosis cases in Kerala, 
India.
PLoS One 2012; 7: e46502.
TB patients should be routinely 
screened for Diabetes Mellitus
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Reza LW, Satyanarayana 
S, Pandey A, Kumar S, 
Devendrappa NM, Anand L, 
Singh G, Kumar AMV, Chadha 
SS, Wilson N, Sachdeva KS, 
Nair SA. LED fluorescence 
microscopy increase the 
detection of smear-positive 
pulmonary tuberculosis in 
medical colleges of India. 
Public Health Action 2013; 3: 
240-242.
A decision to scale-up the use of 
light-emitting diode-fluorescent 
microscopy (LED-FM) in all 
high-workload settings of India
The decision to use LED-FM 
microscopy has already been 
reflected in the national strategic 
plan of RNTCP 2012-17.
Reza LW, Satyanarayana S, 
Enarson DA, Kumar AMV, 
Sagili K, Kumar S, Prabahakar 
LA, Devendreppa NM, Pandey 
A, Wilson N, Chadha S, Thapa 
B, Sachdeva KS, Kohli MP. 
LED-Fluorescence microscopy 
for diagnosis of pulmonary 
tuberculosis under programmatic 
conditions in India
PLoS ONE 2013; 8: e75566.
A decision to scale-up the use of 
light-emitting diode-fluorescent 
microscopy (LED-FM) in all 
high-workload settings of India
Nayak P, Kumar AMV, Claassens 
M, Enarson DA, Satyanarayana 
S, Kundu D, Khaperde K, 
Agrawal TK, Dapkekar S, 
Chandraker S, Nair SA. 
Comparing same day sputum 
microscopy with conventional 
sputum microscopy for the 
diagnosis of tuberculosis – 
Chhattisgarh, India. 
PLoS ONE 2013; 8: e74964.
To continue with the current  
strategy of the spot-early 
morning system of sputum 
specimen collection, contrary 
to WHO recommendations of 
same-day sputum collection
Given similar evidence from 
multiple sources, RNTCP has 
decided to continue with the 
current strategy and not change 
to same-day strategy
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Figure 1. Annual number of publications co-authored by the staffs of The Union South-East Asia (USEA) office 
and contribution of operational research (OR) fellows, 2003-13
Figure 2. Annual number of papers reviewed by the operational research (OR) fellows of The Union South-
East Asia (USEA) office, 2009-13
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Figure 3. Annual number of conference abstracts co-authored by the operational research (OR) fellows of 
The Union South-East Asia (USEA) office, 2009-13
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SUPPLEMENTARY ANNEX 1: LIST OF PUBLICATIONS EACH YEAR BY OPERATIONAL 
RESEARCH FELLOWS OF THE UNION SOUTH-EAST ASIA REGIONAL OFFICE, 2009-13
RESEARCH PAPERS:
2009: [0]
None
2010: [2]
1. Jha UM, S Srinath, Dewan PK, Chadha S, Wares F, Sahu S, Gupta D, Chauhan LS. Risk factors for 
treatment default among re-treatment tuberculosis patients in India, 2006. 
 PLoS One 2010; 5: e8873
2. Satyanarayana S, Shivashankar R, Vashist RP, Chauhan LS, Chadha SS, Dewan PK, Wares F, Sahu 
S, Singh V, Wilson NC, Harries AD. Characteristics and programme-defined treatment outcomes 
among childhood tuberculosis (TB) patients under the national TB Programme in Delhi.
 PLoS One 2010; 5: e13338.
2011: [11]
1. Srinath S, Sharath B, Santosha K, Chadha SS, Roopa S, Chander K, Wares F, Chauhan LS, Wilson 
NC, Harries AD. Tuberculosis “retreatment others”: profile and treatment outcomes in the state of 
Andrha Pradesh, India. 
 Int J Tuberc Lung Dis 2011; 15: 105-109. 
2. Kamineni VV, Turk T, Wilson N, Satyanarayana S, Chauhan LS. A rapid assessment and response 
approach to review and enhance Advocacy, Communication and Social Mobilisation for 
Tuberculosis control in Odisha state, India. 
 BMC Public Health 2011; 11: 463
3. Sachdeva KS, Srinath S, Dewan PK, Nair SA, Reddy R, Kundu D, Chadha SS, Venkatachalaiah AKM, 
Parmar M, Chauhan LS. Source of previous treatment for re-treatment TB cases registered under 
the National TB Control Programme, India, 2010. 
 PLoS ONE 2011; 6: e22061.
4. Pothukuchi M, Nagaraja SB, Kelamane S, Srinath S, Babu S, Dewan P, Wares F. Tuberculosis 
contact screening and isoniazid preventive therapy in a South Indian District: operational issues 
for programme consideration.
 PLoS ONE 2011; 6: e22500.
5.  Srinath S, Nair SA, Chadha SS, Shivashankar R, Sharma G, Yadav S, Mohanty S, Kamineni V, Wilson 
NC, Harries AD, Dewan PK. From where are tuberculosis patients accessing treatment in India? 
Results from a cross-sectional community based survey of 30 districts.
 PLoS ONE 2011; 6: e24160.
6.  Kumar AMV, Gupta D, Rewari BB, Bachani D, Mohammed S, Sharma V, Lal K, Reddy HRR, Naik 
B, Prasad R, Yaqoob M, Deepak KG, Shastri S, Srinath S, Harries AD, Chauhan LS, Dewan P. Will 
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adoption of the 2010 WHO ART Guidelines for HIV-infected TB patients increase the demand for 
ART services in India?
 PLoS ONE 2011; 6: e24297.
7. SB Nagaraja, S Srinath, SS Chadha, S Kalemane, J Jayu, S Achanta, K Reddy, V Potharaju, SRM 
Shamrao, P Dewan, R Zachariah, S Tetali, R Anchala, NK Kannuri, AD Harries, SK Singh. How do 
patients who fail first line TB treatment but who are not placed on an MDR-TB Regimen fare in 
south India? 
 PLoS One 2011; 6: e25698
8. Chadha SS, Sharath BN, Reddy K, Jaju J, Vishnu PH, Rao S,Parmar M, Srinath S, Sachdeva KS, 
Wilson N, Harries AD. Operational challenges in diagnosing multi-drug resistant TB and initiating 
treatment in Andhra Pradesh, India.
 PLoS One 2011; 6: e26659
9.  Jonnalagada S, Harries AD, Zachariah R, Srinath S, Tetali S, Chander K, Rao S, Rao R, Peri S, Anchala 
R, Kannuri NK. The timing of death in patients with tuberculosis who die during anti-tuberculosis 
treatment in Andhra Pradesh, South India 
 BMC Public Health 2011; 11: 921 doi: 10.1186/1471-2458-11-921
10. Satyanarayana S, Nagaraja SB, Kelamane S, Jaju J, Chadha SS, Chnader K, Vishnu H, Wilson N, 
Harries AD. Did successfully treated pulmonary tuberculosis patients undergo all follow-up sputum 
smear examinations?
 Public Health Action 2011; 1: 27 – 29.
11. Takarinda KC, Harries AD, Srinath S, Mutasa-Apollo T, Sandy C, Mugurungi O. Treatment outcomes 
of new adult tuberculosis patients in relation to HIV status in Zimbabwe.
 Public Health Action 2011; 1: 34-39.
2012: [20]
1.  Kondapaka KK, Prasad SV, Srinath S, Kandi S, Zachariah R, Harries AD, Nagaraja SB, Tetali S, 
Anchala R, Kannuri NK, Murthy K, Koppu D, Vangari L, Sreenivas R. Are tuberculosis patients in a 
tertiary care hospital in Hyderabad, India, being managed accoridng to national guidelines?
 PloS ONE 2012; 7: e30281.
2.  Takarinda K, Harries AD, Srinath S, Mutasa-Apollo T, Sandy C, Mugurungi O. Treatment outcomes 
of adult patients with recurrent tuberculosis in relation to HIV status in Zimbabwe: a retrospective 
record review.
 BMC Public Health 2012; 12: 124.
3.  Naik B, Kumar A, Kumaraswamy L, Doddamani S, Krishnappa M, Indander V, Satyanarayana S, 
Gupta D, Dewan PK. HIV prevalence among persons suspected of tuberculosis: policy implications 
for India.
 J Acquir Immune Defic Syndr 2012; 59: e72-76.
4.  Kamineni VV, Wilson N, Das A, Satyanarayana S, Chadha S, Sachdeva KS, Chauhan LS. Addressing 
poverty through disease control programmes: examples from Tuberculosis control in India
 Int J Equity Health 2012; 11: 27
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5. Quazi TA, Sarkar S, Borgohain G, Sreenivas A, Harries AD, Srinath S, Khan K, Bishnu B, Tapader 
S, Phukan AC, Kabir A, Chaddha V, Paul D, Dewan P. Are all medical patients diagnosed with 
tuberculosis in Indian medical colleges referred to the RNTCP? 
 Int J Tuberc Lung Dis 2012: 16: 1083-1085
6.  Durba P, Busireddy A, Nagaraja SB, Satyanarayana S, Dewan PK, Nair SA, Sarkar S, Ahmed QT, 
Sarkar S, Sreenivas SRM, Harries AD, Oeltmann JE. Factors associated with delays in treatment 
initiation after tuberculosis diagnosis in two districts in India. 
 PLoS ONE 2012; 7: e39040.
7.  Kapoor SK, Raman AV, Sachdeva KS, Satyanarayana S. How did the TB patients reach DOTS services 
in Delhi? A study of patient treatment seeking behaviour
 PLoS ONE 2012; 7: e42458
8.  Achanta S, Kumar AM, Nagaraja SB, Jaju J, Shamrao SR, Uppaluri R, Tekumalla RR, Gupta D, Kumar 
A, Satyanarayana S, Dewan PK. Feasibility and Effectiveness of Provider Initiated HIV Testing and 
Counseling of TB Suspects in Vizianagaram District, South India.                                           
  PLoS One 2012; 7: e41378.
9.  Gandhi MP, Kumar AM, Toshniwal MN, Reddy RH, Oeltmann JE, Nair SA, Satyanarayana S, Dewan 
PK, Mannan S. Sputum smear microscopy at two months into continuation-phase: should it be 
done in all patients with sputum smear-positive tuberculosis? 
 PLoS One 2012; 7: e39296.
10.  Nagaraja SB, Kumar AMV, Sachdeva KS, Ramachandran R, Satyanarayana S, Bansal A, Parmar M, 
Chadha S, Nair S, Kumar A, Hinderaker S, Edginton M, Dewan PK. Is one sputum specimen as good 
as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India? 
 PLoS One 2012; 7: e45554.
11.  Balakrishnan S, Vijayan S, Nair S, Subramoniapillai J, Mrithyunjayan S, Wilson N, Satyanarayana 
S, Dewan PK, Kumar AMV, Karthickeyan D, Willis M, Harries AD, Nair SA. High diabetes prevalence 
among tuberculosis cases in Kerala, India.
 PLoS One 2012; 7: e46502.
12.  Malhotra S, Zodpey SP, Chandra S, Vashist RP, Satyanarayana S, Zachariah R, Harries AD. Should 
sputum smear examination be carried out at the end of the intensive phase and end of treatment 
in sputum smear negative pulmonary TB patients?
 PLoS One 2012; 7: e49238.
13.  Ali E, Zachariah R, Hinderaker SG, Satyanarayana S, Kizito W, Alders P, Shams Z, Allaouna M, Draguez 
B, Delchevalerie P, Enarson DA. Does the 65cm height cut-off as age proxy exclude children eligible 
for nutritional assessment in Bangladesh?
 Public Health Action 2012; 2: 103 – 106.
14.  Shams Z, Zachariah R, Enarson DA, Satyanarayana S, van den Bergh R, Ali E, Alders P, Manzi M, 
Allaouna M, Draguez B, Delchevalerie P, Vernaeve L, Harries AD. Severe malnutrition in children 
presenting to facilities in an urban slum in Bangladesh. 
 Public Health Action 2012; 2: 107– 111.
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15.  Ram S, Kishore K, Batio I, Bissell K, Zachariah R, Satyanarayana S, Harries AD. Pre-treatment loss 
to follow-up among smear-positive pulmonary tuberculosis cases: a 10-year audit of national data 
from Fiji.
 Public Health Action 2012; 2: 138– 141.
16.  Satyanarayana S, Nair SA, Chadha SS, Sharma G, Yadav S, Mohanty S, Kamineni V, Wilson NC, 
Harries AD. Health-care seeking among people with cough of 2 weeks or more in India: Is passive 
case finding sufficient? 
 Public Health Action 2012; 2: 157 – 161. 
17.  Satyanarayana S, Kumar AMV, Sharath BN, Harries AD. Fast-track writing of a scientific paper with 
30 authors: how to do it.
 Public Health Action 2012; 2: 186 – 187.
18.  Rani MA, Shriraam V, Zachariah R, Harries AD, Satyanarayana S, Tetali S, Anchala R, Muthukumar D, 
Sathiyasekaran BWC. Does a nutrition education programme change the knowledge and practice 
of healthy diets among high school adolescents in Chennai, India? 
 Health Education Journal 2012: 72; 733-741.  doi: 10.1177/0017896912461093.
19.  Kundu D, Kumar AV, Satyanarayana S, Dewan PK, Nair SA, Khaparde K, Nayak P, van der Bergh R, 
Manzi M, Enarson DA, Deshpande MR, Chandraker S. Can follow-up examination of tuberculosis 
patients be simplified? A study in Chhattisgarh, India
 PLoS One 2012; 7: e51038.
20. Bissell K, Harries AD, Reid AJ, Edginton M, Hinderaker SG, Satyanarayana S, Enarson DA, Zachariah 
R. Operational research training: the course and beyond. 
 Public Health Action 2012: 2(3); 92-97.
2013: [42]
1.  Bishnu B, Bhaduri S, Kumar AMV, Click ES, Chadha VK, Srinath S, Nair SA, Gupta D, Ahmed QT, 
Sarkar S, Paul D, Dewan P. What are the reasons for poor uptake of HIV testing among patients with 
TB in an Eastern India District? 
 PLoS ONE 2013; 8: e 55229.
2.  India Tuberculosis – Diabetes Study Group. Screening of patients with tuberculosis for diabetes 
mellitus in India
 Trop Med Int Health 2013; 18: 636 - 645
3.  India Diabetes Mellitus – Tuberculosis Study Group. Screening of patients with diabetes mellitus 
for tuberculosis in India 
 Trop Med Int Health 2013; 18: 646-654
4.  Dendup T, Dorji T, Edginton ME, Kumar AMV, Wangchuk D, Dophu U, Jamtsho T, Rinzin C. Childhood 
tuberculosis in Bhutan : profile and treatment outcomes. 
 Public Health Action 2013; 3: 11-14. 
CHAPTER 10
172
5.  Shah SK, Kumar AMV, Dogar OF, Khna MA, Qadeer E, Tahseen S, Masood F, Chandio AK, Edginton 
ME. Xpert MTB/RIF under routine conditions in diagnosing pulmonary tuberculosis: a study in two 
hospitals in Pakistan. 
 Public Health Action 2013; 3: 20-22.
6.  Vishnu PH, Bhat P, Bansal A, Satyanarayana S, Alavadi U, Ohri BS, Shrinivas MSR, Desikan P, Jaju J, 
Rao VG, Moonan PK. Is bleach-sedimented smear microscopy an alternative to direct microscopy 
under programme conditions in India? 
 Public Health Action 2013; 3: 23-25.
7.  Kumar AMV, Naik B, Guddemane DK, Bhat P, Wilson N, Sreenivas AN, Lauritsen JM, Rieder HL. 
Efficient, quality-assured data capture in operational research through innovative use of open-
access technology.
 Public Health Action 2013; 3: 60-62.
8.  Basnet R, Shrestha BR, Nagaraja SB, Basnet B, Satyanarayana S, Zachariah R. Universal health 
coverage in a regional Nepali hospital: who is exempted from payment? 
 Public Health Action 2013; 3: 90-92. 
9.  Khann S, Tan Mao E, Rajendra YP, Satyanarayana S, Nagaraja BN, Kumar AMV. Linkage of 
presumptive multidrug resistant tuberculosis (MDR-TB) patients to diagnostic and treatment 
services in Cambodia
 PLoS ONE 2013; 8: e59903.
10.  Sharma SK, Mohan A, Chauhan LS, Narain JP, Kumar P, Behera D, Sachdeva KS, Kumar A, 
Agarwal P, Awadh NT, Bansal A, Baruah S, Baruwa P, Balasangameshwara VH, Balasubramanian 
R, Bhardwaj AK, Bhargav S, Chadha S, Chaddha VK, Chhatwal M, Da Costa AL, Dash DP, Dep J, 
Dhingra S, Dhooria Harmeet S, Frieden TR, Garg A, Granich R, Gulati V, Gupta D, Gupta D, Gupta 
KB, Gupta KN, Jaikishan, Janmeja AK, Jawahar MS, Jethani SL, Jindal SK, John KR, Kalra OP, 
Kalra VP, Kannan AT, Kayshap S, Keshav Chander G, Khushwa SS, Kushwaha RS, Kumar V, Laskar 
B, Leela Itty Amma KR, Leuva AT, Maitra Malay K, Mesquita AM, Mathew T, Mundade Y, Munje R, 
Nagpal S, Nagaraja C, Nair S, Narayanan OR, Paramasivan CN, Parmar M, Prasad R, Phukan AC, 
Prasanna R, Purty A, Ramachandran R, Ramachandran R, Ravindran C, Reddy Raveendra HR, Sahu 
S, Santosha, Sarin R, Sarkar S, Sarma KC, Saxena P, Sehgal S, Sharath N, Sharma G, Sharma N, 
Shridhar PK, Shukla RS, Singh O, Singh NT, Singh V, Singla R, Sinha N, Sinha P, Sinha S, Solanki 
R, Sreenivas A, Srinath S, Subhakar K, Suri JC, Talukdar P, Tonsing J, Tripathy SP, Vaidyanathan 
P, Vashist RP, Venu K.Contribution of medical colleges to tuberculosis control in India under the 
Revised National Tuberculosis Control Programme (RNTCP): Lessons learnt & challenges ahead. 
Indian J Med Res. 2013; 137: 283-94
11.  Mlilo N, Sandy C, Harries AD, Kumar AMV, Masuka N, Nyathi B, Edginton M, Isaakidis P, Manzi M, 
Siziba N. Does the type of treatment supporter influence tuberculosis treatment outcomes in 
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SUMMARY
A structured training course on Operational Research (OR), based on the Union/MSF model, 
was conducted in the South Asian region in 2012. Many innovations were introduced into 
the administration, structure and content of the course. 11 of 12 participants successfully 
completed all pre-defined milestones. Several challenges were identified. The main 
challenges included shortage of time, especially for data analysis and interpretation, and 
insufficient numbers of experienced facilitators. Appropriate modifications have been made 
to the structure and processes of the next course being run in 2013. We describe these 
modifications and the innovations, successes and challenges of this model of training.
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INTRODUCTION
Operational Research (OR) is increasingly recognized as a science that is important to 
reduce the gap between knowledge and implementation, to optimize the performance 
of health programmes and to achieve improved health outcomes.1 Despite recognition 
of the necessity of OR by global health organizations, donor agencies and national health 
programmes, the amount of research in global health that actually happens and gets 
published in both resource-limited and industrialised countries still remains limited.2-4 This 
may be partly due to the limited capacity of health professionals to conduct and publish OR. 
Drawing on lessons from several OR capacity building initiatives in the past,5-7 the Union/MSF 
model was conceived and has been implemented since 2009 with excellent outputs – trained 
participants in low- and middle-income countries who have become independent facilitators 
and mentors in subsequent courses; presentation at international conferences; publications 
in peer-reviewed journals; more importantly, impacting national/local policy and practice.8 
In 2012, we replicated this training model for health professionals in the South Asian region 
with several innovative modifications drawn from lessons learnt from previous courses. In 
the spirit of applying operational research thinking to ‘OR capacity building’, we describe the 
innovations, the successes and the challenges of the first South Asian OR course.9  
METHODS
The Union/MSF training model has been described in detail elsewhere.2, 8 In brief, this is 
an output-oriented mentorship programme with three 5-day modules interspersed over a 
period of 9-12 months – module 1 on ‘research protocol development’, module 2 on ‘data 
entry and analysis’ and module 3 on ‘scientific paper writing’. Participants who submitted a 
scientific manuscript for publication to a peer-reviewed journal within 4 weeks of completion 
of module 3 were considered to have successfully completed the course. 
RESULTS
In this first Asian course held in Nepal in 2012, twelve participants, mostly health professionals 
(physicians, programme managers, paramedical workers and data analysts) working in 
health programmes from India, Nepal, Bhutan, Bangladesh, Pakistan, Sri Lanka, Indonesia, 
Timor Leste and Cambodia, selected through a competitive process, were required to attend 
the three modules and achieve interim milestones linked to each module to remain in the 
course. The number of facilitators varied from module to module – six for modules 1 and 3 
and two for module 2. 
Eleven of twelve participants successfully completed all the milestones and 
submitted 12 scientific manuscripts (one participant completed two projects) on topics 
ranging from tuberculosis, HIV and tobacco control to health system financing, for publication 
in international peer-reviewed journals. Of these, six papers were accepted for publication 
within three months of submission; how many more will be published and what their impact 
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on policy and practice will be is being tracked. One participant met milestones for modules 1 
and 2 successfully, but was not able to complete the project in time; the long delays in local 
ethics approval demotivated the participant to continue on the project. 
Three junior facilitators from this course will facilitate independently and two 
participants from this course will participate as junior facilitators in the next course scheduled 
to start in February 2013. 
There were several innovations introduced into the structure and process of the 
OR course, which are summarized in the Table. We also faced several challenges during the 
course, which are listed in the Box.
DISCUSSION
The success of the Union-MSF Courses was replicated in Asia with most participants 
completing their milestones. There were several innovations with this course.  The 
positioning of modules 1 and 2 back-to-back helped in two ways – one technical and other 
logistical. First, the 2-3 month gap between module 1 and module 2 in the original Union/
MSF model meant that some participants started data collection and capture before module 
2 with several errors. This often meant that they had to repeat their data capture efforts 
once they learnt more appropriate ways of data management in module 2. Having modules 
1 and 2 back-to-back meant that the participants were equipped right from the start with 
not only a clear study protocol but also with the necessary quality-assured tools for data 
capture and analysis. Second, the positioning of the two modules also meant that only two 
trips were required to the course location instead of three, thus saving on resources and 
travel costs with an overall reduction by 25-30%. However, this change posed challenges for 
female participants, especially those with young children, who had to be away from 
family for two weeks.
The peer support strategy was widely appreciated and had multiple advantages. It 
promoted the concept of peer support and learning, and this provided opportunities for fast 
learners to start getting trained as facilitators. Often, the fast learner was quick to understand 
the point and thus was able to engage in the support and teaching of his/her peer. This took 
some of the pressure off facilitators, and was one of the reasons why module 2 could be 
managed with just two facilitators.
Organizing course content in the form of a website and sharing it via Dropbox, a 
file-sharing service, promoted easy access for facilitators (often from different countries) prior 
to the module for their review and inputs. Its offline access feature is advantageous obviating 
the need for continuous internet connectivity. 
There were also challenges. The main challenge was that of shortage of time 
(especially for the data analysis component) and facilitators experienced in conducting 
and publishing OR. To address these challenges, the following modifications were made to 
the course structure in 2013. Module 2 has been extended by a day and module 3 by two 
days – with the additional time to be used for teaching participants about data analysis and 
OPERATIONAL RESEARCH CAPACITY BUILDING IN ASIA: INNOVATIONS, 
SUCCESSES AND CHALLENGES OF A TRAINING COURSE
183
Ch
ap
te
r 1
1
supporting individual projects with data analysis support. We have also increased the number 
of facilitators to 8 for each module – divided into 4 groups of two (one junior and one senior 
facilitator), with each group having to mentor three participants. From the feedback of the 
participants, we will also provide module 2 course materials as a spiral-bound book instead 
of a course folder and examine how this works. If participants find it more user-friendly than 
the folders, we intend to adopt this for the other modules as well. Paying up-front costs for 
open access publications (500-1500 USD) had also been a problem and the way forward is to 
plan this within the course budget. 
While this description is limited by low numbers, we believe that the experience 
will be of value to people involved in or interested in conducting similar courses across the 
globe. Overall, the South Asian OR course successfully achieved its outputs and provided 
several lessons for optimizing it further. We hope that the participants inspired by this course 
continue their work and become leaders in OR in their own networks and countries.10
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Table: Innovations introduced into the Union-MSF model of operational research training in 
South Asia, 2012.
Innovation Description Advantage
Adjoining 
the first two 
modules
Modules 1 and 2 were conducted back-to-back with a 
weekend break in between.
This reduced overall costs 
by 25-30%
Course venue Nepal was chosen as the course venue which provided 
for ‘VISA on arrival’ for all the participants and 
facilitators. 
This simplified travel 
logistics and saved time 
and inconvenience 
for participants and 
organizers.
Introducing new 
sessions into the 
curriculum 
While the core modules remained the same, some new 
sessions were introduced. For example, a session on ‘how 
to take back-up of data’ using a combination of open-
access tools like Dropbox (http://www.dropbox.com) 
and FreeCommander (http://www.freecommander.
com) was taught in module 2. A session on organizing 
and managing references was taught in module 3 using 
another open access tool, Mendeley (http://www.
mendeley.com).  
This met some of 
the felt-needs of the 
participants in the 
described areas. 
Organization of 
course materials
All participants, in addition to a hard back course folder, 
were provided a CD-ROM containing all the course 
materials organized like a website, which was then 
shared via Dropbox, a file-sharing service
This facilitated user-
friendly access for 
participants and 
facilitators (often from 
different countries) of 
course material prior to 
and during  the module 
Introducing a 
milestone for 
Module 2
For the first time, participants were required to submit 
the following as outputs of Module 2 - data collection 
plan, electronic data capture formats in EpiData (http://
www.epidata.dk) and a plan for data analysis including 
dummy tables and figures.
This helped in 
emphasizing the value of 
quality-assurance in data 
capture and analysis in 
operational research, one 
of the key objectives of 
the course.
Mentoring 
junior 
facilitators
The facilitators were paired to provide mentorship 
to four participants in such a way that one senior 
facilitator* was paired with a junior facilitator. All the 
junior facilitators were participants in previous courses.
This helped in grooming 
the junior facilitator to 
become  an independent 
trainer in the future.
Using 
SurveyMonkey
SurveyMonkey (http://www.surveymonkey.com), an 
online survey entry and analysis software was used for 
participant evaluation at the end of the course.
This saved  time in 
analysing evaluations and 
providing feedback
*A senior facilitator is one who is experienced in both conducting and publishing papers and has excellent 
writing skills.
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BOX: CHALLENGES FACED DURING IMPLEMENTATION OF THE UNION-MSF MODEL OF 
OPERATIONAL RESEARCH TRAINING IN SOUTH ASIA, 2012
• Burden of work for facilitators: Having only two facilitators in module 2 created a 
large burden of work. Similarly, six facilitators in module 1 and 3 were also insufficient, 
especially in Module 3, as each facilitators’ group had four participants. With each group 
writing four papers, in literally five days, this number was too small.
• Data analysis and interpretation: Most participants complained that not enough 
time was given in class to this important subject.
• Better organization of course material: Several participants requested that the 
course material be organized as a book instead of a course folder in order to increase 
its shelf life.
• Delays in local ethics approval: Some participants had to wait for a long time (ranging 
from 1-6 months) before obtaining ethics approval from their national/local ethics 
committees. Given the tight timelines of the course, this left them with very little time for 
the actual conduct of the project.
• Scheduling of the sessions on ‘literature search and managing references: Several 
participants commented on the need for bringing this session upstream to module 1 
rather than module 3. This has now been done. 
• Publication in open access journals for enhanced dissemination in resource-
limited settings: This implies additional load on the course budget (ranging from 500-
1500 USD per article).
• Portal of call for applications: We received only 15 applications to our initial call 
which was through the national tuberculosis programme managers of countries in the 
region. We then informed the WHO focal points of countries and the contacts of non-
governmental organizations and extended the deadline for application by a week. 
The number of applications rose to 50 in a week’s time. Drawing on these lessons, we 
advertised on http://www.devnetjobs.org/ in 2013 and got 128 applications.
WHO – World Health Organisation
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12.
Operational research capacity building using ‘The Union/MSF’ 
model: Adapting as we go along
Kumar AMV, Zachariah R, Satyanarayana S, Reid AJ, 
Van den Bergh R, Tayler-Smith K, Khogali M, Harries AD. 
BMC research notes. 2014;7(1):819.
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Background
We have conducted  23 operational research (OR) courses since 2009, based on ‘The Union/ 
Médecins sans Frontières (MSF)’ model, now popularly known as SORT-IT (Structured 
Operational Research and Training Initiative) model - wherein participants are mentored 
through the whole research process from protocol development (module 1) to data analysis 
(module 2) to publication (module 3) over a period of 9-12 months. We have faced a number 
of challenges including shortage of time, especially for data analysis and interpretation, and 
a heavy mentorship burden on limited numbers of experienced facilitators. To address these 
challenges, we have made several modifications to the structure of the OR course. In this 
article, we describe the revised structure and our experience (successes and challenges) of 
implementing it in Asia in 2013.
Findings
The key changes introduced included extending the duration of the course modules (by 
a day each in module 1 and 2 and by three days in module 3), increasing the numbers of 
facilitators and standardizing milestones related to data entry and analysis. We successfully 
implemented this revised structure in the second Asian OR Course held in Nepal in 2013. 
Eleven of twelve participants successfully completed all the milestones and submitted 13 
scientific manuscripts (two participants completed two projects) to international peer-
reviewed journals. Though, this posed two challenges – increased costs and increased time 
away for faculty and participants.
Conclusions
The revised structure of ‘The Union/MSF’ model of OR capacity building addressed previous 
issues of insufficient time and overburdened mentors and we intend to continue with this 
model for future courses. 
OPERATIONAL RESEARCH CAPACITY BUILDING USING ‘THE UNION/MSF’ MODEL: 
ADAPTING AS WE GO ALONG
191
Ch
ap
te
r 1
2
BACKGROUND
Since 2009, the International Union Against Tuberculosis and Lung Disease (The Union) 
and  Médecins sans Frontières (MSF) have been involved in building capacity of health 
professionals in low- and middle-income countries to conduct and publish operational 
research (OR). We use a practical and output-based approach with hands-on mentorship and 
has been described in detail elsewhere. 1-3 In brief, this model is implemented over a period of 
9-12 months and consists of three modules – Module 1 on ‘research protocol development’, 
Module 2 on ‘data entry and analysis’ and Module 3 on ‘scientific paper writing’. To be 
successful, participants have to design and conduct an OR project and at the end of the 
course submit a scientific manuscript to a peer-reviewed journal. We have achieved excellent 
results with this model, with more than 85% of participants completing the course and more 
than 80% of submitted manuscripts being published. The Special Programme for Research 
and Training in Tropical Diseases (TDR) at the World Health Organization (WHO) has adopted 
this model as “The Structured Operational Research and Training InitiaTive (SORT IT)” and is 
committed to its global expansion.3 
To date, we have conducted 23 courses (17 courses completed and six on-going) 
based on The Union/MSF model. Over the years, we have faced a number of challenges 
in implementation of these courses, including shortage of time for data analysis, data 
interpretation and manuscript drafting, and a high mentorship burden on a limited pool of 
facilitators.4 To address these challenges, we have introduced several changes to the structure 
of the OR course. In this article, we summarize these changes and share our experience of 
implementing a revised OR course structure in Asia. 
CONTENTS OF THE ADAPTED COURSE
The changes made to the course structure are summarized in the Table 1. They include an 
increase in the number of days for each module, an increase in the number of facilitators 
and strengthened milestones related to Module 2. In Module 1, an additional day was used 
to introduce new sessions on how to systematically search for published literature and 
organize references. In Module 2, an added day was dedicated entirely to data analysis. 
Module 3 was extended by three days in order to a) provide more intensive and tailored 
support to participants for analysing their data, b) give participants more time to conduct a 
thorough on-line literature review and c) include a new plenary session on manuscript ‘titles 
and abstracts’. The number of facilitators was increased and standardised for each module, 
in order to ensure similar standard mentor-participant pairings in Modules 1 and 3, and to 
allow junior facilitators the opportunity to be trained by senior facilitators within each pairing 
group.  The milestones relating to Module 2 were strengthened and standardized (Table 1).   
We implemented this revised structure in the second Asian OR Course held in Nepal 
in 2013. We had twelve participants, mostly health professionals working in programmes from 
India, China, Nepal, Bhutan, Bangladesh, Pakistan and Sri Lanka. Eleven of twelve participants 
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successfully completed all the milestones with two of them completing two research projects 
each. Thus a total of 13 scientific manuscripts were submitted to international peer-review 
journals. One participant was not able to complete the research project in time due to 
changing her place and institution of work. The key advantages and challenges of the revised 
structure, as mentioned in the end-of–module feedback of participants and facilitators are 
summarized in the Table 2.
DISCUSSION
There were two main problems in our courses - shortage of time for data analysis and 
interpretation and high mentorship load. The problem of time shortage for data analysis 
was addressed in several ways. First, the additional days in Module 2 and 3 were primarily 
used to provide tailored data analysis support for research projects. Second, the number 
of facilitators for Module 2 was increased to six so that each facilitator supported only two 
participants in data analysis. Third, the strengthened milestone focussing on data analysis 
just before Module 3 increased the priority level and attention accorded to data analysis by 
participants and their mentors. 
To reduce the high mentorship load, the module duration was extended which 
took pressure off both facilitators and participants, who on previous courses often worked 
late into the night and way beyond the course timetable. In the revised structure, participants 
had sufficient time to develop the first drafts of their protocols, carry out the data analysis and 
draft their manuscript before facilitators provided their inputs, thus enhancing the iterative 
learning experience. The revised structure also demonstrated the increased emphasis 
on reviewing published literature and organizing references, which had a limited focus in 
previous courses. This led to increased familiarity with previously published literature and 
improvements to both the introduction and discussion sections of the final papers. With 
the perspective of decentralizing OR courses to settings with relatively inexperienced and 
junior facilitators, and with growing diversification of the research portfolio beyond the 
current focus of HIV and tuberculosis, additional days have proved  necessary to ensure the 
quality of outputs. 
The two key challenges in implementing the revised structure were the associated 
increased costs (primarily for hotel and per-diem on additional days) and faculty having to 
commit to being away from duty stations for a longer period of time. The increased costs 
need to be included in future funding proposals to donors. Faculty commitment will be an 
ongoing challenge but will be partly solved by developing and nurturing a pool of senior and 
junior facilitators. It will be important to encourage facilitators who attend Module 1 to also 
attend Module 3 so that there is continuity and familiarity of faculty with the OR protocols. 
In conclusion, the revised structure of ‘The Union/MSF’ model of OR capacity 
building addressed previous issues of insufficient time and overburdened mentors and we 
intend to continue with this model for future courses. We will continue to evaluate the revised 
model of capacity building using the standard SORT-IT indicators.3 
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Table 1: Comparison of the initial and revised structure of the Union-MSF model of operational 
research course.
Aspect Initial Model Revised  Model
Duration of 
the module
Each module was five days in 
duration. In Module 2, about 3.5 
days were used on data entry and 
the rest on data analysis. While 
some courses offered tailored 
support on data entry and data 
presentation in function of the 
participant OR projects, no focus 
could be placed on data analysis in 
function of the specific projects.
Duration of Module 1 and 2 increased to six 
days while that of Module 3 increased to eight 
days.
In Module 1, the extra day was used to introduce 
two new sessions – one on the systematic 
search of published literature and another on 
organizing references.
In Module 2, we allocated two days for data 
entry, two days for data analysis, one day to 
develop data entry tools and the data-analysis 
plan for the participants’ research projects, and 
one day for plenary for presenting the data entry 
formats and dummy analytic tables.
In Module 3, the first two days (Friday and 
Saturday) were dedicated to data analysis and 
interpretation followed by a day’s break (Sunday) 
for self-study and reading published literature. 
Projects requiring ‘multivariate regression 
analyses’ were supported on a case-to-case 
basis. This was followed by five days (Monday 
to Friday) for drafting the manuscript. A new 
plenary was introduced for presenting ‘titles and 
abstracts’.
Number of 
facilitators
In previous courses, the number 
of facilitators for Modules 1 and 3 
varied from 6 to 9 and the number 
of mentor groups varied from 
3 to 4. The facilitators worked 
in pairs - one senior (relatively 
more experienced in conducting 
and publishing OR) and one 
junior facilitator (usually one of 
the successful participants in the 
previous courses).
Number of facilitators in Modules 1 and 3 was 
standardized to eight (each pair of facilitators 
with three mentees)
For Module 2, facilitators varied 
in number from two to six and 
there were a variable number of 
participants per facilitator.
Number of facilitators in Module 2 was 
increased and standardized to six – each had two 
mentees
Strengthened 
milestones
The milestones attached to Module 
2 were weak, subjective and relied 
upon a self-declaration by the 
participant prior to Module 3 
that the data collection had been 
completed. 
The milestones related to Module 2 were 
modified and made more objective – one to be 
met within two weeks of Module 2 (submission 
of a plan for data collection, electronic data 
capture formats in EpiData (http://www.epidata.
dk) and dummy tables and figures to facilitate 
analysis and reporting). The second milestone 
at least six weeks prior to Module 3 included 
submission of proof of study completion 
including the dataset and a draft analysis.
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Table 2: Advantages and disadvantages of the revised strucutre of the Union-MSF model in 
Asia, 2013.
Revised 
structure
Advantages Disadvantages
Extended 
duration of 
module 
• Allowed new knowledge on 
sourcing published literature 
and organizing references to be 
imparted to participants
• More individualized time 
devoted to analysing and 
interpreting data
• Improved manuscript titles and 
abstracts. Less stress and fewer 
hours worked beyond course 
schedule for both participants 
and faculty
• Improved opportunities for 
social networking and alumni 
links between participants and 
mentors
• Increased costs due to additional 
accomodation conferencing and per-diem 
expenses
• Increased time away from duty station for 
faculty and participants
Increased 
number of 
facilitators 
• For Modules 1 and 3,  facilitator 
numbers were standardized 
to two for three participants 
allowing more individual time 
per participant
• Increased costs
Strengthened 
milestones 
for Module 2
• Increased priority accorded to 
data entry and analysis
• Increased hands-on support to 
participants in analyzing data 
• Increased burden on the participants and the 
facilitators to meet milestones
• Increased burden on the module coordinator 
and course co-ordinator to monitor the 
achievement of milestones
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SUMMARY OF STUDY FINDINGS AND COMPARISONS WITH PREVIOUS LITERATURE
This dissertation documents several operational research studies on HIV-associated TB 
that were conducted in India between 2010 and 2012. These studies had a major impact in 
shaping the national policy on TB/HIV collaborative activities in India and thus contributing 
to overall goals of ending TB and HIV epidemics, in line with the sustainable development 
goals of the United Nations. In this section, we summarise and discuss the key findings of 
each study and their policy implications. (See Table) Since these studies were conducted 
under an overarching operational research capacity building initiative, we also discuss the 
key capacity building initiatives, their evolution and outcomes.
ART FOR ALL HIV-INFECTED TB PATIENTS
In 2010, WHO ART Guidelines recommended that ART be initiated in all HIV-infected TB 
patients, irrespective of CD4 count.1 While Indian national TB and HIV programmes wanted 
to make the change, they had major concerns about whether this change would have major 
resource implications in terms of the additional number of people who would need to be 
started on ART, drugs, costs, staff workload and accompanying logistics. In the study that 
we conducted (chapter 2), we found out that nine out of ten HIV-infected TB patients were 
already eligible for ART based on the 2006 WHO ART guidelines and adopting the 2010 
guidelines would add only one additional person (out of ten) requiring ART.2 As a public 
health approach to ART, this strongly justified the adoption of the WHO 2010 ART Guidelines, 
meaning that ART could be extended to all HIV-TB patients with relatively little additional 
burden to the national ART programme. 
The findings of this study were shared with the key policy makers in a national 
technical working group of TB/HIV collaborative activities. Following this, a national policy 
decision was made to provide ART to all HIV-infected TB patients in India.3 There were several 
factors which might have contributed to this decision which included: i) strong national 
evidence from the routine programmatic setting of a large state in India; ii) ownership of 
study findings by the national TB and HIV programme managers who were engaged right 
from the conception of the study until the end and were included as co-investigators and co-
authors; iii) supporting evidence from other settings in Africa;4 and iv) the supportive policy 
recommendation from WHO.1 Although we did not undertake a costing analysis which would 
have provided useful information, this did not deter the policy makers from making the 
decision as the ‘numbers of additional people requiring ART’ were small and it was believed 
that the additional costs could easily be absorbed by the programme. 
Following the implementation of this policy and several other health system 
strengthening measures to improve access to ART (which also included providing transport 
reimbursements for patients travelling to ART centres), there has been a steady increase in 
the number and proportion of HIV-TB patients who are receiving ART during TB treatment 
from less than 50% in 2009 to 98% in 2016.5,6 While the case fatality among HIV-TB patients 
has declined during the same period, it still remains high at 12%.5 This might be related 
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to delays in making the diagnosis of HIV and TB. Several interventions have been initiated 
to address the delays including the provider-initiated HIV testing among presumptive TB 
patients and use of Xpert MTB/RIF as the primary tool for diagnosing TB among PLHIV in 
India.7 There has been an increase in the number of ‘TB patients with a known HIV status’ 
over the years and has reached 72% for 2016.6 However, the impact of all these interventions 
on HIV-TB mortality is yet to be assessed.
HIV TESTING AMONG PRESUMPTIVE TB PATIENTS AND LINKAGE TO ART
In 2010, HIV testing was offered routinely to all TB patients in India, but not to all patients 
with presumptive TB (people with symptoms suggestive of TB and investigated for TB, who 
previously were referred to as “TB suspects”).8 There were many reasons for this stance by 
the Indian TB and HIV programmes. First, the WHO recommendation was mainly based on 
studies from the African region 9–35 which faced a generalized HIV epidemic and other settings 
in Asia36 and America,37,38 which could not be generalised to India. Second, there had not been 
any previous studies on this issue from India barring an incidental finding in a study from 
South India (which reported a HIV prevalence of 8.5% among presumptive TB patients).39 So 
the Indian policy makers sought national evidence before making a decision. 
As a first step towards filling this evidence gap, it was decided to study the HIV 
prevalence among presumptive TB patients in two districts of South India – one district 
in Karnataka State and another in Andhra Pradesh State – both known to have high HIV 
prevalence in the country. The rationale for choosing these districts was that if HIV prevalence 
among presumptive TB patients was low in these settings, then it could be safely assumed 
that the HIV prevalence in other parts of the country would be lower and the policy of routine 
HIV testing in this group of patients would not be worthwhile in the entire country.  The 
findings of these studies have been described in chapters 3 and 4 and are discussed here.40,41
HIV TESTING IN PRESUMPTIVE TB PATIENTS IN HIGH HIV SETTINGS
Chapter 3 describes the findings from Mandya district (Karnataka State), where we found that 
7% of presumptive TB patients were HIV positive as compared to 15% HIV prevalence among 
TB patients. Nearly 90% of all presumptive TB patients who were offered HIV testing accepted 
it, indicating that HIV testing was acceptable. Even though the strategy of ‘HIV testing among 
presumptive TB patients’ was not as efficient as ‘HIV testing among TB patients’ in terms of 
NNS to detect an additional case of HIV, it remained reasonably efficient given the context of 
a concentrated epidemic. In certain age groups (25-54 years), the NNS was lower at 20. More 
importantly, in the context of overall district HIV case-finding efforts, a policy of HIV testing 
of presumptive TB patients had the potential to substantially increase HIV case detection 
relative to existing practice. Thus, all the findings favoured a policy decision of routine HIV 
testing among presumptive TB patients in high HIV-prevalence settings in India. However, the 
evidence was limited to a single district in India and needed additional evidence from other 
parts of the country.40 
DISCUSSION AND CONCLUSION
203
Ch
ap
te
r 1
3
Chapter 4 provides the additional evidence from Vizianagaram district of Andhra 
Pradesh State where the same research was conducted and the findings were replicated.41 
About 85% of presumptive TB patients accepted HIV testing and among them, about 10% 
were diagnosed HIV positive as compared to 8% among TB patients. Thus, the HIV-prevalence 
in ‘presumptive TB patients’ was higher than that found in ‘TB patients’. A workload analysis 
showed that most of the HIV testing centres (27/31) would have a minimal increase in 
workload with an average of only 1-2 extra clients needing to be counselled and tested in a 
day. This meant that the strategy could be implemented using the existing human resources 
with negligible additional burden on the health staff delivering these services. Given these 
findings, it was concluded that routine HIV testing was feasible and effective, detecting a 
large number of new HIV cases with minimal additional workload on staff working in HIV 
testing centres. 
Although, not formally studied, there were other positive implications of this 
strategy. First, the early diagnosis of HIV-infected TB patients and linkage to HIV care and 
support could potentially be life-saving. Second, this strategy identified HIV-infected 
individuals in whom TB had been ruled out and who were therefore potentially eligible for 
Isoniazid preventive therapy (IPT) as per WHO guidelines.42 Third, these individuals might 
also have been eligible for ART, as has been shown in sub-Saharan Africa,43 and getting them 
initiated on this treatment early on might have prevented TB as well as saved their lives.44
The results of both these studies were presented to the policy makers. 
Acknowledging the strong evidence from the operational research studies, the National 
Technical Working Group (NTWG) of TB/HIV collaborative activities took a policy decision 
to implement provider-initiated HIV testing and counselling (PITC) among patients with 
“presumptive TB” in high HIV settings (states of Karnataka, Andhra Pradesh, Tamil Nadu, 
Maharashtra, Manipur and Nagaland) in India.45 It was clear from the two studies that a pre-
requisite for effective implementation of this strategy was availability of HIV testing services 
at every health facility where presumptive TB patients were being evaluated. Thus, the study 
findings made a strong case and supported the national strategy for scaling up HIV testing 
services across the country. Another study from Delhi published around the same time in 
2012 showed that the prevalence of HIV among presumptive TB patients was 31% (42% in 
culture positive TB patients and 26% among those culture negative) providing additional 
evidence in favour of the policy decision.46
 
PITC AMONG PRESUMPTIVE TB PATIENTS: THE IMPLEMENTATION MODEL
While PITC was of value in high HIV settings, how this was best implemented and monitored 
in routine health care settings, especially when taken to large scale, was not known, and 
this implementation-knowledge gap needed to be addressed. Accordingly, a pilot study was 
implemented in the entire state of Karnataka (South India, population 64 million, high HIV 
prevalence). 
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Chapter 5 describes the results of this research and we discuss the key findings 
here.47 As part of this pilot, the strategy was implemented in all 645 microscopy centres of 
31 districts and a total of ~115,000 patients with presumptive TB were offered HIV testing, 
of whom HIV status was ascertained for 62,847 (55%) and 7,559 (12%) were found to be HIV 
positive. Of the latter, about 40% were newly diagnosed and about 90% of them were found 
to be eligible for ART as per the existing guidelines at the time. 
Despite the apparent low levels of HIV testing, the intervention was considered 
feasible and effective. It was considered feasible because: 1) all the interventions including the 
recording and reporting were implemented in a large state by the existing staff and resources 
(including budgets); 2) there was minimal additional workload on the staff except in tertiary 
centres; and 3) only 4% of the patients refused HIV testing. The intervention was considered 
effective as it identified thousands of new HIV-positive, ART-eligible patients who would not 
have otherwise been detected. These findings were presented back to NTWG and a decision 
to nationally scale up this intervention across all high HIV settings was made.3 Changes in 
recording and reporting have also been adopted by the national TB and HIV programmes 
in India following the study.7 While it cannot be attributed directly, we note that some of 
these changes are now reflected in global guidance as well, which includes documenting HIV 
status in the laboratory form requesting for examination of biological specimen for TB and 
the laboratory register (for smear microscopy and Xpert MTB/RIF).48
This study provided insights into the reasons for non-testing among presumptive 
TB patients. Not surprisingly, HIV testing was more likely in sputum microscopy centres with 
co-located HIV testing facilities. This justified the ongoing efforts of the national programmes 
to prioritise the setting up of new HIV testing facilities at hospitals having sputum microscopy 
facilities. This, however, did not address the major reason for non-testing in a substantial 
proportion of presumptive TB patients for whom sputum samples were collected and 
transported from peripheral health institutions to microscopy centres – such patients 
missed the opportunity of getting HIV tested at microscopy centres. This called for further 
decentralization of the HIV testing services to all peripheral health institutions and sputum 
collection centres. The other programmatic challenge was to improve the procurement and 
supply chain management of HIV test kits to enhance HIV testing uptake. Unavailability of 
the laboratory technician or counsellors at the microscopy centre or HIV testing centre was 
another reason for lack of HIV testing. Moving forward, this can be addressed by training the 
other staff within the general health system and motivating and allowing them to perform 
HIV testing in line with the overall approach to integrate the national AIDS control programme 
into the general health system. This has been done in other countries in Africa, and would be 
sustainable in the long term.49,50
HIV TESTING AMONG PRESUMPTIVE TB PATIENTS IN LOW HIV SETTINGS
Considering the high diagnostic yield of HIV among presumptive TB patients in high HIV-
prevalence settings, the national policy making body also requested that similar surveillance 
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efforts be conducted jointly by the national TB and HIV programmes in moderate and low HIV 
settings (HIV prevalence <1% among pregnant women and/or <5% among high risk groups) 
of the country and findings presented before making a national policy decision. Given the 
heterogeneity of the HIV epidemic in India across states/districts, it was agreed that it was not 
possible to define a cut-off value of HIV prevalence to decide if PITC among presumptive TB 
patients was justified. Hence, it was agreed that if the prevalence of HIV among presumptive 
TB patients was as high as or greater than the HIV positivity among the general clients 
attending the HIV testing centres, then the strategy of PITC for presumptive TB patients might 
be justified. To address this knowledge gap, we undertook a study with the aim of assessing 
HIV testing uptake and HIV positivity among presumptive TB patients in Puducherry, a district 
with low HIV prevalence in South India. This is presented in Chapter 7 and discussed here.51
This was one of the first studies from India examining the effectiveness and 
feasibility of implementing the PITC strategy for presumptive TB patients in a low HIV 
prevalence setting under routine programmatic conditions. Overall, the HIV testing uptake 
was low with less than half of presumptive TB patients getting their HIV status ascertained. 
HIV prevalence was relatively higher (3.3%) among presumptive TB patients who were tested 
as compared to antenatal clinic attendees (<1%), TB patients (2%) and clients attending HIV 
testing centres excluding pregnant women (1.6%). This confirmed the findings from other 
studies that ‘presumptive TB patients’ remained an important target group for HIV testing.51 
At about the same time, this study was replicated in eight low HIV prevalence 
districts across the country with similar findings.52 The overall HIV prevalence in low HIV 
settings was 2.6% (95% CI 2.3%-2.9%) and it ranged from 0.2% to 4.6%.52 While the overall 
HIV prevalence was relatively lower compared to high HIV settings, it was higher than the 
HIV prevalence among antenatal women (which ranged from 0.0% to 0.2% in the same 
settings). Another independent study published in 2012 from Punjab reported a prevalence 
of 1.2% among presumptive TB patients.53 All these study findings were presented to the 
NTWG which took a policy decision to extend HIV testing to all presumptive TB patients in low 
HIV settings of India (especially those aged 25-54 years if there were resource constraints). 
With this, HIV testing among presumptive TB patients became a national policy in India.52 
Similar low levels of HIV prevalence have been reported among presumptive TB patients in 
the public health centres of the Republic of Korea (where the HIV prevalence was 8.2 per 
10,000 in 2000 which decreased to 1.9 per 10,000 in 2013)54 and Colombian prisoners (HIV 
prevalence of 2%).55 
ART ELIGIBILITY AMONG HIV-INFECTED PRESUMPTIVE TB PATIENTS
In the evolution of ART eligibility guidelines, several groups (such as TB patients, antenatal 
women, children aged less than 5 years, and those living in sero-discordant relationships) were 
considered high priority and it was recommended that they be started on ART irrespective 
of CD4 cell counts or WHO staging.56 A preliminary assessment from India and another study 
from Zimbabwe had shown that nearly 90% of all HIV-infected presumptive TB patients were 
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eligible for ART and there was high mortality, if these patients were not started on ART.47,57 
Thus, this was another high priority group which deserved to be started on ART irrespective 
of CD4 cell counts. However, there was no systematic evidence on this issue from India. So, a 
study was conducted to assess the proportion of HIV-infected presumptive TB patients who 
were eligible for ART using the guidelines at that point in time (WHO 2013 ART guidelines).56 
The findings of this study have been detailed in Chapter 8 and are discussed here.58
The findings confirmed our hypothesis that nine out of ten HIV-infected 
presumptive TB patients (without TB) were eligible for ART as per the WHO guidelines at the 
time.56 This too was an underestimate as we did not assess all the criteria of ART eligibility at 
that time. For example, we did not have any information about whether the patients in our 
study had co-existing Hepatitis-B infection with severe liver disease, if they were pregnant 
or if they were living in a sero-discordant relationship, all of which were criteria for starting 
ART at the time of the study.59 Some studies had indicated that nearly 75% of PLHIV in 
India were sero-discordant, 60,61 so if we applied this figure to our cohort then nearly all HIV-
infected presumptive TB patients would have been eligible for ART. Hence, as a public health 
approach to ART initiation, we recommended that all HIV-infected presumptive TB patients 
should be initiated on ART irrespective of the CD4 cell count. This recommendation has little 
relevance today with WHO recommending since 2015 that all people living with HIV should 
start on ART irrespective of CD4 cell count or WHO clinical stage.59 India has also accepted 
in principle to implement this 2015 recommendation. We also proposed the addition of an 
extra column in the TB laboratory register to capture ART initiation status, which could be 
used for monitoring ART uptake. This remains relevant to this day.
METHODOLOGICAL INNOVATION: EFFICIENT, QUALITY-ASSURED DATA CAPTURE IN 
MULTICENTRE OR
The multicentre study on HIV testing among presumptive patients nested a methodological 
innovation and this has been described in detail in Chapter 6.62 In this study, we captured 
data in an innovative manner using the freely available resources for data entry, storage, 
sharing and troubleshooting using a combination of three open access technologies – 
EpiData for data capture, Dropbox for sharing files and TeamViewer for providing remote 
support. While internet connection was essential for success of this model, the system did 
not require a large bandwidth, since EpiData file sizes are small (1000 records required ~216 
kilobytes only!). Since Dropbox has the option of offline access to shared folders, offline data 
entry was possible which got synced once internet connection was available. This was a 
major advantage compared to web-based data capture systems, where internet connection 
is a pre-requisite for data entry. Telephone costs were circumvented by using Skype™ (http://
www.skype.com), which was used for periodic video conference calls among the research 
staff for monitoring the project. The use of TeamViewer software to remotely access the 
computers at the data entry sites and troubleshoot meant that frequent travels to study 
sites were not required thus saving travel costs. The use of Dropbox for storing and sharing 
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files meant that there was automatic backup on the cloud with no threat of data loss due 
to a computer crash anywhere. Ensuring quality of data during electronic data capture has 
been one of the most neglected components of operational research. Multicentre studies are 
additionally challenged with issues about logistics of travel, training, supervision, monitoring 
and troubleshooting support. Allocating resources to these issues can pose a significant 
bottleneck for operational research in resource-limited settings. This approach to ensuring 
quality of data capture in multicentre operational research in resource-constrained settings 
has been a great lesson. This model has since been adopted and replicated in other settings 
and other programmes elsewhere, which include a nationwide, multicentre research on 
tuberculosis in India and a large state-wide tobacco survey in Tamil Nadu, India.58,63,64
LESSONS LEARNED, GAPS IN KNOWLEDGE AND FUTURE RESEARCH 
EVIDENCE-POLICY LINKAGE
One of the biggest challenges in policy research is to establish a clear linkage between 
evidence and policy. As described above, we were able to find a clear link between evidence 
and policy in the form of minutes of the NTWG meetings which clearly documented the 
evidence presented during the meetings and the policy decisions taken thereof. For example, 
the minutes of the NTWG meeting that took place on 21st April 2011 clearly documents the 
findings of the study in chapter 2 and the policy decision made to start ART among all HIV-TB 
patients irrespective of the CD4 count.3 Similarly, the minutes of NTWG meetings on 19th July 
2012 and 17th December 2012 document the findings of the operational research studies 
detailed in chapters 2-5 and chapter 7 and the consequent policy decisions.3,45,52 
GAPS IN KNOWLEDGE AND FUTURE RESEARCH
There were some limitations in the research conducted which could be a topic for future 
research. First, we studied only the presumptive pulmonary TB patients who attended the 
government-run sputum microscopy centres. We were not able to assess HIV prevalence 
among extra-pulmonary presumptive TB patients, or those evaluated at private laboratories 
outside the national public programme. Although this information was not required to inform 
the policy question facing national TB and AIDS programmes, this will remain a limitation in 
the assessment of true HIV prevalence among all presumptive TB patients and needs to be 
studied in the future. An extensive search for published literature revealed that HIV prevalence 
was an incidental finding in two studies on extra-pulmonary presumptive TB patients.65,66 The 
findings are no different to those involving presumptive pulmonary TB patients. A study from 
South Africa among patients suspected of having cranial or spinal meningeal tuberculosis 
reported a HIV prevalence of 81%.66 Another study from three countries of Africa (Nigeria, 
Cameroon, South Africa) among patients suspected of tuberculous pericardial effusion 
reported a prevalence of 50%.65 These provide evidence justifying offering HIV testing to 
extra-pulmonary presumptive TB patients too.
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Second, the reasons for non-testing needs further study. While there could be 
multiple reasons in an individual for non-testing of HIV, only one predominant reason was 
captured and that too from the provider’s perspective. In about one-third of patients, the 
reason for non-testing was not mentioned and this is a serious limitation. Future research 
involving qualitative methods should be undertaken to understand patients’ perspectives 
for not getting tested for HIV. This is important as HIV testing is the gateway for HIV care and 
treatment, and it is the first pillar of the UNAIDS 90-90-90 strategy which is the cornerstone of 
helping to end the AIDS epidemic by 2030.67,68 
Third, we did not include children in our studies. There are no studies directly 
examining the HIV prevalence among presumptive TB patients in the paediatric age group. 
But, there are a few studies where HIV prevalence among paediatric presumptive TB patients 
was an incidental finding [Mozambique-13.2%; South Africa-17% to 40%; Tanzania-49% to 
51%].69–74 These support the policy of offering HIV testing to children as well.
Finally, our studies did not assess whether the strategy of moving HIV testing 
upstream to test all presumptive TB patients instead of TB patients alone actually resulted 
in increased linkage to HIV care and support and reduced mortality among HIV-infected TB 
patients. This needs further research.
OPERATIONAL RESEARCH CAPACITY BUILDING
All the studies that have been discussed above happened within an operational research 
capacity building initiative started initially by The International Union Against Tuberculosis 
and Lung Disease (The Union) and Médecins sans Frontières (MSF) and continued further in 
partnership with the Special Programme for Research and Training in Tropical Diseases (TDR) 
at the World Health Organization (WHO/TDR). There were two capacity building initiatives: 1) 
SORT IT (Structured Operational Research and Training Initiative) courses,75 which are well 
known for their outputs with 90% of participants completing the course and publishing their 
research in scientific journals and 2) the global OR Fellowship programme.76 
Dr Ajay Kumar was a participant of the SORT IT course in 2010-11 and the research 
project described in chapter 2 was conducted as part of the training course. Later, Dr 
Ajay Kumar joined the Union as an OR fellow and led several OR courses in India and co-
facilitated many courses in Asia, Africa, Eastern Europe and the South Pacific regions. The 
studies described in chapters 3, 4 and 7 were conducted by the participants of the OR courses 
conducted in India under the leadership and direct mentorship of Dr Ajay Kumar. The other 
studies described in chapters 5, 6 and 8 were undertaken directly by Dr Ajay Kumar in his role 
as OR fellow. The contribution of the OR fellowship programme in strengthening the scientific 
output of The Union South-East Asia (USEA) Regional office is described in Chapter 10.76  
A vital element in assessing the success of operational research (OR) is to measure 
its impact on policy and/or practice. Several follow-up assessments were done to understand 
the impact of the research studies conducted as part of the SORT IT courses on policy and/
or practice. One such assessment is described in Chapter 9, where we report on the impact 
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of research papers on policy/practice that resulted from six SORT IT courses initiated 
between July 2012 and March 2013.77 In this study, about 55% (45/81) of papers assessed 
were considered to have contributed to a change in policy and/or practice. Few capacity-
building programmes track outputs, although this is fast changing,78,79 and the SORT IT model 
creates a benchmark in this area.80 This is encouraging and can be attributed to several 
factors including policy-relevance of the research question, engagement of policy makers 
as co-investigators, ownership of study results especially when programme managers were 
principal investigators of the research project and other windows of opportunity available to 
individual researchers by virtue of these individuals being in national/state level committees. 
We need to view these results, however, with caution because these were self-
reported by the authors of the papers and there is a high likelihood of responder bias. 
We tried to mitigate this by verifying official policy documents wherever possible and by 
adopting a conservative stance in our assessments. However, finding documents that 
provide documentary support of evidence-policy linkage is challenging. The other challenge 
relates to varied interpretations of the authors as to whether their study impacted policy or 
not. Some were modest and did not attribute their study to the policy change while others 
were more aggressive in their attribution. Given the complexities in interpreting policy 
impact assessment, future assessments should focus beyond self-reporting of data and 
use more robust and independent verification of the reported change(s) with all concerned 
stakeholders to enhance the richness and rigour of the assessments. This is difficult to 
do with international and regional courses, but more feasible with national courses that 
have been and are being conducted in India, Pakistan, Myanmar, Sierra Leone,  Liberia, Kenya 
and Zimbabwe. 
Chapter 10 describes the contribution of the OR fellowship programme in strengthening 
the scientific output of The Union South-East Asia (USEA) Regional office.76 This case study testifies 
to the large research output that resulted from placing two OR fellows in the USEA Office, Delhi, 
India. Of particular note, in the six years before the fellows joined there was only one published 
paper from the office while in the first five years since the fellows joined the cumulative number of 
published papers reached nearly one hundred. Before joining as OR fellows, the two individuals 
had little engagement in operational research. They learnt and subsequently taught their craft as 
they developed, with a number of factors facilitating this process such as their own enthusiasm 
and passion for the subject, a supportive and enabling environment and strong mentorship from 
the leadership of the Office and the Centre for Operational Research. Selecting the right individuals 
for the job is an essential determinant of success, but the performance-related contracts that The 
Union offers to all OR fellows allow a way out if a mistake is made in selection and individuals 
fail to deliver. There have been similar successes of OR fellowship programmes in Vietnam81 
and Benin.82    
The SORT IT model has evolved over a period of time with many innovations 
introduced to the administration, structure and content of the course. These are described 
in chapters 11 and 12.83,84 Over the years, we have faced a number of challenges in 
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implementing these courses, including shortage of time for data analysis, data interpretation 
and manuscript drafting, and a high mentorship burden on a limited pool of facilitators. We 
have introduced several changes in the SORT IT model to address these challenges. The key 
changes included increasing the duration of the modules, increased number of facilitators 
and standardized milestones for module 2. The increased costs as a result of the increased 
duration was mitigated to some extent by conducting module 1 and 2 back to back to reduce 
the costs and travel time. Despite the increased costs and increased time away for faculty as 
a result of these changes, this has addressed the previous challenges of insufficient time and 
overburdened mentors. We have continued with this model ever since.
The SORT IT model has evolved further – geographically, methodologically and 
thematically. Geographically, we have now decentralised the courses from global to regional 
and national level. There have also been efforts to replicate SORT IT at the institutional level. 
Methodologically, we have started SORT IT 2.0 in which we encourage participants to undertake 
a research study that incorporates “mixed-methods” design which answers research questions 
not only related to the magnitude of the problem but also explores the reasons and possible 
solutions to the problem. Similarly, pure qualitative research has been experimented with under 
the SORT IT model and there are also plans to use the SORT IT model to conduct a course on 
systematic reviews and meta-analysis. Other models such as e-SORT IT and blended versions 
(partly online and partly face-to-face modules) have been tried, although these are early days to 
comment about the effectiveness of such approaches. We have also expanded thematically and 
have now conducted or are conducting SORT IT courses on specific themes such as multidrug 
resistant tuberculosis in Eastern Europe85 and the Ebola epidemic in West Africa.86
IMPACT OF RESEARCH ON POLICY AND PRACTICE
As discussed above, there are many implications from the studies conducted in this thesis 
for policy and practice change and these are shown in the Table in relation to the research 
question and the methodology used. The broad principal recommendations included: 
acceptance of the WHO guidance that all  HIV-TB patients should start ART regardless of 
CD4 count; a national policy decision that all patients with presumptive TB should be HIV 
tested in both high and low HIV-prevalence settings and that those diagnosed HIV-positive 
should be referred to HIV treatment and care including ART, irrespective of CD4 count; and 
that the SORT IT model of operational research be expanded and used to obtain robust local 
evidence and generate data to further inform policy and practice. The optimization and use 
of SORT IT in India also helped to promote this model internationally and at the WHO. 
CONCLUSION
The body of work contained in this thesis demonstrates the strong role that operational 
research has played to inform policy in the setting of a national TB and HIV programme in 
India. Several key national policy decisions were made on the basis of evidence generated in 
routine programme settings. First, it was decided that ART should be started for all HIV-infected 
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TB patients in India irrespective of CD4 count and WHO clinical staging. This has increased the 
proportion of HIV-TB patients receiving ART from 50% in 2009 to 98% in 2016. Second, a national 
policy decision was taken to offer HIV testing routinely to all presumptive TB patients in India. 
Although this policy has been implemented nationally, there is no data measuring the extent of 
HIV testing in this group from routine reports of the national TB and HIV programmes. There is 
limited data about the reasons for HIV non-testing among presumptive TB patients. Further, the 
impact of these strategies in reducing morbidity and mortality due to HIV-associated TB is yet to 
be studied. Future research needs to focus on these aspects. Third, it was recommended that all 
HIV-infected presumptive TB patients should be started on ART, irrespective of CD4 count and 
clinical staging. This recommendation though has little relevance today with India deciding to 
implement ‘test and treat’ policy. 
Although international and national policies have changed since the start and 
completion of the HIV-TB studies in this thesis, they are still relevant to the larger picture. 
Moving HIV testing upstream to presumptive TB patients identifies a vulnerable group who are 
at high risk of HIV infection and without prompt diagnosis and referral to HIV care are at risk 
of considerable HIV-related morbidity and mortality. Timely ART can prevent this. For those 
who have yet to develop TB, this disease can be prevented and other HIV-related disease 
specifically targeted, prevented or treated. For those who are found to have TB, their prognosis 
can be improved and case fatality decreased. ART also reduces further transmission of HIV to 
uninfected partners and leads to a reduction in HIV incidence. HIV testing and referral to ART for 
presumptive TB patients thus addresses the first 90 of UNAIDS 90-90-90 targets (90% of those 
HIV-infected are identified), the second 90 of UNAIDS 90-90-90 targets (90% of those diagnosed 
are started on ART) and the last 90 of the Stop TB Partnership (90% of those diagnosed with 
TB are successfully treated) as well as tackling TB incidence and mortality which are the key 
indicators for Ending the TB epidemic by 2030.   
The conduct of operational research was facilitated and catalysed greatly by the capacity 
building initiatives driven by The Union which included training public health professionals in 
the SORT IT model of training and the Global OR Fellowship programme. Based on the lessons 
learned in the initial cycles of SORT IT courses, the model has been optimized and expanded 
geographically, thematically and methodologically. Studies have also showcased the impact of 
research conducted in SORT IT courses on policy and practice and the case study from the USEA 
office showed what OR fellows could achieve if provided with the right opportunity, support, 
mentorship and enabling environment. As a result of these initiatives, a great resource pool has 
been created in India which is being drawn on to facilitate OR courses in wider areas of disease 
control both in India and worldwide. With the clock ticking, the scale up and implementation 
of sound OR embedded within TB and HIV/AIDS programmes is essential for meeting the 
international goals. Controlling the TB epidemic desperately requires new tools (new diagnostics, 
new treatments and new vaccines), but these have to rapidly be accommodated and embedded 
into established programmatic settings for them to have any impact on the epidemic. Operational 
research is the only way of ensuring this will happen in an evidence-based way. 
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SUMMARY
Tuberculosis (TB) and the Human Immunodeficiency Virus (HIV) are two of the most deadly 
infectious diseases in the history of humanity. Despite great progress over the years in the 
care of TB and HIV, they still remain the leading infectious causes of death globally. In 2015, 
an estimated 10.4 million patients fell ill with TB and about 1.8 million died due to TB. An 
estimated 1.2 million (11%) new TB cases occurred among people living with HIV (PLHIV) and 
400,000 TB related deaths were among PLHIV. There has been great progress with TB and HIV 
care over the years. It is estimated that TB treatment averted 49 million deaths between 2000 
and 2015, and incidence and death rates fell during this period. Similarly, HIV incidence is 
declining in many parts of the world and access to antiretroviral therapy (ART) has increased 
several fold. Buoyed by these developments, the global community has pledged to end the 
TB and AIDS epidemics by 2030 as part of the larger sustainable development goals.
The global TB burden is primarily driven by the large absolute numbers in India. 
In 2015, an estimated 2.8 million people fell ill with TB in India thus accounting for 27% of 
the global TB burden. Similarly, about 480,000 people died due to TB in India accounting for 
one-third of global TB mortality. About 2.1 million people were estimated to be living with HIV 
in India (prevalence of 0.26%) in 2015 making the country home to the third largest number 
of PLHIV globally. The HIV epidemic in India is heterogenous and concentrated among high 
risk groups, but it is showing a declining trend, probably due to prevention and treatment 
strategies by the National AIDS Control Programme (NACP). With an estimated HIV prevalence 
of 5% among people with TB, India is home to the second largest number of HIV-infected TB 
patients in absolute terms (113,000), next only to South Africa (270,000), and accounts for 
about 10% of the global HIV-TB burden.
The evolution and progress of TB-HIV collaborative activities in India has been 
show cased as a success story globally, particularly for a country with a concentrated HIV 
epidemic. As of now, India follows all the recommendations enshrined in the 2012 WHO 
global policy on TB-HIV collaborative activities, though the extent of implementation varies 
across the components. The basic mechanisms of collaboration between the national TB 
and HIV programmes in India are in place at all levels of the health system (national, state 
and district), and these include joint recording and reporting, joint monitoring and review. 
Since this thesis consists of TB-HIV related operational research studies conducted 
in India during the period 2011-2015, we begin here by providing a brief overview of the 
evolution of TB-HIV care in India and analyse the situation in 2010 which stimulated and 
necessitated the conduct of these operational research studies.
TB-HIV collaboration started in India in 2001, in six selected states of the country 
- Maharashtra, Manipur, Nagaland, Karnataka, Tamil Nadu and Andhra Pradesh. The early 
activities were primarily joint training of health staff in TB-HIV and cross-referrals.  Based 
on evidence from several operational research studies conducted between 2005 and 2008, 
a decision was made at national level to implement a differential strategy in the country 
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- a package of essential TB-HIV interventions (establishing mechanisms of coordination, 
training of staff, Intensified TB case finding at HIV counselling and testing centres and ART 
Centres, risk-based, selective referral of TB patients for HIV testing and linkage to care) to be 
implemented in all states, while an intensified package (routine referral of TB patients for 
HIV testing, decentralised cotrimoxazole preventive therapy and referral to ART to all HIV-TB 
patients) was to be implemented in selected states with a higher burden of HIV, improved 
availability of HIV testing, better treatment infrastructure and services and higher programme 
management capacity. It was decided in 2009 to scale-up the implementation of “Intensified 
TB-HIV activities” nationwide and the goal was reached in July 2012. 
There were several important challenges in implementation of TB/HIV collaborative 
activities. 
1) Challenges in setting up mechanisms of collaboration at all levels of the health system, 
especially at district level was challenging. Surveillance of HIV prevalence among TB patients and 
vice versa was not comprehensive. Administrative guidelines for organizing training of staff were 
not uniform under the NACP and RNTCP and were frequently a source of conflict in programme 
implementation. The existing recording and reporting systems were not optimal. There was a lack 
of time and capacity to conduct policy-relevant operational research among the programme staff. 
2) Challenges in reducing the burden of TB among PLHIV: Intensified TB case finding (ICF) 
activities were established in all HIV testing and counselling centres across the country with 
standardized recording and reporting. But the implementation varied and was suboptimal in low-
HIV prevalence states. Sputum smear microscopy was still the mainstay of diagnosis at the time 
despite its known limitations among PLHIV (limited sensitivity, inability to identify drug resistance). 
The widely acclaimed rapid diagnostic test such as the Xpert MTB/RIF assay was still not widely 
available in India. Isoniazid preventive therapy (IPT) for PLHIV without TB was not a policy at the 
time. The implementation of TB infection control in health care and congregate settings was poor.
3) Challenges in reducing the burden of HIV among TB patients: There were wide variations in 
the implementation of HIV testing among TB patients due to variations in availability of HIV testing 
services and interruptions in supply of HIV testing kits. HIV testing of presumptive TB patients was 
not a national policy at the time, even though WHO recommended moving HIV testing upstream 
by testing all patients with presumptive TB (formerly referred to as TB suspects) as a way of early 
detection of HIV-infected TB patients. While nearly 90% of HIV-infected TB patients received CPT 
at the time, only about 50% HIV infected TB patients were linked to ART care and support. One 
of the reasons ascribed to the low proportion of HIV-TB patients on ART was that not all HIV-
infected TB patients were eligible for ART. India still followed the WHO 2006 guidelines and had 
concerns about adopting the WHO 2010 ART guidelines (these specified that all HIV-infected TB 
patients were eligible for ART irrespective of the CD4-cell count) since there were concerns about 
the resource implications and the increased workload that such a strategy would impose on the 
national ART programme. Other barriers to ART linkage were related to long travel times, distances 
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and financial burdens for patients as ART services were centralised and were provided in selected 
health facilities only.
To address the challenges described above and to improve the care and management of HIV-
infected TB patients in India, several operational research studies were planned and carried 
out. The three key objectives were:
1) To evaluate the additional number of patients that would be initiated on ART if India adopted the 
current 2010 WHO ART guidelines of placing all HIV-infected TB patients on ART regardless of CD4 
cell count 
2) To assess the prevalence of HIV among patients with presumptive TB in different settings with 
different levels of HIV infection and the proportion eligible for starting ART according to 2015 WHO 
Guidelines
3) To document the operational research capacity building initiative undertaken in India, its evolution 
and impact on policy and practice. 
We describe six operational research studies (including two multicentre operational research 
projects) and their findings in this thesis and discuss their overall contribution to changes in 
policy, practice and the improvement of health outcomes among HIV-infected TB patients in 
India. A brief summary of what is covered in each chapter is provided below. 
OBJECTIVE 1: 
In 2010, WHO expanded previously-recommended indications for ART to include all HIV-
infected TB patients irrespective of the CD4 count. India, however, still limited ART to TB 
patients with CD4-cell counts <350/mm3 or with extra-pulmonary TB. We sought to evaluate 
the additional number of patients that would be initiated on ART if India adopted the current 
2010 WHO ART guidelines for HIV-infected TB patients. The findings of this research study 
are described in Chapter 2. This study showed that nine out of ten HIV-TB patients were 
already eligible for ART as per WHO 2006 guidelines and recommended that, as a public 
health approach, ART should be provided to all HIV-TB patients irrespective of CD4 count. 
India adopted the policy of universal ART for HIV-TB patients following this study. 
OBJECTIVE 2:
HIV testing of persons referred for tuberculosis diagnosis (patients with presumptive TB) 
is recommended by WHO but was not a policy in India, where HIV prevalence among TB 
suspects had never been studied. To fill this knowledge gap, a study was conducted in two 
districts of South India to assess the prevalence of HIV among patients with presumptive TB 
and the feasibility of provider initiated HIV testing under programmatic settings. The findings 
of these studies are reported in Chapters 3 and 4. These studies showed that HIV prevalence 
among presumptive TB patients was as high as that among TB patients. 
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Based on the findings of the studies described in Chapters 3 and 4, a national 
policy decision was taken to routinely offer HIV testing to patients with presumptive TB 
in high-burden HIV states of India. However, how this should best be implemented and 
monitored in routine health care settings in India was not known. An operational research 
was conducted in Karnataka State (South India, population 64 million and accounting for 
10% of India’s national HIV burden) to test processes and learn results and challenges of 
screening presumptive TB patients for HIV within routine health care settings. The findings 
of this operational research study are described in Chapter 5. The processes piloted in this 
study have now become part of programme guidelines and practice. An innovative process 
using open-access technologies like EpiData, Dropbox and TeamViewer was used to co-
ordinate quality-assured data capture in this multicentre study. This model of data capture is 
described in detail in Chapter 6.
While it became clear that HIV testing among presumptive TB patients was of 
value in high-HIV burden settings of India, it was not clear if it was of value in low-HIV burden 
settings. A study was undertaken in Puducherry to answer this question. The findings of 
this study are described in Chapter 7. This study showed HIV testing among presumptive 
TB patients was worthwhile even in low HIV settings, especially when offered to people 
aged 25-54 years. 
Chapter 8 describes the results of an operational research study conducted in the 
state of Karnataka to assess the proportion of HIV-infected presumptive TB patients eligible 
for initiating ART as per the WHO guidelines at the point in time. This study showed that most 
of the HIV-infected presumptive TB patients were eligible for ART and made a strong case for 
universal ART in this group. 
OBJECTIVE 3:
To catalyse the generation of evidence, we built capacity of several public health professionals 
in India using the SORT IT (Structured Operational Research Training Initiative) model of 
capacity building, developed by the International Union Against Tuberculosis and Lung 
Disease (The Union) and Medecins Sans Frontieres in partnership with the WHO’s Special 
Programme for Research and Training in Tropical Diseases (WHO-TDR). In addition, the 
defender of this thesis was mentored under a Global OR fellowship programme run by The 
Union in 2012. The SORT IT model and its adaptations, the OR fellowship programme and the 
impact of these on policy and practice have been described in a series of original research 
and viewpoint articles. Most of the papers described in this thesis are a result and outcome 
of these two initiatives. We describe in chapters 9-12 the evolution of this model of capacity 
building and its impact on policy and practice.  
In conclusion, the body of work contained in this thesis demonstrates the strong 
role that operational research has played to inform policy and change practice in the setting 
of a national TB and HIV programme in India. Several key national policy decisions were made 
on the basis of evidence generated in routine programme settings which included starting 
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ART for all HIV-infected TB patients irrespective of ART and offering HIV testing routinely to 
all presumptive TB patients in India. The conduct of operational research was facilitated and 
catalysed greatly by the capacity building initiatives driven by The Union which included 
training public health professionals in the SORT IT model of training and the Global OR 
Fellowship programme. Studies have also showcased the impact of research conducted in 
SORT IT courses on policy and practice and the case study from the USEA office showed what 
OR fellows could achieve if provided with the right opportunity, support, mentorship and 
enabling environment. As a result of these initiatives, a great resource pool has been created 
in India which is being drawn on to facilitate OR courses in wider areas of disease control 
both in India and worldwide.
 
The full citations of the published studies that make up this thesis are shown below:
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SAMENVATTING
Tuberculose (tbc) en het humaan immunodeficiëntievirus (hiv) zijn twee van de dodelijkste 
infectieziekten in de geschiedenis van de mensheid. Ondanks de grote vooruitgang die 
in de loop der jaren is geboekt in de tbc- en hiv-zorg vormen zij wereldwijd nog steeds de 
belangrijkste infectieuze doodsoorzaken. In 2015 raakten er naar schatting 10,4 miljoen 
mensen besmet met tbc en stierven er ongeveer 1,8 miljoen als gevolg van tbc. Naar 
schatting deden 1,2 miljoen (11%) nieuwe tbc-gevallen zich voor onder mensen met hiv 
en er waren 400.000 tbc-gerelateerde sterfgevallen onder mensen met hiv. In de loop der 
jaren is er grote vooruitgang geboekt op het gebied van tbc- en hiv-zorg. Naar schatting zijn 
er door de behandeling van tbc tussen 2000 en 2015 49 miljoen sterfgevallen voorkomen 
en zijn de incidentie en het sterftecijfer in deze periode gedaald. Op dezelfde manier 
neemt de hiv-incidentie in vele delen van de wereld af en is de toegang tot antiretrovirale 
therapie (ART) meermaals toegenomen. Ondersteund door deze ontwikkelingen heeft de 
wereldgemeenschap zich ertoe verbonden om tegen 2030 een einde te maken aan de tbc- en 
aids-epidemieën als onderdeel van de grotere doelstellingen voor duurzame ontwikkeling.
De wereldwijde tbc-last wordt voornamelijk veroorzaakt door de grote absolute 
aantallen in India. In 2015 zijn naar schatting 2,8 miljoen mensen in India ziek geworden 
door tbc, wat 27% is van de wereldwijde tbc-last. Ook stierven in India ongeveer 480.000 
mensen als gevolg van tbc, wat een derde van de wereldwijde tbc-sterfte is. In 2015 leefden 
er in India naar schatting 2,1 miljoen mensen met hiv (prevalentie van 0,26%), waarmee 
het land op de derde plaats op de ranglijst komt van landen met grote aantallen mensen 
met hiv. De hiv-epidemie in India is heterogeen en geconcentreerd onder risicogroepen, 
maar vertoont een dalende trend, die waarschijnlijk ten gevolge ligt aan de preventie- en 
behandelingsstrategieën van het nationale aidsbestrijdingsprogramma (NACP). Met een 
geschatte hiv-prevalentie van 5% onder mensen met tbc staat India nummer twee op de 
ranglijst van landen met grote aantallen hiv-geïnfecteerde tbc-patiënten in absolute termen 
(113.000), naast Zuid-Afrika (270.000), en is het land verantwoordelijk voor ongeveer 10% van 
de wereldwijde hiv-tbc-druk.
De evolutie en vooruitgang van de tbc-hiv-samenwerkingsactiviteiten in India 
vormen wereldwijd een succesverhaal, vooral gezien het feit dat het een land is met een 
geconcentreerde hiv-epidemie. Vanaf nu volgt India alle aanbevelingen op die zijn vastgelegd 
in het wereldwijde beleid van de WGO voor 2012 inzake tbc-hiv-samenwerkingsactiviteiten, 
hoewel de mate van implementatie per onderdeel verschilt. De basismechanismen voor 
samenwerking tussen de nationale tbc- en hiv-programma's in India zijn van kracht op alle 
niveaus van het gezondheidssysteem (nationaal niveau, deelstaatsniveau en districtsniveau), 
en deze omvatten gezamenlijke registratie en rapportage en gezamenlijke monitoring en 
evaluatie. 
Aangezien dit proefschrift zich richt op operationeel onderzoek naar tbc-hiv in India 
in de periode 2011-2015, beginnen we hier met een kort overzicht van de evolutie van de tbc-
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hiv-zorg in India en analyseren we de situatie in 2010 die de uitvoering van dit operationeel 
onderzoek stimuleerde en noodzakelijk maakte.
De samenwerking in de instellingen in de tbc- en hiv-zorg in India begon in 2001, 
in zes geselecteerde deelstaten van het land: Maharashtra, Manipur, Nagaland, Karnataka, 
Tamil Nadu en Andhra Pradesh. De eerste activiteiten betroffen voornamelijk de gezamenlijke 
opleiding van gezondheidswerkers op het gebied van tbc en hiv en onderlinge consultatie. 
Gebaseerd op bewijsmateriaal uit verscheidene studies op het gebied van operationeel 
onderzoek die tussen 2005 en 2008 werden uitgevoerd, werd op nationaal niveau besloten 
een differentiële strategie te volgen, waarbij een pakket van essentiële tbc-hiv-acties (het van 
creëren van coördinatiemechanismen, opleiding van personeel, intensievere opsporing van 
tbc-gevallen in de hiv-advies- en testcentra en de centra voor antiretrovirale therapie (ART), op 
risico gebaseerde, selectieve verwijzing van tbc-patiënten voor hiv-testen en koppeling aan 
zorg) wordt uitgevoerd in alle deelstaten, terwijl een geïntensiveerd pakket (routineverwijzing 
van tbc-patiënten voor hiv-testen, gedecentraliseerde preventieve cotrimoxazoltherapie 
en verwijzing van alle hiv-tbc-patiënten naar ART-centra) moest worden uitgevoerd in 
bepaalde deelstaten met een hogere hiv-last, verbeterde beschikbaarheid van hiv-testen, 
een betere behandelingsinfrastructuur en betere diensten en een hogere programma-
managementcapaciteit. In 2009 werd besloten om de implementatie van geïntensiveerde 
tbc-hiv-activiteiten landelijk op te schalen. Dit doel werd in juli 2012 bereikt. 
Er waren verschillende belangrijke uitdagingen bij de uitvoering van de tbc-hiv-
samenwerkingsactiviteiten. 
1) De uitdagingen bij het opzetten van samenwerkingsmechanismen op alle niveaus van het 
gezondheidssysteem waren enorm, vooral op districtsniveau. Het toezicht op de prevalentie van 
hiv onder tbc-patiënten en vice versa was niet volledig. De administratieve richtlijnen voor de 
organisatie van de opleiding van het personeel waren niet uniform onder het NACP en het herziene 
nationale programma voor tuberculosebestrijding (RNTCP) en vormden vaak een bron van 
conflicten bij de uitvoering van het programma. De bestaande registratie- en rapportagesystemen 
waren niet optimaal. Er was gebrek aan tijd en capaciteit om beleidsrelevant operationeel 
onderzoek uit te voeren onder de programmamedewerkers. 
2) Uitdagingen bij het verminderen van de tbc-last bij mensen met hiv: In alle hiv-test- 
en adviescentra in het hele land werden intensief tbc-gevallenonderzoek (ICF) opgezet met 
gestandaardiseerde registratie en rapportage. Maar de uitvoering varieerde en was suboptimaal 
in staten met een lage hiv-prevalentie. De sputumuitstrijkmicroscopie was destijds nog steeds de 
steunpilaar van de diagnose, ondanks de bekende beperkingen onder mensen met hiv (beperkte 
gevoeligheid, onvermogen om resistentie tegen geneesmiddelen te identificeren). De alom 
geprezen snelle diagnostische test zoals de Xpert MTB/RIF-test was nog steeds niet op grote schaal 
beschikbaar in India. Toentertijd maakte preventieve isoniazidtherapie voor mensen met hiv 
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zonder tbc nog geen deel van het beleid uit. De tbc-besmettingsbeheersing in de gezondheidszorg 
en instellingen waar veel mensen samenkomen was slecht geregeld.
3) Uitdagingen bij het verminderen van de hiv-belasting onder tbc-patiënten: Er waren 
grote verschillen in de implementatie van hiv-testen onder tbc-patiënten vanwege variaties in 
de beschikbaarheid van op hiv testende diensten en vertragingen in de levering van hiv-testkits. 
Het testen op hiv van vermoedelijke tbc-patiënten was toentertijd geen nationaal beleid, 
alhoewel de WGO wel de aanbeveling deed om alle vermoedelijke tbc-patiënten (die vroeger 
tbc-verdachten werden genoemd) te testen en zo te komen tot een vroege opsporing van met 
hiv besmette tbc-patiënten. Terwijl bijna 90% van de met hiv geïnfecteerde tbc-patiënten op dat 
moment preventieve cotrimoxazole therapie ontving, kreeg slechts ongeveer 50% van de met 
hiv geïnfecteerde tbc-patiënten ART-zorg en -ondersteuning. Een van de redenen voor het lage 
aandeel hiv-tbc-patiënten in de ART-zorg was dat niet alle met hiv besmette tbc-patiënten voor 
ART in aanmerking kwamen. India volgde nog steeds de richtlijnen van de WGO uit 2006 en had 
moeite met de goedkeuring van de WGO-richtlijnen voor ART uit 2010 (volgens welke alle met 
hiv geïnfecteerde tbc-patiënten in aanmerking kwamen voor ART, ongeacht het aantal CD4-
cellen) omdat er bezorgdheid bestond over de implicaties voor de beschikbare middelen en de 
toegenomen werklast die een dergelijke strategie met zich mee zou brengen binnen het nationale 
ART-programma. Andere belemmeringen voor de koppeling met ART hielden verband met de 
lange reistijden, afstanden en financiële lasten voor patiënten, aangezien ART-diensten werden 
gecentraliseerd en alleen in bepaalde zorgfaciliteiten werden verleend.
Om de hierboven beschreven uitdagingen aan te pakken en om de zorg voor met hiv 
geïnfecteerde tbc-patiënten in India te verbeteren, werden verschillende operationele 
onderzoeken gepland en uitgevoerd. De drie belangrijkste doelstellingen waren: 
1) Het evalueren van het extra aantal patiënten waarmee de ART-centra te maken zouden krijgen als 
India volgens de WGO-richtlijnen voor ART uit 2010 alle met hiv besmette tbc-patiënten ongeacht 
de CD4-celtelling opnam in het ART-programma; 
2) Het beoordelen van de hiv-prevalentie bij vermoedelijke tbc-patiënten in verschillende settings 
met verschillende niveaus van hiv-infectie en het percentage dat in aanmerking komt voor ART 
overeenkomstig de WGO-richtsnoeren van 2015;
3) Het documenteren van het initiatief voor capaciteitsopbouw op het gebied van operationeel 
onderzoek in India, de ontwikkeling ervan en het effect ervan op het beleid en de praktijk. 
In dit proefschrift beschrijven we zes operationele onderzoeken (waaronder twee 
multicentrische projecten) en de bevindingen waartoe ze hebben geleid en bespreken we 
hun algemene bijdrage aan veranderingen in het beleid en de praktijk en aan de verbetering 
van de gezondheidsresultaten onder met hiv geïnfecteerde tbc-patiënten in India. Hieronder 
volgt een korte samenvatting van wat er in elk hoofdstuk wordt behandeld. 
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DOELSTELLING 1: 
In 2010 breidde de WGO eerder aanbevolen indicaties voor ART uit met alle met hiv 
geïnfecteerde tbc-patiënten, ongeacht de CD4-telling. India beperkte ART echter nog steeds 
tot tbc-patiënten met CD4-celtellingen <350/mm3 of met extrapulmonale tbc. We wilden het 
extra aantal patiënten evalueren dat in de ART-zorg terecht zou komen als India de WGO-
richtlijnen voor met besmette tbc-patiënten uit 2010 zou implementeren. De bevindingen 
van dit onderzoek worden beschreven in hoofdstuk 2. Deze studie toont aan dat negen van 
de tien hiv-tbc-patiënten al in aanmerking kwamen voor ART volgens de richtlijnen van de 
WGO uit 2006 en adviseert dat, als volksgezondheidsbenadering, ART moet worden verstrekt 
aan alle hiv-tbc-patiënten ongeacht de CD4 telling. Na deze studie heeft India het beleid met 
betrekking tot ART voor hiv-tbc-patiënten goedgekeurd. 
DOELSTELLING 2:
De WGO adviseert om personen die voor tuberculosediagnose (vermoedelijke tbc-patiënten) 
worden doorverwezen, te testen op hiv, maar dit was geen gangbaar beleid in India, waar 
de hiv-prevalentie onder vermoedelijke tbc-patiënten nooit was bestudeerd. Om dit 
kennishiaat op te vullen, werd een studie uitgevoerd in twee districten in Zuid-India om de 
hiv-prevalentie onder vermoedelijke tbc-patiënten en de haalbaarheid van provider initiated 
testing (waarbij de hiv-test wordt aangeraden door de zorgverlener in een klinische setting) 
te beoordelen. De bevindingen van deze studies worden gerapporteerd in hoofdstuk 3 en 4. 
Deze studies toonden aan dat de hiv-prevalentie onder vermoedelijke tbc-patiënten net zo 
hoog was als onder tbc-patiënten. 
Gebaseerd op de bevindingen van de studies die in hoofdstuk 3 en 4 worden 
beschreven, werd een nationaal beleidsbesluit genomen om de hiv-test aan te bieden aan 
vermoedelijke tbc-patiënten in deelstaten van India met een hoge hiv-last. Hoe dit het beste 
zou kunnen worden uitgevoerd en gecontroleerd in routinematige zorgkaders in India wist 
men echter niet. Er werd operationeel onderzoek uitgevoerd in de deelstaat Karnataka (Zuid-
India, 64 miljoen inwoners en verantwoordelijk voor 10% van de nationale hiv-last in India) om 
processen te testen en de resultaten en uitdagingen van de hiv-screening van vermoedelijke 
tbc-patiënten binnen de reguliere gezondheidszorg te achterhalen. De bevindingen van dit 
operationele onderzoek worden beschreven in hoofdstuk 5. De processen die in deze studie 
zijn getest, zijn nu onderdeel geworden van de programmarichtlijnen en de praktijk. Een 
innovatief proces met behulp van ‘open access’-technologieën zoals EpiData, Dropbox en 
TeamViewer werden gebruikt om het vastleggen van kwaliteitgerelateerde gegevens in deze 
multicentrische studie te coördineren. Dit model van gegevensvastlegging wordt in detail 
beschreven in hoofdstuk 6.
Terwijl het duidelijk werd dat het testen op hiv van vermoedelijke tbc-patiënten 
van waarde was in settings met een hoge hiv-last in India, was het niet duidelijk of het ook 
van waarde was in situaties met een lage hiv-last. Om deze vraag te beantwoorden werd 
onderzoek verricht in Puducherry. De bevindingen van dit onderzoek worden beschreven in 
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hoofdstuk 7. Dit onderzoek toont aan dat het testen op hiv van vermoedelijke tbc-patiënten 
de moeite waard is, zelfs in lage hiv-settings, vooral bij mensen van 25-54 jaar. 
Hoofdstuk 8 beschrijft de resultaten van een operationeel onderzoek die in de staat 
Karnataka is uitgevoerd om het aandeel van met hiv besmette vermoedelijke tbc-patiënten 
te beoordelen dat in aanmerking komt voor ART volgens de geldende WGO-richtlijnen. Deze 
studie toont aan dat de meeste vermoedelijke tbc-patiënten die met hiv besmet zijn in 
aanmerking komen voor ART en pleit nadrukkelijk voor ART voor deze groep. 
DOELSTELLING 3:
Om de bewijsgaring te katalyseren hebben we de capaciteit van verschillende 
gezondheidsprofessionals in India opgebouwd met behulp van het SORT IT (Structured 
Operational Research Training Initiative) model voor capaciteitsopbouw, ontwikkeld door 
de Internationale Unie tegen Tuberculosis en Longziekte (de Unie) en Artsen Zonder Grenzen 
in samenwerking met het speciale programma voor onderzoek en training op het gebied van 
tropische ziekten van de WGO. Daarnaast werd de verdediger van dit proefschrift begeleid 
in het kader van een Global OR-fellowship-programma van de Unie in 2012. Het Structured 
Operational Research and Training (SORT IT) model en de aanpassingen daarin en het OR-
fellowshipprogramma en de impact hiervan op het beleid en de praktijk zijn beschreven 
in een reeks originele onderzoeksartikelen en gezichtspunten. De meeste papers die in 
dit proefschrift worden beschreven, zijn het resultaat van deze twee initiatieven. In hoofdstuk 
9-12 beschrijven we de evolutie van dit capaciteitsopbouwmodel en de impact ervan op 
het beleid en de praktijk.  
Concluderend kan worden gesteld dat het werk dat in dit proefschrift is vervat, 
aantoont dat operationeel onderzoek een belangrijke rol heeft gespeeld bij het opstellen 
van een nationaal tbc- en hiv-programma in India en dat operationeel onderzoek een 
belangrijke rol heeft gespeeld bij het bepalen van het beleid en het veranderen van de 
praktijk. Verscheidene zeer belangrijke nationale beleidsbesluiten werden genomen op 
basis van bewijsmateriaal dat binnen routinematige programmakaders werd verkregen, 
zoals het besluit om alle met hiv besmette tbc-patiënten in aanmerking te laten komen 
voor ART en het besluit om hiv-tests aan te bieden aan alle vermoedelijke tbc-patiënten in 
India. Operationeel onderzoek werd vergemakkelijkt en werd zeer sterk gekatalyseerd door 
de capaciteitsopbouwende initiatieven die door de Unie werden ontplooid, waaronder 
de training van gezondheidszorgprofessionals in het gebruik van het SORT IT-model en 
het Global OR-Fellowshipprogramma. De studies hebben ook het effect van onderzoek 
aangetoond dat in SORT-IT-cursussen werd uitgevoerd met betrekking tot het beleid en de 
praktijk. De casestudy van het bureau USEA toont aan wat OR-medewerkers kunnen bereiken 
met behulp van de juiste kansen, steun, goed mentorschap en een stimulerende omgeving. 
Als resultaat van deze initiatieven is een grote pool van middelen gecreëerd in India, die 
wordt aangesproken om OR-cursussen op bredere gebieden van ziektebestrijding zowel in 
India als wereldwijd te faciliteren.
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